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“La conoscenza scientifica non gode di un accesso immediato alla realtà di cui parla.  
Non è come aprire gli occhi e constatare che si è fatto giorno.” 
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Preface 
 
 
Cancer affects all the humankind. It is one of the most leading causes of death worldwide, with 
approximately 14.1 million new cases and 8.2 million cancer related death in 2012. This trend is 
projected to rise by about 75% over the next two decades. [World Cancer report 2014]  
About 30% of cancer deaths are due to behavioural and dietary risks. Viral or bacterial infections 
are responsible for up to 20% of cancer deaths, but chronic infections and ageing remain the major 
risk factors. It is clear that cancer is a generic term for a multiplicity of different diseases that can 
affect any part of the body. It arises from normal cells that mutate in tumor cell and grow beyond 
usual boundaries, invading adjoining parts of other organs; the latter process is referred to as 
metastasis. Metastases are the major cause of death from cancer.  
Identification of hexogenous causes, screening protocols, high-risk groups, means of diagnosis, 
and effective therapies vary across tumor types. An understanding of cancer biology behind each of 
them is critical to rationally develop designed target therapy and in order to offer effective 
preventive options. Cancer mortality can be reduced if cases are detected and adequately treated at 
an early stage. For this reason, it is crucial to improve the early diagnosis and develop new 
accessible and affordable screening methods for specific target therapies. Emerging evidences 
demonstrated that there are thousands of point mutations, translocations, amplifications and 
deletions that may contribute to cancer development, and that the mutational range can differ even 
among histopathologically identical tumors. Furthermore, it is becoming clear that many oncogenic 
signalling pathways converge to adapt cancer cell metabolism in order to support their high growth 
rate and their survival. In view of these fundamental discoveries alterations to cellular metabolism 
should be considered a crucial hallmark of cancer. The knowledge of cancer cell metabolism will 
help to design more efficient treatment strategies both to slow down tumor progression and to 
improve the response to therapy, resulting in positive clinical outcomes12.  
Emerging evidences indicate that most of the cancer cells have an increased glycolytic rate and a 
detriment of oxidative phosphorylation to support abnormal cell proliferation; this phenomenon 
is known as aerobic glycolysis or Warburg effect. This switching toward glycolysis implies that 
cancer tissues metabolize approximately tenfold more glucose to lactate in a given time and the 
amount of lactate released from cancer tissues is much more greater than the amount from 
 vii 
normal ones. Therefore, the investigation of the metabolic differences between normal and cancer 
cells is very important in cancer research with great potential impact on clinical applications.  
The aim of this PhD project was to investigate the cellular metabolic alterations at single cell 
level, by monitoring glucose and lactate, in order to provide a better insight in cancer research.  
For this purpose, electrochemical techniques have been applied. The field of electrochemistry is 
in constant progress and can substantially impact on the future of medical devices. Indeed, there are 
already several clinical applications that assert the validity of the electrochemical approach in 
medicine and in medical devices. Ad hoc modified enzyme-based electrode biosensors used as 
probes for Scanning Electrochemical Microscopy (SECM) were employed in this work. 
Advancements in this technology and its applications in the non-invasive study of cellular 
metabolism at single cell level were demonstrated.  
The work is mainly divided in three parts: 
Part I. Designs, Principles and Methods (chapters 1-7). The first part of the thesis provides a 
general overview and introduction about the basic knowledge of the project topic. The main aspects 
about the cellular metabolism and electrochemistry are briefly presented, underlining the 
importance of Warburg effect in cancer research and the potentiality of Scanning Electrochemical 
Microscopy as a new possible approach for clinical application. In this part the specific issue of the 
biosensor manufacturing, which are used in combination with SECM for real-time metabolites 
detection, are addressed. Moreover, the practical protocols for the enzyme-immobilization methods, 
which were optimized in this work, and their full characterization have been deeply described.    
 Part II. Case Studies (chapters 8-11). In this part are reported the main in in vitro studies that 
have been done using the optimized enzyme-based electrode biosensors for metabolic investigation 
on normal and cancer cells. The aim of this second part is not only to show the results obtained 
during this work, but also to demonstrate the great potential of this technique in real medical and 
biological fields.   
Part III. Conclusions and Future Directions (chapter 12). The last chapter concerns a brief 
summary of the obtained results, describing the main advantages and disadvantages of the 
technique. Future technical upgrades to improve the analytical setup are suggested and new 
biological challenges are proposed. 
 
 
 
 
 
 viii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 x 
 
 
 
 
CONTENTS 
 
 
Preface 
 vi 
PART I       PRINCIPLES, DESIGNS, AND METHODS  
1 Cellular Metabolism and Cancer 1 
1.1 Background and Historical Overview of Energy Metabolism 1 
1.1.1 Introduction 1 
1.1.2 Energy 2 
1.1.3 Metabolism  3 
1.1.3.1 Enzymes & Coenzymes (ATP and NAD+/NADH) 3 
1.1.3.2 Catabolism & Anabolism 4 
1.1.4 Energy Processing 4 
1.1.4.1 Oxidative Phosphorylation  5 
1.1.4.2 Glycolysis: Anaerobic and Aerobic 5 
1.2 Altered Metabolism in Cancer  7 
1.2.1 Introduction 7 
1.2.2 Metabolic Adaptations to the Microenvironment (e.g. hypoxia) 8 
1.2.3 Importance of Studying Cancer Metabolism 9 
1.3 Approaches for Targeting Cancer Cell Metabolism 10 
1.3.1 Introduction 11 
1.3.2 Existing Approaches 11 
1.3.2.1 Targeting Glucose 11 
1.3.2.2 Targeting Lactate 11 
1.3.2.3 Targeting Glutamine 12 
1.3.3 Perspectives of Personalized Therapies 12 
 !
2 The Warburg effect: Historical Background and Current Views 15 
2.1 History of the Warburg Effect 15 
2.1.1 Warburg’s Life 15 
2.1.2 From the Earliest Studies to the Actual Warburg Effect 16 
2.2 Translating the Warburg Effect to the Clinic  19 
 xi 
2.2.1 FDG-PET Imaging 19 
  
3 Electrochemistry in Biology and Medicine 23 
3.1 Bioelectrochemistry 23 
3.1.1 History 23 
3.1.2 Main Concepts 24 
3.1.3 Bioelectrochemistry in Medicine 25 
3.1.4 Some Applications 26 
3.2 Main Electrochemical Techniques Employed in this Work 27 
3.2.1 Cyclic Voltammetry 27 
3.2.2 Chronoamperometry 28 
3.2.3 Amperometric i-t curve 29 
3.2.4 Differential Pulse Amperometry 29 
3.2.5 Scanning Electrochemical Microscope 29 
 !
4 Scanning Electrochemical Microscopy 31 
4.1 Introduction and Principles of SECM 31 
4.1.1 Background 31 
4.1.2 Overview on BioSECM Setup 33 
4.1.3 Ultramicroelectrodes (UMEs) 34 
4.1.4 Feedback Mode (Negative & Positive) 36 
4.1.4.1 Approach Curves (ACs) 37 
4.1.5 Collection-Generation Mode (TG/SC and SG/TC modes) 38 
4.2 Applications of SECM 39 
4.2.1 Overview of Some Examples  39 
4.2.2 SECM Imaging 40 
4.3 Biological Systems 41 
4.3.1 Introduction 41 
4.3.2 Experiments on Single Living Cells 42 
4.3.2.1 Monitoring Cellular Redox Balance 43 
4.3.2.2 Monitoring Cellular Respiration 43 
4.3.2.3 Monitoring Cellular Metabolism  44 
 !
5 Enzyme-Based Ultramicroelectrode Biosensors 49 
5.1 Microelectrodes Designs for Enzyme-Based Biosensors 49 
5.1.1 Introduction 49 
5.1.1.1 Antibody-Antigen Interaction 50 
5.1.1.2 Enzymatic Interaction 50 
5.1.2 Biosensors in Medical Diagnostic 50 
 xii 
5.1.3 Crucial Features 52 
5.2 Oxidase-Based Biodetection 53 
5.2.1 Introduction 53 
5.2.1.1 Cofactors 53 
5.2.1.2 Oxidases 53 
5.2.2 Glucose Oxidase (GOx) 54 
5.2.3 Lactate Oxidase (LOx) 55 
5.2.4 Electrode Materials for H2O2 Detection 56 
5.3 Immobilization Methods and Protocols 56 
5.3.1 Introduction 56 
5.3.2 Materials 57 
5.3.3 First technique: Cross-linking  57 
5.3.3.1 Glutaraldehyde (GDA) 58 
5.3.4 Second Technique: Polymer Enzyme Entrapment 60 
5.3.4.1 Poly-o-aminophenol 62 
5.3.4.2 Polypyrrole and Derivates 62 
5.3.5 Third technique: pH Shift-Induced Deposition 63 
5.3.5.1 Electrophoretic Deposition Paints (EDPs) 64 
5.3.6 CuCl2 Nanoparticles 65 
 !
6 Enzyme Ultramicroelectrode Biosensors Features 69 
6.1 Enzyme-Related Biosensors Parameters 69 
6.1.1 UME Biosensors Calibration  69 
6.1.2 Sensitivity and Limit of Detection (LOD) 71 
6.1.3 Response Time 73 
6.1.4 Stability 73 
6.1.5 Reproducibility 75 
6.1.6 Spatial Resolution 76 
6.1.7 AFM Analysis 77 
6.1.8 Effect of Analysis Solutions on Biosensor performance  80 
6.1.9 Other Sensoristic Parameters 81 
6.1.9.1 Biosensors Efficiency 82 
6.1.9.2 Permeability 82 
6.1.9.3 Selectivity 84 
6.1.9.4 Electrode BioFouling 85 
6.2 Kinetics of Enzyme-Based UME Biosensors 85 
6.2.1 Introduction 85 
6.2.2 New Stochastic Model 88 
6.3 Conclusions and Remarks 91 
 xiii 
PART II     CASE STUDIES  
7 In Vitro Cell Culture Models 99 
7.1 Human Mammary Epithelial Cells (MCF10A) 99 
7.1.1 Introduction 99 
7.1.1.1  Ras Oncogene in Human Cancer 100 
7.1.2 In vitro Cancel Model: RasV12 and pBabe MCF10A 100 
7.1.3 MCF10A Growth Media 101 
7.1.4 RasV12 Retroviral Infection 101 
7.1.5 Ras Expression by Western Blot Analysis 102 
7.1.6 Ras Expression by Immunofluorescence Analysis 103 
7.2 Other Models of Human Carcinoma Cell Lines 104 
7.2.1 A549 104 
7.2.2 HeLa 104 
7.2.3 HepG2 105 
 !
8 Investigation of D-Glucose Uptake on Breast Cancer and Normal Cells 107 
8.1 Drop-cast Pt 10µm GOx-based UME Biosensors 107 
8.1.1 Approach Curves 107 
8.1.2 Glucose Uptake Profiles 110 
8.2 Electropolymerized Pt 10µm GOx-based UME Biosensors 113 
8.2.1 Approach Curves 113 
8.2.2 Glucose Uptake Profiles 113 
8.2.3 SECM Imaging 114 
8.3 Effects of Solutions Analysis on Cellular Metabolism 116 
8.3.1 Cell Counting 116 
8.3.2 Cell Cycle by Flow Cytometry (FACs) 118 
 !
9 Study of Cell Topographical Contribution 121 
9.1 Voltage-Switching Mode on SECM 121 
9.1.1 Introduction 121 
9.1.2 Operational Strategy on Glucose Uptake Analysis 122 
9.1.2.1 Voltage Switching Mode  123 
9.1.2.2 Healthy and Metabolically Stopped Cells 124 
9.1.3 Biofouling Correction 125 
9.2 Redox Mediators 126 
9.2.1 Redox Mediator Selection 126 
9.2.1.1 Hexaammineruthenium(III)Chloride – [Ru(NH3)6]Cl3 127 
9.2.2 MTT Test  128 
 xiv 
10 Investigation of L-Lactate Release on Breast Cancer and Normal Cells 133 
10.1 Drop-cast Pt 10µm LOx-based UME Biosensors 133 
10.1.1 Introduction 133 
10.1.2 Comparison with the EnzyChrom BioAssay Kit 134 
10.1.3 Approach Curves 135 
10.1.4 Lactate Release Profiles 136 
10.2 Application #1:   
 
Kinetic Study on Oncogene Expression Monitoring Lactate Release  
139 
10.2.1 Experimental Strategy 139 
10.2.2 Preliminary Results 141 
10.2.3 Immunofluorescence 142 
10.3 Application #2:  
 
Efficacy of Anticancer Drugs on Lactate Release Inhibition 
143 
10.3.1 Overview on the Analyzed Drugs  143 
10.3.2 Results and Discussion 145 
10.4 Application #3:  
 
Monitoring L-Lactate Level on Other Cancer Cell Lines 
147 
10.4.1 HeLa and HepG2 cells Lactate Production 147 
 !
11 Investigation on Breast Cancer Human Cells Oxygen Consumption 149 
11.1 Flexible Potential Pulse Profile 149 
11.1.1 Introduction 149 
11.1.2 Technique 150 
11.2 O2 uptake upon Drugs Administration on MCF10A pBabe cells 151 
11.2.1 Results on pBabe O2 Consumption 151 
11.3 O2 uptake upon Drugs Administration on MCF10A RasV12 cells 153 
11.3.1 Results on RasV12 O2 Consumption 153 
11.4 Final Remarks 155 
11.4.1 RasV12 and pBabe Cells Topography 155 
11.4.2 Conclusions 155 
 
  
PART III   CONCLUSIONS & FUTURE DIRECTIONS  
12 Concluding Remarks 161 
12.1 Main Advantages and Disadvantages 161 
12.1.1 Innovation of our System 161 
 xv 
12.1.2 Limitations 164 
12.2 Future Tasks 164 
12.2.1 Technology upgrades: Dual Electrode and in vivo Application 164 
12.2.2 Biological Claims 165 
  
 !
APPENDIX  
A.1 AFM Setup and Technique Principles 171 
A.2 Protocol for Cell Counting Using Trypan Blue 172 
A.3 Cell Cycle Analysis by Flow Cytometry (FACs) 173 
A.4 Cell Viability MTT Test 174 
A.5 Protocol for EnzyChrom L-lactate BioAssay Kit System  174 
A.6 Microinjection Setup 175 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


 PART I            
 
 
 
PRINCIPLES, DESIGNS, AND METHODS 
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 1 
Chapter 1 
Cellular Metabolism and Cancer 
 
 
Abstract 
Cellular metabolism is a set of biochemical reactions that take place within the cell. These reactions are turned on and 
off or sped up and slowed down according to the cell's immediate needs. At any given time, the numerous pathways 
involved in building up and breaking down cellular components are balanced in a coordinated mode. Reactions 
involved in energy production are coordinated as well and unbalance in energetic metabolism is typical of many disease 
states, including cancer. Emerging evidences indicate that cancer cells have an increased glycolytic rate and a detriment 
of oxidative phosphorylation to support abnormal proliferation.  
 
Key words Energy, Metabolism, Oxidative Phosphorylation, Aerobic Glycolysis, Cancer, Target Therapies 
 
 
 
1.1  Background and Historical Overview of Energy Metabolism  
1.1.1 Introduction 
 
 
 
 
 
 
 
 
 
“In 1986 explorers set out to reach the North Pole by dogsled from Ellesmere 
Island at latitude 83° north. Their objective was to make the journey without 
resupply along the way and thus to re-enact the famous expedition by Admiral 
Robert Peary in 1909. Each of the modern explorers’ sleds was huge – 16 feet 
(5 m) long, and loaded with 1400 pounds (630 kg) of material. Of the two-
thirds of a ton on each sled, most was food for people and dogs. Most of the 
weight of the food, moreover, was required to meet energy needs […] Two 
people’s needs for energy were to be met by the supplies on each sled. The 
sleds needed to be pulled and pushed over numerous ice ridges 20-60 feet 
high on the way to the pole. Even during the progress over level ice fields, the 
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way for the sleds’ runners had to be cleared by the explorers often. A trek to 
the North Pole by dogsled would be immeasurably easier if there were no 
need for food energy for people and dogs. The need for energy is equally 
consequential in the natural world. Every species regularly risk their lives to 
obtain energy, or die because they did not obtain enough. Why do we need 
energy?” (Cit. Animal Physiology, 3rd Ed. 2012)1. 
 
1.1.2 Energy 
 
All-living organisms are very organized systems. The assembling molecules 
that compose living organisms are routinely exchanged with molecules 
present in the external environment, and their assembly is more important 
than the molecule structures. The second law of thermodynamics, one of the 
greatest achievements of intellectual history, provides a basic interpretation 
about the nature of organized systems1.  
“The second law of thermodynamics states that no process is possible in 
which the sole result is the absorption of heat from a reservoir and its 
complete conversion into work.” It can be also expressed in terms of entropy. 
“The entropy of an isolated system increases in the course of a spontaneous 
change: ΔStot > 0”2.  
One of its corollaries is the following: order can be conserved or enhanced 
within the same system only if the latter is not isolated. Therefore, once 
energy gets inside a system, order has to be conserved or even increased.  
A broader and simpler definition, often used in biology, is that energy is the 
capacity to maintain order1. Without an energy input, the blood might not 
flow through the circulatory system and the molecule assemblies within cells 
and tissues would become more disorganized and full of structural defects, 
losing their biochemical and functional properties. Furthermore, ionic species 
and electrons would be randomly distributed across the cell membrane, and 
this electrical randomization might highly interfere with the main cellular 
functionalities. The living organisms would even die if they loose their inner 
organization, because order is essential for life1. 
The external chemical energy, such as food and sun, are used by all organisms 
to carry out the three essential needs: i) biosynthesis of macromolecules 
(carbohydrates, proteins, lipids and nucleic acids), ii) maintenance of the all 
processes for supporting the integrity of the main physical functionalities in 
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living systems (e.g. circulation, respiration, nervous coordination, gut motility 
and tissue repair), and iii) generation of external work, seen as the 
mechanical forces by which living organisms act on the surrounding 
environment (e.g. muscle contraction)1. 
 
1.1.3 Metabolism 
 
 
 
 
 
 
 
 
 
 
ATP 
 
 
 
 
 
 
 
 
NAD+/NADH 
 
 
 
 
 
 
 
 
Cell metabolism is the entirety of the biochemical reactions through which 
every living cell acquires energy, channels it into useful functions, and 
dissipates it1. All these thousand reactions are part of particular metabolic 
pathways that are organized by the presence of enzymes and coenzymes3. 
Enzymes act as selective catalysts, decreasing the activation energies, 
accelerating the reaction rate and enhancing the specificity of the metabolic 
pathways, to digest and synthesize any kind of molecule present in living 
systems3. They also turn the reactions in response to environmental changes. 
Most of the enzymes are proteins that may employ organic and inorganic 
cofactors to assist the catalysis. Coenzymes act as temporary group-transfer 
intermediates, carrying different functional groups between the reactions. One 
central coenzyme is adenosine triphosphate (ATP), composed by an adenine 
ring, a ribose sugar and three-phosphate groups3.  
Usually, a cellular system is far away from the equilibrium and it has a 
relative high Gibbs free Energy, hence, it is able to do work4. The energy 
(ΔG°) released by cleaving a phosphate unit from ATP to ADP at standard 
condition is equal to -30.5 kJ/mol = -7.3 kcal/mol5. Living cells maintain the 
ATP concentration fivefold higher than the ADP one. This displacement from 
equilibrium means that the cell has a large amount of energy stored and that 
can come out from the hydrolysis of ATP4.  
Other important coenzymes are nicotinamide adenine dinucleotide (NAD+) 
and nicotinamide adenine dinucleotide phosphate (NADP+) that act as 
hydrogen acceptors. They mainly act in combination with dehydrogenase, 
enzymes that oxidase substrates and reduce NAD+ into NADH (see catabolic 
reactions) or NADP+ into NADPH form (see anabolic reactions). As a 
consequence they are employed as hydrogen donors for any kind of 
reductases6. Metabolism consists of two subsets of processes: catabolic 
processes that break down large organic molecules and oxidize food 
molecules to provide energy, and anabolic processes that use the energy 
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Catabolism 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anabolism 
 
 
 
 
 
 
 
 
released by catabolism to synthesize complex molecules that include all the 
constituents of living cells, such as membranes, chromosomes, enzymes, 
antibodies, neurotransmitters and hormones1. ATP acts as a bridge between 
catabolism and anabolism3. 
Catabolism involves three basic stages4: stage 1. Digestion of large organic 
molecules (proteins, polysaccharides and lipids) into their smaller components 
(amino acids, simple sugars as glucose, fatty acids and glycerol), this happen 
outside the cells. Stage 2. Absorption of these components by cells and their 
conversion in acetyl coenzyme A (acetyl CoA) accompanied by a production 
of a limited amount of ATP and NADH. The major breakdown route is 
glycolysis, an 11-steps enzymatic reaction, where sugars, such as glucose and 
fructose, are converted into pyruvate and some molecules of ATP are 
generated. Stage 3. Into the mitochondria Acetyl CoA is oxidised by using 
oxygen as electron acceptor into water and carbon dioxide, through the Krebs 
Cycle, also known as the tricarboxylic acid cycle (TCA cycle). The electrons, 
coming out from TCA cycle, flux through electron transport chain, creating a 
proton gradient that drives the ATP synthesis, which is stored by reducing the 
coenzyme NAD+ into NADH.  
Anabolism involves three basic stages as well4: stage 1. Precursors production 
(e.g. amino acids, monosaccharides and nucleotides). Stage 2. Activation of 
these precursors into reactive forms using the high chemical energy released 
when ATP is turned in ADP. Stage 3. Assembly of these precursors into 
complex molecules (e.g. peptides, proteins, polysaccharides, lipids and 
nucleic acids). Different enzymatic pathways constitute these processes and 
are often allocated in different part of the cell, but at the same time they are in 
some way intimately linked to allow organisms to grow and reproduce, 
maintain their structures and respond to the external stimuli.  
 
1.1.4 Energy 
Processing 
 
 
 
 
A quantitative understanding of the rules, which regulate this kind of energy 
conversion, is crucial for a qualitative and quantitative characterization of the 
relative advantages linked to the different modes of energy processing. 
Metabolic rate is the way in which all living organisms transform nutrients 
into both thermal energy and biological work, required for providing life.  
These transformations involve the interconversion of two forms of chemical 
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OxPhos 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glycolysis 
 
 
 
 
 
 
energy: the redox potential difference between the donor and acceptor couples 
in the electron transport chain and the ADP phosphorylation potential7. The 
coupling between the electron transfer chain and ADP phosphorylation could 
involve electrons, in case of oxidative phosphorylation (OxPhos), and 
chemical groups in glycolytic processes.  
“OxPhos is a mode of energy processing where cell carries out the ADP 
phosphorylation during the oxygen-dependent transmission of electrons down 
the respiratory chain. This reaction produces NADH, which fuels OxPhos to 
maximize ATP production with minimal production of lactate”7.  
The respiratory chain or electron transfer chain consists of four multimeric 
enzyme complexes (Complex I, II, III, IV) positioned along the mitochondrial 
membrane. Electrons from the reduced forms of NADH and FADH enter in 
the chain and reduce complex I and II, respectively. Coenzyme Q10 (or 
ubiquinone) is an electron carrier present in the inner mitochondrial 
membrane that accepts an electron from either complex I or II and donates it 
to complex III. Cytochrome c, another electron carrier, present in the 
mitochondrial intermembrane space, accepts an electron from complex III and 
donates it to complex IV. The latter one donates electrons to molecular 
oxygen, which results in the formation of water. During the electron flow, 
complex I, III and IV pump the protons from the mitochondrial internal 
matrix toward the intermembrane space generating an electrochemical 
gradient across the mitochondrial inner membrane. Finally complex V 
employs the energy of the electrochemical gradient to generate ATP from 
ADP8. This pathway is a high efficient way of releasing energy; 38 molecules 
of ATP for every glucose molecule used, in comparison to alternative 
fermentation processes such as anaerobic glycolysis, which produces only 2 
molecules of ATP per glucose9. 
In general glycolysis (lysis of glucose) first requires the conversion of glucose 
to pyruvate and then to lactate. In most cells glycolysis is inhibited by the 
presence of oxygen, which allows the mitochondria to oxide pyruvate to water 
and carbon dioxide. This inhibition was termed the ‘Pasteur effect’, after 
Louis Pasteur demonstrated that glucose flux was reduced by O2 presence in 
fermentative organisms. He first observed that aerating yeasted broth causes 
yeast cell growth to increase, while conversely, fermentation rate decreases10.  
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Anaerobic 
Glycolysis 
 
 
 
 
 
“Anaerobic glycolysis (glycolysis suppressed by oxygen) describes another 
mode of energy generation when oxygen is supply limited. In this process, 
cells direct the pyruvate generated by glycolysis away from the mitochondrial 
OxPhos pathway. This is achieved by generating lactate. This process does 
not occur within the mitochondria, but in the liquid protoplasm of the cell. 
This generation of lactate allows glycolysis to continue, but results in a 
lowered ATP production rate. The rate-limiting factors for net ATP 
production are the efficiencies of glucose delivery and lactate removal”7. 
The amount of ATP production is small, around 5% of total ATP generated 
from OxPhos, but at the same time the speed of the reaction is very fast, 
around 100 times more than OxPhos.  
 
 
 
Figure 1. Glucose Metabolism in living cells. Blood delivers glucose and oxygen (on 
haemoglobin) to tissue, where they reach cells by diffusion. Glucose is taken up inside the 
cell by the use of specific transporters, and it is metabolized in pyruvate by glycolysis, 
generating 2 ATP per glucose. In the presence of O2, the pyruvate enters in the mitochondria 
and is oxidized to CO2 and H2O, generating 36 ATP per glucose. In absence of O2, pyruvate 
is reduced to lactate, which is exported out of the cell. Both processes produce H+, which 
cause acidification of the extracellular space (adapted from Nature Reviews Cancer, 2004)9.  
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Aerobic 
Glycolysis 
 
“Aerobic glycolysis (glycolysis not suppressed by oxygen) refers to the 
conversion of glucose to pyruvate and then to lactate regardless of whether 
oxygen is present or not. This process is also localized in the liquid 
cytoplasm. This property is shared by normal proliferative tissue”7. 
It is worth to underline that the terms aerobic and anaerobic glycolysis are 
imprecise, although they have been used extensively in the literature. Both 
type of glycolysis follow substantially the same pathway, the terms aerobic 
and anaerobic are used to emphasize the difference with respect to their 
dependence on oxygen. 
All cells use both pathways to generate energy, but they preferentially rely on 
OxPhos, switching to glycolysis only in case of oxygen depletion. Marathon 
runners and other athletes benefit from this shift. However, increased aerobic 
glycolysis is uniquely observed in most cancer cells7. 
 
1.2  Altered Metabolism in Cancer 
1.2.1 Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The link between altered metabolism and cancer is not new: since the early 
period of cancer biology research, many metabolic alterations as a common 
feature of tumor tissues were described11 (e.g. the Warburg Effect; discussed 
in Chapter 2). Over the past 25 years, the progress in cancer research has 
revealed that the main characteristics of cancer cells phenotypes resulted from 
numerous and heterogeneous mutations, which alter critical regulatory 
processes (signalling pathways). Now it is becoming clear that many 
oncogenic signalling pathways converge to adapt cancer cell metabolism in 
order to support their high growth rate and their survival in the tumor 
environment. DNA sequencing data suggest that the mutations in genes 
controlling metabolism and leading to carcinogenesis are even more 
numerous and heterogeneous than previously thought. Some of these 
metabolic alterations seem to be strongly linked to malignant tumors11. In 
view of these fundamental discoveries, alterations to cellular metabolism 
should be considered a crucial hallmark of cancer.  
Clinical data about tumor metabolic profiles will be highly required in future 
to determine which metabolic alterations are prevalent in specific types of 
cancer. This knowledge will help to design more efficient treatment strategies 
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both to slow down tumor progression and to improve the response to therapy, 
resulting in positive clinical outcomes12. 
 
1.2.2 Metabolic 
Adaptations 
to the Micro-
environment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition to the genetic changes, the altered tumor microenvironment has a 
major role in altering many metabolic signalling pathways of cancer cells. 
Tumors vasculature is structurally and functionally abnormal; there is spatial 
and temporal heterogeneity in oxygenation, pH and unusual concentrations of 
glucose and many other metabolites, such as glutamine and lactate 11.  
These extreme stressful conditions cause several cellular feedbacks that might 
contribute to alter the metabolic phenotype of tumors and can influence their 
progression11. For example normal cells commonly do not take up nutrients 
from the environment unless stimulated by grow factors, while cancer cell 
overcome this growth factor dependence by acquiring genetic mutations and 
functionally reprogramming metabolic signalling pathways to meet needs 
during the process of tumor progression12. 
Many of these transformed cells achieve the majority of the required energy 
from aerobic glycolysis, converting most of the incoming glucose to lactate 
rather than metabolize it by OxPhos into the mitochondria11. Despite ATP 
production by glycolysis can be more rapid than by OxPhos, it is much less 
efficient in terms of ATP generated per unit of glucose consumed. This shift 
explains why cancer cells show an abnormal high rate of glucose uptake in 
order to meet the three crucial requirements: i) larger energy production, ii) 
sufficient macromolecular biosynthesis, seen as building blocks synthesis and 
iii) maintenance of redox balance11. The reasons why cancer cells prefer a less 
efficient metabolism, at least in term of ATP productions, is still unknown and 
an argument of discussion. However, two possible explanations are suggested: 
i) a consequence of mitochondrial damages or ii) an adaptive response to 
tumor hypoxia. Nowadays there are many studies that belie the first 
hypothesis, rather demonstrating the key role of mitochondria function in 
tumors13. Concerning these studies, it was observed that even in glycolytic 
tumors OxPhos is not completely shut down. It is clear from clinical data, as 
well as in vitro and in vivo experimental studies, that cancer cells are capable 
of using alternative fuel sources, such as amino acids, fatty acids and even 
lactate to proliferate, leaving glucose for energy production11.  
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Hypoxia Regarding the second hypothesis, even if it was observed that hypoxia might 
influence several molecular pathways involved in cellular metabolism, many 
cancer cells appear to use glycolytic metabolism even before exposure to 
hypoxic conditions. For example, lung cancer cells exhibit aerobic glycolysis 
even when they are exposed to oxygen during cancer progression14. Thus, 
although tumor hypoxia is clearly important for many aspects of cancer 
biology, causing an increase of the glycolytic capacity and a decrease of the 
mitochondrial respiration, the available evidence suggests that it is a late-
occurring event that may not be a major contributor in the glycolytic 
switching of cancer cells. Only extreme hypoxia ([O2] < 0.02%) causes 
endoplasmic reticulum (ER) stress and activates the unfolding protein 
response, which provides a further adaptive mechanism that allows cancer 
cells to survive under these adverse metabolic conditions11-14. 
 
1.2.3 Importance 
of Studying 
Cancer 
Metabolism 
 
For all these reasons it is worth to underline that the relationship between 
tumor microenvironment and cancer cell metabolism is not a simple cause-
and-effect one, in which metabolism is a self-correcting system where a set of 
enzymes enables the cell to respond to changing bioenergetics demands. 
Instead, there is a complex, dynamic and regulated relationship between 
metabolism and cancer microenvironment14.  
Metabolites concentrations are governed by their supply by the vasculature 
and the demand of the tissue. Metabolism is programmed every time to meet 
the requirements for cell proliferation or to meet the specific needs of each 
differentiated tissue; as a consequence these changes have profound effect on 
the environment surrounding the cells. Metabolic adaptations are needed to 
give cells the ability to drive cell nutrient uptake and coordinately to regulate 
metabolic pathways in order to support an altered proliferation14. 
This aspect emphasizes the importance of studying metabolic regulation both 
in vitro and in vivo using appropriate model systems, as well as the need for 
more sophisticated measurements of cell metabolism and microenvironment 
of human tumors. Efforts to model human metabolism and select rational 
target combinations are on going. Complementing these models with a more 
complete understanding of biochemical pathway in cancer cells will help to 
determine the best targets for possible intervention13. 
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1.3  Approaches for Targeting Cancer Cell  Metabolism 
1.3.1 Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As before mentioned, cancer cells exhibit alterations of a number of metabolic 
pathways in order to support their high rates of proliferation. This provides 
the cells with the ability to continually generate ATP, to support cell survival, 
and crucial biosynthetic precursors for cell growth. Since most of cancer cells 
are dependent on these metabolic changes, altered pathways represent a very 
attractive therapeutic target13. The common assumption that a therapeutic 
window obtained by using particular anticancer drugs, which can act on these 
alterations, is due to the more rapid proliferation of cancer cells is not 
necessarily true. Cancer cells have a cell cycle time that is estimated to be 30-
40 hours and may proliferate as frequently as every 10 hours under optimal 
tissue culture conditions, but most cancer cells proliferate more slowly in 
vivo13. Metabolism is a complex network of reactions and there are several 
different metabolic programmes among all cancer cells; every type of cancer 
follows a specific altered route. This may explain why chemotherapies acting 
on metabolism are efficacious in some cancers but not in others, despite the 
need for all cancer cell to synthesize the same macromolecules13. It is worth to 
underline that the same pathways are required in normal proliferating cells. 
Therefore, a better understanding of how metabolism is altered in specific 
cancer will provide an insight into which enzymes represent promising 
targets, in order to identify drugs that can successfully act on these metabolic 
enzymes and have minimal effects on normal tissues11. Recent advances in 
metabolite profiling methodologies are providing new tools for understanding 
molecular fluxes through pathways; furthermore, an increased utilization of 
techniques, such as 13C Magnetic Resonance Spectroscopy, can allow direct 
visualization of how metabolism is altered in patients, as a result of new 
therapies. This technique include the use of dynamic nuclear polarization to 
generate hyperpolarized 13C-labbeled metabolites to track metabolism in 
tumors in vivo15; it will be especially important for studying how cell 
metabolism is influenced by the tumor microenvironment and for selecting the 
right drugs targeting cancer cell metabolism for specific patients.   
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1.3.2 Existing 
Approaches 
 
 
 
 
 
 
 
 
 
Targeting 
Glucose 
 
 
 
 
 
 
 
 
Targeting 
Lactate 
 
 
 
 
 
 
 
 
 
 
 
Structural information and basic knowledge of some target enzyme already 
exist for many potential drugs. However, improve this number and improve 
the human metabolism models with the relative biochemistry comprehension 
remains a challenge for the development of successful therapies13. Despite a 
renewed interest in exploring metabolic enzymes as targets for cancer therapy, 
very few molecules are currently used in clinical trials. However, new 
compounds showed encouraging results in preclinical models and they will 
probably enter in clinical trials in the next few years12. These new drugs have 
the potential to limit the macromolecular synthesis needed for cell growth, 
limiting pathways important for supplying nutrients and preventing an 
adaptive response to cell stress.  
For example, one of the principal nutrients for living cells is glucose. Many of 
the studies exploring glucose utilization of cancer cells illustrate the need for 
pharmacological agents to inhibit glucose uptake. Various agents have been 
shown to block glucose uptake by cancer cells, but so far a specific glucose 
transport inhibitors has not reported. It may be difficult to act directly on the 
main glucose transporter (GLUT1) without having a negative effect on normal 
tissues; however, there are some passive glucose transporters that are not 
expressed in normal cells, but are present at high level in cancer cells, that 
could be used as possible therapeutic targets13. 
 
Lactate is excreted mainly from cancer cells11. The inhibition of lactate 
production and lactate transport out of the cells are two strategies that directly 
target the Warburg effect (see Chapter 2) in cancer: 1) The family of 
monocarboxylate transporters (MCTs) comprises the major proteins that are 
responsible for lactate export in cancer cells: targeting those transporters using 
small molecules inhibits the proliferation of cells that rely on aerobic 
glycolysis. 2) Lactate dehydrogenase (LDH) is the enzyme that interconverts 
pyruvate and NADH into lactate and NAD+, respectively. When LDHA, the 
form of LDH that is over-expressed in many cancer cells and absent in normal 
ones, is knocked down, cancer cell proliferation is severely impaired both in 
vitro and in vivo. Furthermore, LDHA inhibitors slow the growth of tumors in 
mice and can induce tumor regressions, indicating that this enzyme, as well as 
MCTs inhibitors, are promising therapeutic targets for cancer therapy13. 
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Targeting 
Glutamine 
 
 
 
In some cancer cells glutamine was observed to be an alternative fuel source. 
This one is the major source of nitrogen for nucleotide and amino acid 
synthesis, but many cancer cells metabolize an excess of glutamine to supply 
their high level of proliferation. Glutamine also has an important role in 
replenishing intermediates of the Krebs Cycle that are depleted by 
biosynthetic reactions. It was observed that the growth of cancer cells could 
be selectively inhibited by targeting the activity of: i) glutaminase, the enzyme 
that convert glutamine to glutamate and is required for proliferating, and ii) α-
ketoglutarate, which is found to be at abnormal levels in some human cancers. 
It was demonstrated that blocking glutamine entry could slow in particular the 
growth of fibroblasts and breast cancer cells13.  
 
1.3.4 Perspectives 
of 
Personalized 
Therapies  
 
Personalized cancer therapy is a treatment strategy founded on the idea that 
each person is a unique metabolic entity. Personalization of metabolic 
therapies as broad-based cancer treatment strategy will require a fine-tuning 
process based on the understanding of individual human physiology12. 
Despite the promises of personalized metabolism cancer treatments, it is 
worth to underline that many of these drugs acting on metabolism are not 
already available in clinic or have produced disappointing results when tested 
in clinical trials, indicating that there are many challenges that must be 
addressed to advance this field13-16. 
The most recent personalized approach is based on the sequencing of tumor 
DNA, which reveals the specific genomic alterations that have implications 
for cancer treatment. Genetic factors of the patients can be associated with 
drug metabolism, drug response and drug toxicity. Cancer molecular profiles, 
cancer sites and other patient characteristics are potentially used for 
determining optimum individualized therapy options12-16. 
However, many experts agree that personalized cancer medicine, defined here 
as a treatment based on the molecular characteristics of a cancer from an 
individual patient, has great potential in the therapy of many cancers.  
Therefore, it is crucial to have new imaging technologies and approaches that 
can measure the specific metabolic response upon drug administration in 
order to guide the selection of the most beneficial treatment12. 
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Chapter 2 
The Warburg Effect:  Historical Background and 
Current Views 
 
 
Abstract 
Otto Warburg pioneered quantitative investigations of cancer cell metabolism and respiration. Warburg and co-
workers showed in 1920s that cancer cells are characterized by metabolic alterations, involving a shift from the 
generation of ATP through oxidative phosphorilation to ATP generation through glycolysis, even under normal oxygen 
concentration. This phenomenon today is known as aerobic glycolysis or Warburg effect. This switching toward 
glycolysis implies that cancer tissue metabolizes approximately ten fold more glucose to lactate in a given time than 
normal tissue and the amount of lactate released from cancer tissues becomes two orders of magnitude greater than the 
amount of normal ones. 
 
Key words Warburg Effect, Glucose, Lactate, Positron Emission Tomography (PET) 
 
 
2.1  History of the Warburg Effect 
2.1.1. Warburg’s 
Life 
 
Otto Heinrich Warburg was one of the first true interdisciplinary scientists1. 
Warburg, spent his entire career in Germany, completed his Chemistry Ph.D. 
dissertation in 1906 and he concluded his studies in Medicine in 1911, obtaining 
a Habilitation in physiology in 1913. One year later he was appointed head of 
the Department on Physiology of the Kaiser Wilhelm Institute (which later 
became the Max Planck Institute) for Biology. During the First World War, 
Warburg volunteered for military service, but he was convinced from Albert 
Einstein to fulfil his patriotic duty doing research rather than serving at the front. 
In 1931 he was awarded the Nobel Prize in Physiology or Medicine for his 
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discovery of the respiratory chain enzyme cytochrome c oxidase. Warburg was 
allowed to continue working during the Nazi period plausibly because he was 
working on cancer, a disease that Hitler morbidly feared. He enjoyed working 
with his hands until his death in 1970, at the age of 87 years. Warburg was a firm 
believer in quantitative methods in biology research; he is famous principally 
for his quantitative physical-chemical approaches to investigate the rapid 
growth of cancer cells, however, he was also the first one to use thin tissue slices 
for physiology research, he improved manometric techniques to measure 
changes in pressure accompanying cell and tissue processes, and he is credited as 
the inventor of the single-beam spectrophotometer1.  
 
2.1.2 From the 
Earliest 
Studies to 
the Actual 
Warburg 
Effect   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In his early studies on sea urchin eggs, Warburg observed a rapid increase in O2 
consumption and a subsequent rapid cell division upon fertilization, hence he 
postulated that cancer tissues might also take up more O2 than normal tissue1-2a. 
To address this hypothesis, Warburg used his improved manometric techniqu2b 
to measure O2 and glucose consumption in thin tissue slices, measuring also the 
CO2 emission, which is equivalent to lactate production1. 
 
CH3CHOHCOOH + HCO3
- → CH3CHOHCOO
- + H2O + CO2 
 
Warburg and co-workers discovered that Flexner-Jobling rat liver carcinoma 
does not take up more O2, but that, even in the presence of O2, such tissue 
produces lactate. This indicates that in tumor cells most of the pyruvate is 
directed away from mitochondria to produce lactate through the action of the 
lactate dehydrogenase enzyme (LDH), bypassing the pyruvate utilization in the 
Krebs Cycle in order to generate ATP to meet the cell’s energy demands1. 
Lactate production, for normal cells, is typically restricted to anaerobic 
conditions when oxygen levels are low, however, cancer cells preferentially 
direct glucose towards lactate production even when oxygen is plentiful3.  
This phenomenon is called aerobic gycolysis or, from his discoverer, the 
Warburg Effect 4. 
This glycolytic production of ATP under aerobic conditions was found to be a 
characteristic of most cancer cells and, in addition, the most glycolytic tumor 
cells were also found to be the most aggressive ones4-5. Furthermore, Warburg 
and co-workers determined how O2 affects this aerobic glycolysis, defining a 
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molar ratio, known as the Meyerhof quotient that takes into account the amount 
of O2 required to convert one glucose molecule to lactate under aerobic and 
anaerobic conditions1-5. They observed that the quotient is more or less 
equivalent for both cancer and normal tissues, meaning that the O2 consumption 
of cancer tissues should be the same as that of normal ones1. Since the increased 
production of lactate by cancer cells is not nullified by higher O2 consumption, 
and lactate is widely recognized as an indicator of respiratory insufficiency in 
biological systems, Warburg was strongly convinced that the respiration must be 
altered in cancer tissues. He also assumed that aerobic glycolysis was a universal 
property of cancer cells due to the defects in mitochondrial respiration and he 
suggested that cancer might be caused by impaired mitochondrial metabolism1.  
In contrast to these findings, recent studies have demonstrated that tumor 
mitochondria are fairly functional regarding the respiration and ATP synthesis. 
They show normal respiratory control ratios and normal oxidation abilities 
owning to the respiratory substrates. Warburg himself misinterpreted his own 
early observations. In fact, his in vitro findings show that, in the same time 
interval normal and cancer cells metabolize glucose in different ways: 
 
Normal cell metabolize 1 molecule of glucose → 36 molecules of ATP 
Cancer cell (in presence of O2) metabolize:  
1 molecule of glucose → 36 molecules of ATP +  
10 molecule of glucose → 20 molecules of lactate = 20 molecules of ATP 
Tot: 11 molecule of glucose → 56 molecules of ATP + 20 molecules of lactate 
Cancer cell (in absence of O2) metabolize  
Tot: 13 molecule of glucose → 26 molecules of ATP + 26 molecules of lactate 
 
These data are in agreement with the proper functioning of mitochondria6.  
Moreover, in recent past, many studies on cancer cells have documented 
preferably oncogenic nuclear and mitochondrial DNA mutations in proteins 
involved in respiration, rather than mitochondrial defects4. Hence, in a critical 
analysis of Warburg’s theory, Sidney Weinhouse concluded: ‘‘no substantial 
evidence has been found that would indicate a respiratory defect, either in the 
machinery of electron transport, or in the coupling of respiration with ATP 
formation, or in the unique presence or absence of mitochondrial enzymes or 
cofactors involved in electron transport”7. 
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Nowadays, the Warburg effect is generally used to explain the alterations in 
signalling pathways that govern glucose uptake and lactate release, which are 
also involved in the regulation of mitochondrial activity. Independently of 
mitochondrial defects or damages, most cancer cells do display high rate of 
glycolysis, aerobic or anaerobic, and this property is now widely used for tumors 
visualisation and monitoring in clinic. 
 
Recently the field of cancer biology, pharmacology and clinical oncology have 
seen a rapid increase of new technologies that allow the study of genes and 
proteins expression from cell extracts and from intact cells in culture8. However, 
it is necessary to study and investigate on cancer cells in their physiological 
environmental without altering and stressing them9.  
 
 
 
 
Figure 1. Schematic representation of the main differences among oxidative phosphorylation, 
anaerobic glycolysis and aerobic glycolysis, the last also called the Warburg effect. Warburg 
observed that cancer cells tend to convert most glucose to lactate regardless of the presence of 
O2. Differently normal cells in presence of O2, channel the pyruvate into the mitochondria, where 
it is oxidized to CO2 and H2O, generating ATP to meet cell’s energy demands. This upregulation 
of lactate release allows glycolysis to continue, by the cycling of NADH back to NAD+, but 
results in a decreased ATP production10. 
 
 19 
2.2  Translating the Warburg Effect to the Clinic  
2.2.1 FDG-PET 
Imaging 
The employment the Warburg effect in combination with tracers was found a 
good strategy to develop a non-invasive imaging tool8.  
Currently one of the most powerful diagnostic technology widely used in 
oncology for cancer detection is FDG-PET (2-deoxy-2-[18F]fluoro-D-glucose 
positron emission tomography) that can be used both for staging the tumor and 
for monitoring the therapy response. This is a highly sensitive, non-invasive 
molecular imaging technique, introduced for the first time 50 years ago in 
hospitals, that exploits cancer cells’ preferential utilization of aerobic glycolysis, 
instead of oxidative phosphorylation10. This technique is based on the 
employment of a molecule similar to glucose, fluorodeoxyglucose (FDG) as a 
radiolabelled tracer, which is injected in non-pharmacological doses into the 
patient. Fluorine-18 (18F) is a fluorine radioisotope that is an important source of 
positrons (it decays to stable Oxygen-18) and it is characterized by a short half-
life (around 20 - 30 minutes)8. 
This molecule after the in vivo injection is taken up and trapped in cells by 
phosphorylation, but is not subject to further metabolism and once 
phosphorylated is unable to diffuse out of cells. Therefore, it accumulates at a 
rate proportional to glucose utilization, providing a way to assess glucose uptake 
rates in cells. Tumor tissues, which take up more glucose than surrounding 
tissues, can be non-invasively visualized in cancer patients by FDG-PET. 18F 
undergoes positive beta decay, a type of radioactive decay in which a proton 
inside the atomic nucleus is transformed into a neutron emitting a positron and 
electron neutrino [18F → 18O + e+ + νe]. The emitted positron collides and 
annihilates with a nearby electron releasing two gamma rays with an 
approximately 180-degree relative angle8. The PET scanning machinery detects 
these two gamma rays and using computational software calculates the 3D origin 
inside the body. The positron annihilation event could recognize areas of 
abnormal metabolic behaviour of cancer in vivo and it can localize the precise 
site of cancer cells, with a spatial resolution around 0.5 cm (Figure 2).  
Clinical PET is approved for many investigations, such as staging of cancers, 
differentiation between residual tumor and scarring, diagnosis of suspected 
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recurrences, monitoring response to therapy, prognosis and radiotherapy 
treatment planning in many typologies of cancers (not all)11. Despite its 
widespread use in clinical oncology, some cancers remain difficult to be imaged 
by FDG-PET, such as hepatocellular carcinoma, prostate and pancreatic cancer. 
It is possible that these tumor types do not exhibit the Warburg effect metabolic 
phenotype or there is a low density of cancer cells in these kinds of tumor 
tissues11. 
PET scanning can also monitor uptake of other nutrients (e.g. glutamine and 
glutamate). However, the uptake of those nutrients is not specific to cancer cells. 
A better understanding of how increased nutrient uptake supports different stages 
of tumor progression will be important to exploit metabolism for therapeutic 
benefit12. 
 
 
                               
    
Figure 2. Small-animal FDG-PET imaging. MicroPET imaging of two mice 1h after intravenous 
injection of FDG. Increased fluorescent signal indicates area of FDG accumulation that marks 
high glucose consumption. On the left, the arrows indicate the spleen and the heart that often 
scores positive due to high energetic demand of the myocardium, the circle indicates the thymus 
whereas the saturation of the signal in the bladder is due to the high physiological urinary 
excretion of the tracer. On the right, the arrow indicates an empty bladder and the circles mark a 
thymoma and infiltrated lymph nodes. Notably, the spatial resolution of FDG-PET analysis are 
does not reach more than half cm. 
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Chapter 3 
Electrochemistry in Biology and Medicine  
 
 
Abstract 
“The topic of this chapter is devoted to the subject matter of electrochemistry in the service of, and how it relates to, 
medicine. In the on going process of “globalization,” we are witnessing not only the tendency of commercial unification 
of the globe, but also the rapidly emerging interdisciplinarity among different scientific and technical disciplines, as well. 
The word "nanotechnology" is the underlying thread in this technological melding process.  
With the advent of relativity and quantum mechanics in the early part of the twentieth century, and the development of 
molecular biology in the second half, it is now accepted that mathematics, physics, chemistry, and biology constitute 
different parts of the same broader scientific discipline. Such interdependency, and subsequent confluence, of different 
disciplines are becoming one of the hallmarks of the twenty-first century.” (Cit. The Electrochemical Society Interface) 
Electrochemistry and its constant progress can substantially impact on the future of medical devices. Indeed there are 
several applications that assert the validity of the electrochemical power in medicine and in medical devices, beyond its 
well-known employment in analytical applications.  
 
Key words Electrochemistry, Biology, Medical Applications, Electrochemical Techniques 
 
 
3.1  Bioelectrochemistry 
3.1.1 History The beginnings of electrochemical study in biological systems are closely 
related to the names of Luigi Galvani (1737-1798), who first coined the term 
animal electricity to describe that the impetus behind muscle movements was 
electrical energy carried by a fluid, and Alessandro Volta (1745-1827), which, 
embracing this new field, discovered the electrochemical series and the law of 
the electromotive force (efm) of the galvanic cell. In view of these findings 
Volta invented the voltaic pile, an early electric battery1.  
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The first modern work in this field is attributed to Julius Bernstein (1839-
1917), a German physiologist, who is recognized for his correct “membrane 
hypothesis”. This hypothesis describes the resting and action potentials of 
nerve and muscle as diffusion potentials of K+ ions through the cell membrane, 
from cytoplasm (high concentration) to extracellular solution (low 
concentration). He pioneered the experimentations of nerve conduction of 
impulses and transmission of the information in the nervous system.  
Among all the prominent electrochemists who have contributed to this field, 
John Bockris (1923-2013) has to be mentioned, for his findings regarding 
biological substances with characteristics of semiconductors.  
They are just some leading examples, but the domain of physical 
electrochemistry, a discipline having broad applications to many areas of 
technology, has grown considerably over the past century. Thanks to many 
contributors all over the world, electrochemistry gained a solid theoretical 
background, it is supported by a strong technological development, and it 
maintains close connections with medical disciplines2. 
 
3.1.2 Main 
Concepts 
 
 
 
 
 
 
 
 
Scientists use electrochemistry for studying oxidation (loss of electrons) and 
reduction (gain of electrons) processes that a material of single molecules 
undergoes during an electrical stimulation. These observations give 
information about the concentrations, the kinetics, the reaction mechanisms and 
the chemical status of the species under investigation, both free in the solution 
or linked onto the electrode surface. Electrochemical techniques can be used 
for several purposes and offer a different perspective in respect to spectroscopy 
or other optical techniques.  
In an electrochemical experiment one can mainly measure the potential (E), the 
current (i), the charge (Q) and the time (t).  
In most electrochemical techniques a three-electrodes configuration is used 
comprising: the working electrode (WE), the reference electrode (RE) and the 
counter (or auxiliary) electrode (CE). All of them are immersed in an 
electrolytic solution that permits the electrical conduction between the 
electrodes and connected to a potentiostat. The latter can control the working 
potentials and measure the resulting current or the opposite, such as in 
potentiometric techniques3.  
 25 
It is worth to underline that the working electrode, where the electrochemical 
reactions take place, is usually made of an inert material, such as platinum or 
glassy carbon. The first one is suitable because it does not corrode, it catalyses 
proton reduction, useful for H2O2 detection, with a high intrinsic exchange 
current density, and it has an excellent reproducibility of the potential. Instead, 
the second one combines glassy and ceramic properties with those of graphite; 
it has a high temperature resistance, low density, low electrical and thermal 
resistance, extreme resistance to chemical attack and it is impermeable to gases 
and liquids3. 
The potential of WE is measured versus the reference. Typical reference 
electrodes are saturated calomel electrode [SCE; E = +0.241 V vs SHE] and 
silver/silver chloride [Ag/AgCl 3M KCl; E = +0.197 V vs SHE], which have 
stable and well-known electrode potentials3. Since potential is a measurement 
of the voltages difference between two electrodes, the fixed value of the 
reference electrode provides a way to control the potential of the working 
electrode. The counter electrode is typically a wire of an inert material, such as 
platinum. Various electrochemical techniques, including cyclic voltammetry, 
chrono-amperometry and pulsed approaches can be performed through the 
combined measurement of potential, current, charge and time.  
In paragraph 3.2 brief descriptions and relevant parameters of the 
electrochemical techniques employed in the present work are provided. 
 
3.1.3 Bioelectro-
chemistry in 
Medicine 
Medicine is an applied field of science that has always exploited technologies 
and techniques coming from several areas of interest. Innovations in the 
synthesis of new medications, improvement on diagnosis technologies and on 
mechanical implantations, among many of others, improve human health and 
increase the life span of individuals4.  
The goal of medicine is to treat patients in the best way possible, and it requires 
a great deal of research from a wide variety of fields. As medical treatments 
and technologies evolve, electrochemistry is playing an increasingly role in the 
development of medical treatments and devices. Blood, saliva, urine and other 
biological fluids, which contain ions, hormones, enzymes, proteins etc., act as 
electrolytes, providing a conductive environment that promotes the 
electrochemical exchange of electrons. This exchange of electrons between the 
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redox active molecules within the cells is at the base of the functioning of 
many vital biological processes. The real-time monitoring of these processes, 
using electrochemical devices, gives a great and unique improvement on the 
comprehension of the involved mechanisms5. 
 
3.1.4 Some 
Applications 
Nowadays many electrochemical devices and methods, listed below, are used 
in biology and in medicine4-6, and new approaches are under study.  ! Electrochemical biosensors are used for monitoring cellular dynamics, 
such as cellular redox environment, exocytosis and cellular adhesion. For 
these purposes many devices have been developed, such as interdigitated 
electrode arrays, nanopillars, nano- or micro-electrodes and microchip 
based biological systems, which are important for the development of 
point-of-care testing, monitoring and for medical research and drug 
development. Among these cancer biomarker sensors, glucose sensors and 
DNA arrays for multiple gene analysis have to be mentioned. ! Electrode/self-assembled monolayer (SAM) has been widely used to 
explore fundamental aspects of electron exchange mechanism between 
electrodes and redox active biomolecules, such as proteins. These devices, 
with nanoscopically tunable physical properties, provide a unique powerful 
system for fundamental electron transfer studies and nanotechnological 
applications. ! Surface modification of implants, namely surface bio-functionalization or 
coating of different substrates for medical devices such as drug eluting 
stents, orthopaedic and dental implants (e.g. bone-binding metals). ! Applications of nanoelectrochemistry and nanoelectrodes for studying the 
transport of electrons through the cell membrane, the ion channels, the 
transporters in pore-suspending membranes and neurotransmitters. ! Nanowire-based electronic devices emerged as a powerful platform for 
ultra-sensitive, rapid, direct electrical detection and quantification of 
biological and chemical species in solution. These devices can be used for 
sensing proteins, DNA, viruses and cells, down to the ultimate level of a 
single molecule. These ones are promising building blocks for nanoscale 
bioelectronic interfaces with living cells and tissues, since they have the 
potential to form strongly coupled interfaces with cell membrane.  
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! DNA microarrays offer a high throughput method for simultaneously 
evaluating large numbers of genes. Electrochemical-based DNA arrays 
provide many advantages over radioisotope- or fluorophore-based 
detection systems. ! Electrochemical Scanning Probe techniques used in the investigation of 
immobilized biomolecules: due to the high spatial resolution of the 
Scanning Electrochemical Microscope (SECM), this technology has been 
suggested as a readout method for locally immobilized, micro-meter-sized 
biological recognition elements, including a variety of DNA arrays with 
different formats and detection modes. ! Employment of biomimetic membranes for studying the functions of single 
proteins, such as ions channels and transporters, and smaller lipophilic 
biomolecules. They are common in pharmaceuticals, as well as for the 
investigation of phase stability, protein-membrane interactions, and 
membrane processes. They are also useful to design membrane-based 
biosensors and devices for assaying membrane-based processes.  
 
3.2  Main Electrochemical Techniques Employed in this Work 
3.2.1 Cyclic 
Voltammetry 
Cyclic Voltammetry (CV) is one of the most common electroanalytical 
techniques for its ability to characterize electrochemical systems with high 
sensitivity. CV experiments could be used for several applications, such as 
determination of the reversible or non-reversible behaviour of the redox couple, 
the number of electrons involved, the formal potentials, the rate constants, the 
formation constants, the reaction mechanisms and the diffusion coefficient of 
the redox species. In CV experiment, the potential is ramped linearly versus 
time. The scan starts from an initial potential toward either high potential or 
low potential depending on the initial polarity, and then it scans back. The 
resulting current is recorded as function of potential. The following diagram 
shows a typical potential waveform applied as function of time. One can run 
single-cycle or multi-cycle CV; the repetition of the potential waveform can 
also allow the build-up of reaction products at the electrode surface, such as 
electropolymerization of a polymer7. 
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3.2.2 Chrono-
Amperometry 
Chronoamperometry (CA) is another common electroanalytical technique, 
useful for determining diffusion coefficients and for investigating kinetics and 
mechanisms of the reactions. In CA, the potential is stepped from an initial 
potential toward either high E or low E depending on the initial polarity, and 
then it will step back. The following diagram shows the potential waveform 
applied in time. The CA response requires a supporting electrolyte to insure the 
absence of ion migration and no other competitive reactions. From CA other 
useful value can be calculated: the active area of the electrode, which in many 
cases does not correspond to the geometric area, due to the roughness factor 
that increases the active area of the electrode. In multiple CA, slow 
heterogeneous electron transfers exhibit a strong dependence on time width of 
the potential step and slow diffusion of the species at the electrode can affect 
the shape of the resulting current if the pulse width is not enough large7. 
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3.2.3 Amperometric 
i-t Curve 
In Amperometric i-t Curve, a constant potential is applied and the current, also 
due to the faradaic processes occurring at the electrode, is recorded in function 
of time. The following diagram shows the potential waveform applied as the 
function of time and the sample scheme7.  
 
 
3.2.4 Differential 
Pulse 
Amperometry 
 
In Differential Pulse Amperometry (DPA), two flexible potential pulses are 
applied after a cleaning step, which could be used for electrode conditioning 
The current is sampled at the end of each pulse step and is recorded as a 
function of time. This mode is very useful to monitor two different redox 
species in solution. In the experimental set up employed in the present work, 
only the difference of the two current samples in consecutive step is displayed, 
but the two single data sets are available. The time step is chosen in order to 
have a good compromise between i) longer sample intervals with better signal 
averages and decreased noises and ii) less species depletion due to the tip 
reaction for shorter time steps. The following diagram shows the potential 
waveform applied as function of time and the current sampling scheme7.  
 
 
3.2.5 Scanning 
Electro-
chemical 
Microscope 
The scanning electrochemical microscope (SECM) can examine chemistry at 
high resolution in proximity of interfaces. It is based on the use of small 
electrodes scanned in close proximity of a surface with high precision. SECM 
can be employed to obtain chemical reactivity images of surfaces and also in 
quantitative measurements of reaction rates. For the all details see Chapter 4. 
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Chapter 4 
Scanning Electrochemical Microscopy 
 
 
Abstract 
Scanning Electrochemical Microscopy (SECM) is a scanning probe technique that employs micro-nano electrode probes, 
which is moved in the proximity of the sample surface recording an amperometric signal. The signals obtained depend on 
the topography and reactivity of the sample. The SECM response is sensitive to the presence of conducting materials and 
electroactive species. For this reason, SECM is useful for high-resolution imaging of heterogeneous and homogeneous 
reactions on surfaces, in order to characterize them and measure the local kinetics. In this chapter an historical 
background, the basic principles and the instrumentation used to obtain images and surface reaction-kinetic information 
are briefly discussed. This technique has been proved to be useful for a broad range of interdisciplinary applications, such 
as biological system, sensors and probing reactions at the liquid/liquid surface.  
 
Key words Scanning Electrochemical Microscopy, UMEs, Approach Curves, SECM Imaging, Biological System 
 
 
4.1  Introduction and Principles of SECM 
4.1.1 Background Scanning Electrochemical Microscopy (SECM) is a member of the Scanning 
Probe Microscope, which appeared for the first time in 19891. SECM employs 
an ultramicroelectrode (UME) as probe to scan in close proximity to a surface 
of interest. The electrochemical response provides quantitative information of 
interfacial physiochemical processes2. SECM UMEs, with a radius a in the 
range of tens of nm to 25 µm,3 can induce chemical changes and collect 
electrochemical information while approaching or scanning the substrate. The 
probe is held by a support and it can be moved in an electrolytic solution in 
close vicinity of interfaces. For this reason SECM is a powerful tool for 
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studying structures and processes in micrometer- and submicrometer-sized 
system. It can be used to analyze electron, ion and molecule transfer at solid 
substrates of different types (e.g. glass, metal, polymer and biological 
material),, liquid/liquid or liquid/air interfaces (e.g. mercury, oil) to investigate 
their nature and properties4. The movement of the tip is actuated by using a 
three dimensional positioner composed by three stepper motors for coarse 
positioning and a XYZ piezo block for finer displacement. This set up gives a 
spatial resolution of 1.6 nm and allows a maximum travelling distance of 2.5 
cm2-4. The precise positioning capability (micrometer and nanometer scale) 
makes SECM a high spatial resolution imaging technique and offers the 
possibility to precisely reposition the tip. An interesting advantage of the 
repositioning is the capability of mapping and recording the topography of the 
surface and subsequently scanning the same area at constant height in order to 
obtain the contributions of both surface topography and reactivity to the probe 
current. Moreover, the nature of the probe and the way it interacts with the 
substrate determine which information can be obtained during SECM 
experiment. There are several operational modes of SECM2-4: i) the tip 
generation-substrate collection mode (TG/SC), where the probe is used to 
electrochemically generate a reactant that is detected at the substrate, which acts 
as a second working electrode; ii) the substrate generation-tip collection mode 
(SG/TC), where the species are generated at the substrate and the tip collects 
current changes. This method is useful in studies of reactions and concentration 
profiles at substrate surfaces; iii) the feedback mode, the most used operational 
mode, where the probe current due to a redox mediator in solution is monitored. 
In this case the UME current is perturbed by the presence of the substrate: it can 
be a negative feedback if there is a hindering of the electroactive species 
diffusion to the probe, causing a decrease current in respect to the one recorded 
in bulk or a positive feedback where the current, upon oxidation or reduction at 
the UME, is regenerated to the original state by the substrate (paragraph 4.1.4 
and 4.1.5). Nowadays, there are several applications of SECM in biophysical 
and biochemical fields, even at single cell and subcellular levels. Those include 
measurements of flows through membranes5, investigation of local transport 
properties and kinetic parameters of intracellular enzymatic redox processes6, 
which are essential for cellular respiration, metabolism and protein synthesis.  
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4.1.2 Overview on 
BioSECM 
Setup 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference & 
Counter 
Electrodes 
Software 
For this work, SECM measurements were performed using an experimental 
setup coupling a 910B SECM (CH Instruments Inc., Austin, TX) and a Nikon 
ECLIPSE 200 inverted microscope. The position system of 910B CHInstrument 
was removed from the original stage and mounted on the plate of the inverted 
microscope. The modifications for the optical/electrochemical microscope 
coupling were accomplished in house in our workshop. This setup is very 
helpful to assist the UME movement along the axis during approach, scan 
curves and imaging, in order to minimize the opportunities of UME damaging. 
Furthermore, the optical microscope is used to assess the morphology of the 
substrate, in our case, living cells and the scan area. The positioning system is 
controlled by a computer, which is used also for data acquisition. Figure 1 
shows the entire apparatus.  
A bipotentiostat controls the potential (range ±10 V) of the tip and/or the 
substrate versus the reference electrode and it is able of measuring a broad 
range of current responses (range ±10A): with sensitivity from pA (or even sub-
pA) currents to much higher currents, recorded at macroscopic substrates4. The 
BioSECM apparatus instrument is mounted on a vibration-free table inside a 
Faraday cage to isolate it from environmental vibrations and electromagnetic 
noise. This kind of insulation is fundamental for high-resolution (nm-scale) and 
low-current measurements (pA and sub-pA).  
The experiments were carried out in a 3.5 cm Petri dish, usually used for cell 
cultures, located on the inverted microscope plate holder and constituting the 
electrochemical cell by itself. The SECM probes (from CHI) are 10 µm Pt 
ultra-microelectrodes with RG = 10 (see paragraph 4.1.3). The tips were 
cleaned prior to use with alumina (0.05 mm) or diamond paper and sonicated 
for some minutes in a bath sonicator. The cell (Petri dish containing electrolytic 
solution and used for the cell culturing) was also equipped with a platinum wire 
as a counter electrode and an Ag/AgCl (3M KCl) as a reference electrode. In 
this work, all the potentials are referred to the Ag/AgCl (3M KCl).  
The CHI900 software allows extensive experimental control and analysis of 
acquired data, but for data elaborations, computation of integrals and statistics 
OriginPro7.5 was utilized. The post processing of the bi-dimensional images 
was performed using the software “MIRA”, written by Prof. G. Wittstock7. 
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Figure 1. BioSECM Setup. A) SECM is mounted on the stage of a Nikon ECLIPSE 200 
Inverted Microscope, on a vibration-free table inside a Faraday cage. B) Picture of the 
BioSECM apparatus. C) Part of the Scanning Electrochemical Microscope Components. 
Stepper motors and 3D piezo positioner (blue square) control the movement of the probe: 10 
µm Pt UME (D), that act as WE. In the electrochemical cell (3.5cm ∅ Petri dish) are allocated 
also the CE and the RE (Counter and Reference electrodes). 
 
4.1.3 Ultramicro-
electrodes 
(UMEs) 
 
 
 
 
One of the fundamental part of the instrumentation is the probe, a micrometer-
sized UME sharpened to allow closer approach to the substrate surface4.  
The probe is 10 µm Pt wire sealed in a glass capillary under vacuum and 
connected with silver epoxy to a larger copper or silver wire to permit the 
contact with the potentiostat. The two important features of the UME geometry 
are: the radius of the conductive core -a- and the total tip radius (also 
comprehensive of the glass support thickness) -r-4. In order to use an electrode 
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Advantages 
as SECM probe the dimensionless parameter RG, equal to r/a, has to be enough 
small: typical UME used in this work has an RG of 10 (Figure 2b)2. 
Once the electrode is immersed in a solution containing a redox mediator (R), at 
concentration c, and a supporting electrolyte, which decreases the solution 
resistance and insures that the transport of R to the electrode occurs by 
diffusion, a proper potential can be applied. Consequently, if the electrode is 
positioned in bulk solution (the probe is far away from the substrate, that means 
at distance greater than several active UME diameters) the R species is reduced 
or oxidised at the electrode, resulting in a current flow (Figure 2a).  
Figure 2c displays a typical UME voltammogram at scan rate of 10 mV/s. The 
current, under these conditions, is driven by hemispherical diffusion of the 
redox mediator to the electrode surface and it reaches a steady state controlled 
also by the rate of mass transfer of R. For a conductive disk electrode of radius 
a in a insulating support (like our probe), the diffusion-controlled current under 
the steady state has been evaluated by the method of the Bessel expansion and 
is expressed by: 
  iT,∞= 4nFc*Da 
 
where D is the diffusion coefficient of the redox mediator, F is the Faraday 
constant (96485 s⋅A/mol) and n is the number of the electrons transferred during 
the reaction. ∞ means the bulk situation with a long distance between the probe 
and the substrate9.  
 
The use of ultramicroelectrodes offers several advantages: first of all, because 
the flux of the species to the small electrode disk is quite large by diffusion2, the 
current is immune to convective effects, and also independent from the radius 
of the insulating support. UME reaches steady state in a relatively short time, in 
our case fractions of a second, and, as a consequence, SECM scanning probe 
can be treated as a steady-state system. Moreover, due to the small currents that 
characterize the SECM experiments with ultramicroelectrode working 
electrodes (generally from nA to pA), the ohmic potential drops in solution and 
the charging current in double-layer are negligible2. Finally, thanks to their very 
small size, they allow experiments in microscopic domains, dimensions of the 
same order of living cell systems (typical cell dimensions: 20 ÷ 100 µm). 
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Figure 2. a) Electrode behaviour in bulk solution: the redox mediator reaches the tip by 
hemispherical diffusion. b) Frontal outline of the tip of a 10µm Pt UME. c) Typical cyclic 
voltammogram for a 10µm Pt UME in PBS (pH 7.4) containing 1mM of FcMeOH.  
E = 0÷0.4 V versus Ag/AgCl 3M KCl. Scan rate = 10 mV/s. 
 
4.1.4 Feedback 
Mode 
 
 
 
 
 
Negative 
Feedback 
 
 
 
 
 
 
Positive 
Feedback 
 
 
 
 
 
 
 
 
 
In a feedback-mode SECM experiment the tip UME is placed in a solution 
containing an oxidized (or reduced) form of a redox mediator and is moved 
along z-axis, since it reaches the proximity of the substrate. Once applied a 
potential, the reduction or oxidation of the mediator at the tip surface produces a 
steady-state current (iT,∞). The recorded approaching current changes when the 
electrode is close enough to the substrate, depending on its characteristics: if the 
substrate is an insulating material, like a piece of glass or a plastic Petri dish, 
the diffusion of the redox mediator at the electrode surface is hindered and the 
current decreases in respect to iT,∞. The closer the tip gets to the substrate, the 
smaller iT becomes2 (iT is the probe current recorded during the measurement). 
In an ideal system, when the distance between the substrate and the UME 
approaches zero, even the recorded current is zero. This mechanism is called 
negative feedback (Figure 3b).  
When the substrate is an electrically conductive material, like a gold or a 
platinum electrode, the diffusion of the redox mediator to the probe is still 
hindered by the substrate, but there is also the regeneration of the redox centre. 
This species generated at the substrate diffuses to the tip and leads to an 
increase of current compared to iT,∞
2. This mechanism is called positive 
feedback (Figure 3a). When the distance between the substrate and the tip 
approaches zero, iT becomes very high owing to the electron-tunnelling regime2.  
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Approach 
Curves (ACs) 
 
 
 
 
Steady-state current-distance curves are called approach curves (ACs) (Figure 
3), since the probe is moved along the z direction through the solution. The plot 
is reported in dimensionless form by plotting IT  = iT /iT,∞ versus L = d/a. By 
fitting these experimental current-distance curves to theoretical equations it is 
mandatory to determine the zero separation point (L = 0), which in turn allows 
one to establish the distance scale essential for any quantitative SECM 
measurement. Analytical expressions were numerically calculated by Mirkin 
and Bard in function of several RG values10. The following theoretical equation 
fits within 1% the experimental current-distance curves for conductive 
substrates, over L interval from 0.04 to 10 and RG values between 1.1 to 10: 
 
 
 
where L = d/a and k1, k2, k3, and k4 are parameters listed in Table 1. While, for 
an insulating substrate, the accuracy of the following equation is around 1% for 
L ≥ 2 when RG = 1.11 and L ≥ 0.2 for any other RG values present in Table 2: 
 
 
 
Table 1. RG dependence on k1, k2, k3, and k4 for ACs under hindered diffusion control4. 
RG k1 k2 k3 k4 % Error Validity Range 
1002 0.13219 3.37167 0.8218 -2.34719 <1% 0.3-20 
100 0.27997 3.05419 0.68612 -2.7596 <1% 0.4-20 
50.9 0.30512 2.6208 0.66724 -2.6698 <1% 0.4-20 
20.1 0.35541 2.02259 0.62832 -2.55622 <1% 0.4-20 
15.2 0.37377 1.85113 0.61385 -2.49554 <1% 0.4-20 
10.2 0.40472 1.60185 0.58819 -2.37294 <1% 0.4-20 
8.13 0.42676 1.46081 0.56874 -2.28548 <1% 0.4-20 
5.09 0.48678 1.17706 0.51241 -2.07873 <1% 0.4-20 
3.04 0.60478 0.80683 0.39569 -1.89455 <0.2% 0.2-20 
2.03 0.76179 0.60983 0.23866 -2.03267 <0.15% 0.2-20 
1.51 0.90404 0.42761 0.09743 -3.23064 <0.7% 0.2-20 
1.11 -1.46539 0.27293 2.45648 8.995E-7 <1% 2-20 
 
Table 2. RG dependence on k1, k2, k3, and k4 for ACs under positive feedback control4. 
RG k1 k2 k3 k4 % Error Validity Range 
1002 0.7314 0.77957 0.26298 -1.29077 <0.2% 0.1-200 
10.2 0.72627 0.76651 0.26015 -1.41332 <0.3% 0.1-200 
5.1 0.72035 0.75128 0.26651 -1.62091 <0.5% 0.1-20 
1.51 0.63349 0.67476 0.36509 -1.42897 <0.2% 0.1-200 
10 0.68 0.78377 0.3315 -1.0672 <0.7% 0.05-20 
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Since approach curves involve only dimensionless variables, they do not 
depend upon the concetration or diffusion coefficient of the redox mediator. 
The AC shapes depend upon RG, since the sheath around the conductive part of 
the electrode blocks the diffusion of the redox mediator as well. Therefore, it 
might be difficult to fit approach curves obtained with coated UMEs, such 
enzyme-based biosensor (Chapter 5), because the real value of “a” is unknown. 
 
 
 
Figure 3. Schematic representation of the probe movement along z axis toward a conductor 
material (a) and an insulating material (b). Experimental (dots) and theoretical (dashed lines) 
approach curves for a pure positive (grey) and negative (black) feedback obtained using 10µm 
Pt UMEs with a RG = 10. The measurements were performed in PBS (pH 7.4) containing 1mM 
of FcMeOH. E = + 0.3 V versus Ag/AgCl 3M KCl.  
 
4.1.5 Collection – 
Generation 
Mode 
 
 
TG/SC mode 
 
 
As we have already mentioned above, there are two possible modes for this 
typology. In the tip generation/substrate collection mode (TG/SC) the tip is held 
at a potential where an electroactive species is generated; the latter one diffuses 
across the tip/substrate gap to reach the substrate surface where the applied 
potential it is different, and the species will react and be collected in function of 
current generated. A TG/SC experiment includes measurements of both tip and 
substrate currents. In most cases the substrate is considerably larger than the tip, 
so that the collection efficiency (isubstrate/iT) is essentially 1 (100%) for a stable 
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SG/TC mode 
tip generated species. If the species reacts during its transit from tip to substrate 
isubstrate/iT becomes smaller, and its change with the separation d allows the 
determination of the rate constant of homogeneous reaction. These dynamic 
changes can be recorded as a function of time. 
The alternative mode is the substrate generation-tip collection (SG/TC) mode. 
In this case at the tip is measured the current due to a product of the reaction 
that occurs at the substrate. For example a scan in z direction can monitor the 
concentration profile in the diffusion layer generated by a macroscopic 
substrate, and ideally the tip should not perturb the diffusion layer at the 
substrate. While a scan along x or y can identify the parts of the sample in 
which the reaction takes place or occurs at higher rate. This mode is very useful 
for monitoring corrosion, enzymatic reactions and other heterogeneous 
processes that happen at the substrate surface. In this thesis this mode was used 
to detect at the probe living cell metabolism. 
 
4.2  Applications of SECM 
4.2.1 Overview of 
Some 
Examples 
This section illustrates a wide range of applications of SECM that have 
appeared during these last years. Below, we give an overview and some 
examples that might help to put the technique in perspective before the detailed 
treatments of few of them.  
(a) Imaging: by scanning the tip in x-y plane and measuring current changes, 
one can obtain both the topographical of conductive and insulating substrates. 
Of particular interest is the use of SECM to perform “chemical imaging” 
observing differences in reaction rates at different locations on the surface. This 
mode is very useful in studying biological materials (e.g. enzymes sites), and 
other surfaces (see paragraph 4.2.2)2a.  
(b) UME shape characterization: by recording voltammogram and approach 
curves one can identify recessed tips or tips with shape different than a disk2b.  
(c) Homogeneous and heterogeneous kinetics measurements: by measuring an 
approach curve or voltammogram with the tip close to a substrate, one can 
investigate the electron transfer reactions rates at the electrode surface. 
Moreover, rate reaction constants of tip-generated species, as they diffuse 
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between tip and conducting substrate, can be determined from steady-state 
feedback current or TG/SC experiments or by transient measurements2c.  
(d) Biological systems: there have been a number of applications of SECM to 
biological systems. These include imaging of living cells or tissues, studies of 
enzymatic reactions and investigation of transports of species through skin2d.  
(e) Reactions that occur on liquid/liquid interfaces, through membranes and 
thin films: by employing locally several electrochemical methods one can study 
ion and electron transfer processes at the interface, the permeability of a 
membrane and the thickness of a film2e. 
(f) Reactions that occur at insulating and semiconductor surfaces: by following 
the current over time one can monitor rates of surface reactions, such as 
dissolution, adsorption and surface diffusion2f.  
(g) Due to its ability to position the tip with high spatial resolution in three 
dimensions, SECM can be also used to probe electrochemistry in very small 
volumes of solution (3 ÷ 20 µL), and in thin liquid layers2g. 
(h) Fabrication; it is proved that SECM can be used also to carry out metal 
deposition, metal and semiconductor etching, local polymerization and other 
surface modification procedures with high spatial resolution2h. 
 
4.2.2 SECM 
Imaging 
 
 
A three-dimensional SECM image could be obtained in two ways: while the tip 
is scanned in the x-y plane, in the first method, called constant height mode, the 
UME is fixed along the z axis and the current changes are measured in function 
of the UME location (x,y,i). In the second case, called constant current mode, 
the current is fixed and the UME-substrate distance changes, necessary to keep 
the value constant, are measured in function of the probe location (x,y,z)2a.  
The resolution of such images is largely governed by the UME radius, a, and 
the distance between the probe and the sample, d. Smaller UME size and lower 
UME-sample operational distances increase the resolution of the image. The 
constant current mode is tricky to perform, because small electrodes are very 
delicate, and there might be irregularities in the sample surface, or a tilt of the 
substrate that can cause a “tip crash” during scanning11. While, in constant 
height mode, it is useful to keep the UME at a known distance from the sample 
in order to avoid any kind of damages.  
Probe Approach Curve mode allows the electric probe to approach the surface 
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of the substrate, and it might be useful for studying surface processes as well. 
The step size is automatically adjusted to permit fast surface approach for larger 
distances (by using stepper motors), and for finer z-control movements over 
short distances a vertical piezo positioner is used. The current can be 
automatically stopped at a fixed percentage (we usually use ± 25%) of the 
steady-state current in order to avoid the probe touching the surface. 
Probe Scan Curve mode controls the probe movement along x, y, and z 
direction, while the probe and substrate potentials are controlled and currents 
are measured. The rate of the UME movement has to be chosen in order to 
permit the reaction to take place at the electrode in steady state during scanning. 
By using this mode, we are able to measure flows through membranes and 
investigate local transport properties and kinetic parameters of intracellular 
enzymatic redox processes, such as for cellular respiration and metabolism. 
SECM, such as STM and AFM, routinely offer µm resolution images of surface 
structures in bulk electrolyte solutions; however, SECM remains unique 
because, beside topography, it provides also images of local chemical and 
electrochemical reactivity of surface features. Since its response is also related 
to the rates of the heterogeneous reactions at the substrate. In particular, it is 
useful in identifying and understanding functional aspects of several substrate 
structures, such as membranes, polymers, leaves, films and biological systems. 
 
4.3  Biological Systems 
4.3.1 Introduction 
 
The last two decades have seen the development of several SECM-based 
approaches in order to i) study the charge transfer reactions in biological 
systems, such as immobilized enzymes12 and processes referred to whole 
cells13,14, ii) map cellular redox activities6,15,16 and cellular metabolism17-19, and 
iii) image topography of biological specimens or biomolecules20,21.  
The two main advantages that make SECM suitable for investigating biological 
system are: (1) the measurements may be carried out in buffered solutions or 
also directly in cell culture medium, a preferred environment for most 
biological samples; (2) SECM is a SPM working in no contact mode, thus the 
interference with the sample is much lower in respect to other SPM techniques, 
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such as AFM or STM (Figure 4). The next paragraph presents just few 
biological SECM applications, selected from a broader range, mainly related on 
investigation of living cells. 
 
4.3.2 Experiments 
on Single 
Living Cells  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The use of SECM to study living cells offers several unique opportunities 
owing to the wide range of analytes that may be detected by the suitable choice 
of the UME. The technique is not invasive, sensitive, quantitative and capable 
of a good temporal and spatial resolution2d. The two main types of experiments 
conducted on living cells by SECM are generation/collection and amperometric 
feedback mode measurements4. Both of them involve the UME positioning in 
the proximity of the sample. By using approaches curves, the electrode is 
positioned at a known distance (d) from the plastic bottom Petri dish, on which 
living cells were cultured at low density to permit the imaging of single cells 
without interferences from neighbouring ones. The approach curve on plastic 
dish gives a negative feedback because the UME, which is used to oxidize (or 
to reduce) the redox species added in the electrolytic solution, is approaching an 
insulating material. Most of SECM profiles and images of living cells reported 
in literature6,11-26, were obtained in constant height mode, where the probe is 
fixed on z and moved horizontally in the x-y plane above the substrate surface. 
Using SECM measurements, one can map i) the redox reactivity of a cell6,15-16, 
ii) image the cell topography under either positive or negative feedback 
conditions18-21, and iii) measure the fluxes of oxygen18-21, ATP22 and other 
metabolites (e.g. glucose and lactate)17 across cell membrane.   
A serious problem of using constant-height mode for cells imaging arises from 
the significant variations in height, size and shape among different cells. For 
example, among the scanned cells there can be some bigger than others, 
therefore it is challenging to get a high-resolution image of a heterogeneous 
field of cells without damaging any of them, and at the same time, if the 
distance UME-dish is too large, some flat cells may be not clearly imaged. One 
way to obviate this difficulty is to scan the dish at a distance with a small 
percentage of negative feedback, ensuring the imaging capability and a relative 
large UME-dish separation of scan. The second procedure is to scan a relative 
small area. The measurements in this work were carried out directly in the cell 
growth media without the serum, that it has been shown to disturb the electrical 
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signal (see Chapter 6.1.8) or in phosphate buffered saline (pH 7.4).  
Imaging of cells in feedback mode could be used to measure the cell redox 
reactivity. SECM can monitor the release of redox species from living cells or 
the interaction of exogenously added redox species (i.e. redox mediators) with 
living cells providing information on cellular metabolism and/or topography. In 
case of a redox mediator that does not interact with the living cell, the recorded 
SECM current decreases while approaching the cell resulting in a purely 
negative feedback15. In this way cellular topography contribution can be 
mapped in every SECM measurement (see Chapter 9). Alternatively, an 
increase of current - with respect to the purely negative feedback - may be 
recorded when the redox mediator reacts with some cellular component capable 
to regenerate the redox mediator back to its pristine form (regeneration 
current)23. The electrochemical signal reflects the thermodynamic equilibrium 
involving the complex interacting with the redox systems present within the 
cell. The analysis of cellular redox balance is useful to quantify the changes of 
redox species associated for example to oncogene expression and malignant 
phenotypes23. Whereas, generation/collection mode usually refers to 
experiments that measure redox active or electroactive species, directly or 
indirectly, produced or consumed by the cell.  
One of the main examples of SG/TC mode used in cell analysis is the study of 
the respiratory activity of a single cell16, which probes the oxygen gradient 
concentration near the cell surface18-19. Also others redox species, capable of 
participating in the electron transport chain, might be monitored17-22. A lot of 
research groups reported investigation on oxygen consumption in a wide variety 
of living cells and living systems. By measuring the rate of oxygen 
consumption, some authors addressed a number of biomedical problems from 
the drug sensitivity of cancer cells24 to viability of bovine embryos25 and 
mitochondrial respiration in neuronal cells26.  
In our case the electrochemical detection of O2 in normal and cancer cells has 
been investigated using a 10 µm Pt UME tip. When a potential of -0.7V is 
applied, the reduction of O2 generating a current that is proportional to the 
amount of local O2 concentration (see Chapter 11):  
 
O2 + 2 H2O + 2e - → H2O2 + 2 OH - 
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Low currents correspond to low oxygen levels, and such areas coincide with the 
locations of the living cells. Using this approach, some drugs, able to interact 
with the mitochondrial respiration chain, were employed to investigate the 
respiration capability of both cancer and normal cells. 
Another main application of the tip collection mode is the study of the cellular 
metabolism at single cell level, by probing gradient concentration of some 
metabolites, such as ATP22, glucose and lactate17, in the close proximity of cell 
surface. For real-time quantitative measurements of glucose and lactate on 
living cells, enzyme-based microelectrode biosensors were used (see Chapters 5 
and 6). Such biosensors are very suitable for this type of investigation because 
enzymes achieve molecular recognition of substrates (i.e. analytes of interest) 
based on structural complementarity and they offer high selectivity toward a 
single analyte optimized by natural evolution17. The electrode efficiency 
depends on: i) the enzyme concentration entrapped into the polymer film 
attached to the probe, ii) the ability of the matrix to recycle the enzyme by 
reducing/oxidizing it and iii) shuttling the electrons to the electrode surface 
through the enzymatic layer.  
Cliffel and co-worker17 have manufactured enzyme UME biosensors for SECM 
use in detection of lactate and glucose. By employing such devices they 
obtained glucose uptake and lactate release profiles of single cancer cells as a 
proof of concept for the application of SECM toward the study of basic 
metabolic processes that are affected by disease in cancerous cells.  
Inspired by Cliffel’s work, in this work several methods of enzyme 
immobilization (e.g. cross-linking and electropolymerization) were investigated 
in order to achieve the best sensors in terms of sensitivity, response time, linear 
range and stability. By coupling these obtained sensitive and non-invasive 
enzyme-based UME biosensors with SECM, a further knowledge of metabolic 
alterations on cancer cells is provided. Indeed, glucose uptake and lactate 
release on both transformed and normal human breast cells were monitored, 
with high spatial and time resolutions, providing evidence about the glycolytic 
switching present in tumors. Follow out the metabolic differences between 
cancer and normal cells could be a powerful tool also in clinical application: for 
example for detecting cancer cells among neighbouring normal ones in patient 
biopsies.  
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Figure 4. Block diagram of the BioSECM apparatus. Stepper motors and 3D piezo positioner 
control the movement of the probe: 10 µm Pt UME, which is the working electrode, CE 
(counter or auxiliary electrode) is a Pt wire, RE (reference electrode) is Ag/AgCl 3M KCl. The 
solution of analysis for metabolic measurements was chosen ad hoc to avoid perturbation of the 
cellular status (see Chapter 6.1.8). The UME can be modified by attaching enzymes, such as 
glucose oxidase and lactate oxidase, in order to monitor glucose and lactate level above a single 
living cell see (Chapter 5 and 6).  
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Chapter 5 
Enzyme-Based Ultramicroelectrode Biosensors 
 
 
Abstract 
Nowadays real time quantitative measurements of metabolites at single cell level, both in#vitro#in#culture#systems#and in#
vivo,#are feasible by the use of microsensors. In particular, enzyme-based micro-biosensors offer high selectivity toward a 
single analyte, optimized by natural evolution, and they give the opportunity to improve sensitivity, time scale and 
information content. Enzymes achieve molecular recognition of substrates (i.e. analytes of interest) based on structural 
complementarity, leaving little space for error. They catalyze with high specificity chemical reactions and for this reason 
they have been successfully widely employed in sensor designs. Moreover, enzyme-based amperometric biosensors are 
irreplaceable tools for the non-invasive study of  metabolism at the cellular level.  
 
Key words Enzyme electrode, Biosensor, Glucose Oxidase, Lactate Oxidase, Immobilization Techniques 
 
 
5.1  Microelectrodes Designs for Enzyme-Based Biosensors 
5.1.1 Introduction 
 
 
 
 
 
 
 
 
 
An electrochemical biosensor is defined as a “self-contained integrated 
device, which is capable of providing specific quantitative or semi-
quantitative information using a biological recognition element retained in 
direct spatial contact with an electrochemical transduction element”1. It is 
composed by a biological recognition element in contact with an 
electrochemical transduction element2. The sensitive biological element (e.g. 
tissues, cells, microorganisms, organelles, cell receptors, enzymes, antibodies 
and nucleic acids) is the component that interacts (binds or recognizes) with 
the analyte under detection, whereas the electrochemical transducer is 
designed to transform the signal, resulting from the interaction of the analyte 
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present into the surrounding medium with the biological element molecule, 
into an easily quantifiable electrical signal. In other setups the transducer can 
also be optical, acoustic, calorimetric, thermometric, piezoelectric and 
magnetic2. Translating the recognition of a molecule into an electrical signal 
can be performed in at least two different ways: (1) In many cases, the analyte 
can be bound to the biological receptor utilizing a very specific binding 
affinity (e.g. antibody/antigen interaction). This recognition results in a 
physiochemical change, that in combination with a tracer, such as fluorescent 
molecule, enzyme or radioisotope can generate a signal. There are some 
limitations in using this type of sensors because the binding capacity is 
strongly affected by environmental conditions, such as pH and temperature, 
and generally the interactions are irreversible3. (2) Most electrochemical 
biosensors, presently used in several fields, are based on the specific binding 
capabilities and catalytic activity of enzymes, which are directly immobilized 
on the surface of an electrode or microelectrode. Analyte detection is achieved 
in different ways: i) enzyme converts the analyte into a product that is 
electrochemically detectable, ii) enzyme is inhibited or activated by the 
specific analyte producing an electric signal, and iii) the changes of enzyme’s 
properties due to the interaction with the analyte might be monitored. This 
type of biosensors has many advantages: first of all, they offer a high 
selectivity toward a single analyte, optimized by natural evolution. Enzymes 
achieve molecular recognition of substrates with high sensitivity (the analytes 
of interest) based on their structural complementarity, leaving little space for 
error. Thanks to the small electrode dimensions, they can enhance the time 
scale resolution and information content. Moreover, such biosensors catalyze 
with high specificity a broad range of chemical reactions and enzymes are not 
consumed during these reactions, thus the biosensor can be easily reused in 
continuous. For all of these reasons they have been widely and successfully 
employed in sensor designs. However, one of the main disadvantages of 
enzyme biosensors is their lifetime, which is limited by the enzyme stability. 
 
5.1.2 Biosensors in 
Medical 
Diagnostic 
Leland C. Clark Jr. was an American biochemist and he is considered the 
“father of biosensors”, inventing the first electrochemical device for 
measuring oxygen in blood, water and other liquids; today this polarographic 
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device is known as the Clark electrode. Some years later, Clark used this 
electrode for manufacturing the first biosensor that measured glucose 
concentration in blood, by monitoring the decrease of oxygen concentration 
due to the enzymatic activity of glucose oxidase4.  
Since then, a huge number of biosensors have appeared in literature and a 
great number with an application in medical diagnostics. Currently, 80% of 
the commercial devices based on biosensors are used in this domain5, starting 
with the first commercial apparatus for monitoring glycaemia in diabetic 
patients produced by Yellow Spring Instruments (YSI Inc. 1975).  
Apart from the impressive space occupied in the market and in literature by 
the glucose biosensors (Table 1) and other enzyme-based catalytic biosensors 
or immunosensors, recently DNA-based sensing has appeared for real 
applications in clinical diagnostic to detect the presence of pathogenic species 
responsible of infections, to identify polymorphism and to detect point 
mutations6. Despite the huge number of publications on biosensors in the 
diagnostics field, the commercialization of this technology is only minimally 
feasible, besides the blood glucose and lactate biosensors and few others. This 
is due to the fact that the validation of the procedures has to be conducted in 
real samples to prove the efficacy of the biosensors, in order to transfer these 
technologies from the laboratory to the diagnostics market7. 
 
  Table 1. Market-leading biosensor companies and target/sector involved2. 
Company Target/sector 
Abbott  
(Molecular Diagnostics and Diabetes Care) 
Glucose 
Affymetrix Pharmaceutical and general bioscience research 
Applied and HTS Biosystems Affinity chip 
ARKRAY, Inc. Glucose 
Bayer Diagnostics/ Kyoto Daiichi/ Menarini Glucose 
Becton Dickinson Glucose 
Biacore Affinity sensors for pharmaceutical 
Biosite Medical 
Eppendorf Glucose and Lactate 
LifeScan Glucose 
Molecular Devices Diagnostics 
Nova Biomedical Glucose, Urea, lactate and creatinine 
Roche Diagnostics Glucose 
YSI Glucose and lactate 
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Briefly, we could mention just the main fields of biosensor applications1-2: 
1. Biosensors for metabolites analysis (glucose, lactate, O2, etc.); 
2. Biosensors for cancer biomarkers, such as prostate specific antigen 
(PSA), interleukin-6 (IL-6) and interleukin-8 (IL-8); 
3. Biosensors for hormones detection (e.g. progesterone); 
4. Biosensors for pathogens, such as virus, fungus and bacteria (i.e. 
Salmonella and Listeria monocytogenes) in food and water; 
5. Determination of drug and drug metabolism in human body and in food; 
6. Drug discovery and evaluation of biological activity of new compounds; 
7. Routine analytical measurements of folic acid, biotin, vitamins, etc.; 
8. Biosensors for cardiovascular diseases (e.g. troponin I and troponin T); 
9. Nucleic acid biosensors to detect mutations of DNA/RNA; 
10. Biosensors for toxic substances before and after bioremediation. 
 
5.1.3 Crucial 
Features 
 
Over the last decade the research activity in biosensors area strikingly 
increased in the clinical field. Nowadays, a lot of efforts are dedicated to the 
miniaturization of devices, without affecting sensitivity.  
An optimal enzyme-based UME biosensor must have crucial features; high 
sensitivity (seen as current response correlated to analytes presence), low 
detection limits (in the order of µM to nM), fast response time (≈ sec), 
excellent spatial resolution (µm), good permeability, stability and 
reproducibility, reduced cost, easy-manufacturing and causing minimal 
perturbations to surroundings. 
The main goal of this work is to develop a method to study non-invasively 
living cell metabolism with a high spatial and temporal resolution. The 
technique is based on functional imaging of cells using SECM coupled with 
enzyme-based UME biosensors for detecting metabolite gradients at single 
cell level. This system requires sensor specificity with appropriate spatial and 
temporal resolution within acceptable sensitivity and limits of detection 
(LOD) for each analyte. It is necessary to achieve optimum balance among all 
the figures of merit for our specific application. The major part of the thesis 
work was dedicated to the optimization of the enzyme immobilization onto 
UME probes and in the next sections some of the developed methods are 
discussed and described in details.  
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5.2  Oxidase-Based Biodetection 
5.2.1 Introduction 
 
 
 
Cofactors 
 
 
 
 
 
Oxidases 
 
 
 
 
 
 
 
 
 
 
 
 
 
One of the most spread class of enzyme-based biosensor are based on 
enzymes belonging to the class of oxidoreductases, which is directly 
immobilized on the electrode surface. 
Oxidoreductases are enzymes that catalyze the transfer of electrons from a 
substrate to a cofactor, a molecule contained within the polypeptidic chain.  
There are a wide variety of cofactors like iron, copper ions, iron-containing 
hemes, but flavins (e.g. flavin adenine dinucleotide, FAD/FADH2, or 
mononucleotide, FMN) and nicotidamines (e.g. NAD+/NADH or 
NADP+/NADPH) are the most frequently present8.  
Twenty-two different subtypes of oxidoreductases have been identified9, but 
only oxidases, enzymes that use O2 as electron acceptor, have been employed 
so far for biosensors in metabolites detection. For FAD-dependent oxidases, 
the oxidation of the substrate follows a two-step reaction:  
 
Substrate + Enzyme - FAD → Oxidized product + Enzyme - FADH2 
 
Enzyme - FADH2 + O2 → Enzyme - FAD + H2O2 
 
From an electrochemical point of view, these enzymes are well suited for the 
design of electrical biosensors, because they convert a molecule, which is not 
inherently electroactive (the substrate), into an active molecule such as 
hydrogen peroxide, which can be readily re-oxidised into molecular oxygen on 
the electrode surface, producing an electric signal:  
 
H2O2 → 2H + + O2 + 2e –  
 
The current, which can be recorded by a potentiostat, is directly proportional 
to the substrate/analyte concentration. 
Another advantage of using oxidases is that they employ oxygen as 
cosubstrate, which is available in non-limiting concentrations both in most 
biological media and in vivo. Only in particular conditions, such as hypoxia 
and ischemia (low pO2), the enzymatic reaction can become O2-limited, which 
might impact the performance of the electrode10. Additionally, it is worth to 
mention that oxidases activity is pH-dependent11 and temperature-dependent12; 
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typically, it increases with the temperature, until the enzyme is denatured, and 
its optimal pH range is from 5.0 to 7.511. 
There are many oxidase enzymes available in nature, with a high number of 
potential uses. Since we are studying cell metabolism, we are looking for 
glucose uptake and lactate release at single cell level. Therefore, we mainly 
focused our attention on: glucose oxidase and lactate oxidase 
 
5.2.2 GOx Glucose oxidase enzyme (GOx) is a β-D-glucose:oxygen 1-oxidoreductase, 
which catalyzes the oxidation of β-D-glucose to β-D-glucono-δ-lactone, by 
utilizing oxygen as an electron acceptor with simultaneous production of 
hydrogen peroxide. GOx is a flavoprotein (FAD-dependent enzyme), thus the 
catalytic reaction can be divided into a reductive and an oxidative step13: 
 
β-D-glucose  + GOx - FAD → β-D-glucono-δ-lactone + GOx - FADH2 
GOx - FADH2 + O2 → GOx - FAD + H2O2 
 
GOx is a dimeric glycoprotein consisting of two identical polypeptide chain 
subunits that are covalently linked together via disulfide bond. Its molecular 
weight ranges from approximately 130 to 175 kDa14. It binds specifically to β-
D-glucose and does not act on α-D-glucose (the other hemiacetal form of 
glucose); however, it is able to oxidise all of the glucose in solution (pH 7.0) 
because the equilibrium between α and β anomers is driven towards the β-side 
as it consumed in the reactions13.  
The most common microbial source for fermentative production of GOx is the 
Aspergillus niger14. There are several types of GOx commercially available, 
which differ for the number of enzymatic units per gram. We investigated 
three of them: i) GOx Type II (Sigma) 15÷50 U/mg solid, ii) GOx Type X-S 
(Sigma) 100÷250 U/mg solid and iii) GOx (Calbiochem®) ≥ 250 U/mg solid. 
By adopting cross-linking immobilization method (see paragraph 5.3.3), we 
compared the three enzymes in order to find the best one for our further 
studies on cellular metabolism. We observed that, once the enzyme is attached 
to the electrode surface, Calbiochem® GOx shows the best sensitivity but the 
highest response time, while GOx Type X-S displays the best compromise 
(Table 2). Therefore, we have decided to use the latter for the entire project 
(see Chapter 6 for the procedure of characterization method).  
 55 
  Table 2. Comparison among several types of commercial GOx drop-cast on 10µm Pt UME 
Enzyme U/mg @ Lot Sensitivity 
(pA/1mM of glucose) 
Response Time 
(sec) 
GOx Type II 17.3 78.6 2.3 
GOx Type X-S 123.9 275.4 8.1 
GOx Calbiochem® 312 343.1 19.5 
  
5.2.3 LOx Lactate oxidase (LOx) belongs to the α-hydroxy-acid oxidase flavoenzyme 
(FMN) family, which catalyzes the conversion of α-hydroxy acids to α-keto 
acids via a two-electron reduction of the FMN cofactor. Although the details 
of the mechanism are still under debate, the most widely accepted model is a 
ping-pong mechanism with sequential reductive and oxidative steps: the first 
step involves the production of α-keto molecule (pyruvate) from the α-
hydroxy substrate (lactate), followed by the transfer of two electrons and two 
protons from the reduced cofactor to molecular oxygen to generate hydrogen 
peroxide, and ultimately to regenerate the oxidized cofactor, as follow15: 
 
L-lactate  + LOx - FMN → pyruvate + LOx - FMNH2 
LOx - FAMNH2 + O2 → LOx - FMN + H2O2 
 
LOx is believed to be active as a tetramer (Figure 1). Each tetramer forms a 
biologically active unit and its molecular weight is approximately 50 kDa16. 
Most of the commercially produced LOx is isolated from Pediococcus species 
(Sigma) with an enzymatic activity ≥ 20U/mg solid. 
 
 
 
Figure 1. Overall structure of L-lactate oxidase. On the left the tetramer, describing half of the 
asymmetric unit. On the right the monomer structure viewed from the active sit where FMN 
cofactor is located [RCSB Protein Data Bank]. 
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5.2.4 Electrode 
Materials for 
H2O2 
Detection 
The classical electrode material for the H2O2 detection is platinum. 
H2O2 oxidation has to be shown to be catalyzed by the presence of platinum 
oxides (Pt-(OH)2) on the surface of the electrode10.  
 
H2O2 + Pt(OH)2→ Pt + 2H2O + O2  
Pt + 2H2O → Pt(OH)2 + 2H + + 2e –  
 
At platinum electrodes, H2O2 is oxidised at potentials above 0.4 V (anodic 
current) and is reduced lower than 0.1 V (cathodic current). Generally, in 
most microelectrode biosensors recording schemes, the current is recorded at 
a constant potential of 0.5 V ÷ 0.7 V vs. Ag/AgCl to achieve continuous and 
fast-response H2O2 detection.  
A similar reaction can occur on other noble metals for examples palladium, 
ruthenium, or rhodium, but not on gold, which yields very low H2O2 oxidation 
current. Even with carbon the H2O2 detection is unfavourable; there is no 
detectable reduction and oxidation starts at much higher potential (≈ 0.75V). 
However, Pt is a rather soft metal, therefore, to avoid the material breach, for 
in vivo microelectrode applications or implantable devices, more rigid Pt/Ir 
(90:10) alloys are currently employed10. An elegant compromise for H2O2 
detection consists on electrodepositing a thin layer of Pt (or another suitable 
metal) on carbon electrode; this procedure combines the valuable mechanical 
properties of carbon fibres with the optimal electrochemical properties of Pt. 
 
5.3  Immobilization Methods & Protocols 
5.3.1 Introduction 
 
In order to transduce the signal, enzyme has to be confined on the electrode 
surface. Enzyme immobilization is a key step in biosensor preparation that 
impacts on the overall performance. Among the wide variety of techniques 
employable, we have investigated: i) covalent immobilization by cross-linking 
with glutaraldehyde, ii) enzyme entrapment in polymer matrices by means of 
various polymers (e.g. o-aminophenol, polypyrrole and derivates), and iii) 
adsorption through physical or electrostatic interactions (e.g. electrophoretic 
paints). For biological applications, cross-linking and electropolymerization 
are the most widely used methods, because of their reliability and stability.  
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In this section, the influence of the immobilization method developed for 
biosensor construction on its final operating parameters is explored. Moreover, 
the optimized experimental protocols for each method both applied to glucose 
oxidase (GOx) and lactate oxidase (LOx)-based biosensor are described in 
detail. All of them are compared in terms of sensitivity, LOD, linear range, 
response time, stability, reproducibility and spatial resolution. We also studied 
the permeability of the hydrogel matrix, the effects of the analysis solutions on 
the biosensor performance and the kinetics of the system (see Chapter 6). 
 
5.3.2 Materials The materials were purchased as follows: β-D-glucose BioXtra ≥ 99.5%, 
Sodium L-lactate ≥ 99%, glucose oxidase (GOx) Type X-S from Aspergillus 
niger (100-250U/mg), lactate oxidase (LOx) from Pediococcus species 
(37U/mg), glutaric dialdehyde (GDA) as 25% solution in water (GDA), o-
aminophenol PESTANAL® (oAP), pyrrole ≥ 98% (Pyr), o-phenylenediamine 
(oPD), phenol (Phen), potassium phosphate monobasic and dibasic, acetic acid 
and sodium acetate, [Ru(NH3)6]Cl3 hexaammineruthenium(III)chloride, 
ferrocenemethanol 97%, ferrocenecarboxylic acid 97%, sodium ferrocyanide, 
were purchased by Sigma Aldrich. Bovine serum albumin (BSA) from ID Bio, 
PBS (pH 7.4) and RPMI 1640 medium are from Lonza, DMEM medium (no 
glucose, no sodium pyruvate, no red phenol) from Gibco, Triton X-100 from 
VWR, and MQ water from Millipore. Pyrrole-derived monomer used in our 
studies was kindly supplied by Serge Cosnier’s laboratory. The commercially 
available D-glucose is composed exclusively by α-anomer, due to the high 
solubility of β-anomer. For this reason the 50 mM glucose stock solutions 
were allowed to mutarotate at least 24h before using. 
 
5.3.3 First 
Technique: 
Cross-linking  
 
 
 
 
 
Cross-linking is a process based on the covalently binding of two or more 
molecules. Enzymes present a variety of functional groups that can be readily 
bound together by many cross-linking agents. This property has been 
extensively used for biosensor fabrications. The two main chemical functions 
in an enzyme are the amine (-NH2) and carboxyl (-COOH) groups. Amino 
groups are present on N-terminal end and on every lysine residue. Similarly, 
carboxylic groups are present at C-terminal end and on every glutamic and 
aspartic acid residues. Because they are charged at physiological pH, amino 
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GDA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and carboxyl groups tend to be exposed on the outer surface of the protein, 
which make them primary candidates for reacting with a cross-linker agent17. 
An important parameter to tune is the distance between the reactive groups of 
the linker, which determine the flexibility of the protein matrix and the degree 
of freedom that the enzyme retain once immobilized. Immobilization by 
covalent linking using glutaraldehyde is one of the most used coupling method 
in enzyme technology18-19. It is a gentle procedure because the reaction 
proceeds in aqueous buffer solution under conditions close to physiological 
pH, ionic strength, and temperature17-18. 
Glutaraldehyde (GDA), a linear 5-carbon dialdehyde, is a small molecule 
(MW 100), a clear, colourless to pale straw-coloured, pungent oily liquid that 
is soluble in all proportions in water and alcohol, as well as in organic 
solvents18. GDA is commercial available, cheap and with a high reactivity. 
Bearing two aldehydes groups, it can rapidly react with amine groups of 
proteins and enzymes, at around neutral pH, and it is more efficient than other 
aldehydes in generating thermally and chemically stable ramified three-
dimensional network (Figure 2)19. The reaction can be accomplished in a few 
minutes, and the method requires minimal equipment. For these reasons GDA 
is still used as a reference method on biosensor fabrication, even if it is a very 
toxic molecule and one should manipulate it with caution; hence, its possible 
clinical applications are limited17. The optimized procedure for immobilizing 
both GOx and LOx on UME biosensor using GDA is described below. The 
optimal conditions have been determined by trial and errors because the 
process is critically dependent on a delicate balance of factors, such as the 
nature of the enzyme (its lysine content may affect the reactivity with GDA), 
the pH, the ionic strength of the solution, the temperature, the reaction time, 
and the concentrations of both enzyme and reagents (GDA and the inert, 
lysine-rich protein carrier, added in the solution to avoid extensive 
modification of the enzyme within the matrix)20-21. The latter condition should 
be chosen carefully in order to favour intermolecular cross-linking between 
enzyme molecules instead of unwanted intra-molecular links. In fact, if low 
concentrations of enzyme and GDA are used, the system tends to induce intra-
molecular cross-linking, by enhancing the probability that the functional 
groups of GDA will react with the same enzyme molecules20. If the 
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concentration of the cross-linker species is low, the enzyme may be not fixed 
properly and they would eventually escape from the matrix of the biosensor20. 
Meanwhile, at high GDA concentrations, the extent of cross-linking is high 
enough to form a tight structure by excluding water molecules to make the 
enzyme derivative insoluble. The enzymatic activity is found to be inversely 
proportional to the GDA concentration used, because extensive cross-linking 
may result in a distortion of the enzyme structure (i.e. the active site 
conformation)21. Because of this distortion, the accessibility and 
accommodation of the substrate may be reduced, thus affecting the retention 
of biological activity and the sensitivity of the biosensor20.  
The best biosensor performance was obtained using a final solution of 12:88 
enzyme to bovine serum albumin (BSA) mass ratio, which serves as a matrix 
to protect the oxidase enzyme activity during immobilization20. The mixed 
solution is cross-linked with 1.4% (vol/vol) of GDA22-23. 
 
 
 
Figure 2. Reaction scheme for protein cross-linking by glutaraldehyde. Aldehyde groups react 
preferentially with amino groups present within the enzyme to produce covalent bonds. 
 
GDA 
Protocol 
 
The enzyme (8 mg/mL for GOx or 10 mg/mL for LOx) and BSA (62.5 mg/mL) 
are dissolved in PBS (pH 7.4) containing 0.02% v/v Triton X-100. After 
enzyme and BSA are thoroughly dissolved, 14 µL/mL buffer of 25% w/w GDA 
is added and quickly mixed. This solution, referred to the protein matrix, is 
set-aside for one minute until it turns slightly more yellow. It is mandatory to 
prepare a new solution for each biosensor because after a while the enzymatic 
solution tends to gelify and it is not possible to drop-cast it again. After 1 min, 
the enzymatic solution is hand-cast onto the surface of the UME by touching 
for 6-10 minutes the tip of the UME to a tiny droplet (5µL) of the solution 
deposited in a plastic dish. A thin layer adheres to the UME tip surface and it 
is let to air-dry for 2h, to prevent that the matrix dissolves or lifts off when 
used in solution. Optimal drying time vary depending on temperature, 
humidity and the type of enzyme. The biosensor can be stored at RT until use.  
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5.3.4 Second 
Technique: 
Polymeric 
Enzyme 
Entrapment  
 
 
 
 
 
 
 
 
 
 
 
 
The basic principle of enzyme entrapment consists in creating a polymer layer 
on the electrode surface. The enzyme to be immobilized on the biosensor is 
added to the monomer solution, and during the polymerization process, 
enzyme molecules are mechanically, electrostatically entrapped or adsorbed in 
the matrix created by the polymer. Because there are no strong chemical bonds 
between enzyme and polymer, but the enzymes are mainly entrapped by 
physical constraints, it is presumed that such procedures result in better 
preservation of enzymatic activity17. Electropolymerization is a simple and 
attractive method for biosensor fabrication, and in literature are reported many 
different procedures to follow24-36. Monomers such as o-aminophenol, pyrrole 
and pyrrole-derivatives (Figure 3) are the most widely used, because they are 
conductive polymers, stable at RT and they can be easily used with different 
electrolytes, including aqueous solutions. We have investigated several 
methods for functionalizing the UME probe: in Table 3 and 4, the protocols 
are compared in terms of sensitivity and time of fabrication, by changing the 
type of monomer, the amount of enzyme used and the electrochemical 
technique. In general, during an electropolymerization process, the applied 
potential generates reactive radicals that react with neighbouring monomer 
molecules, thereby producing a polymer layer on the electrode surface. In this 
way it is easy to control the thickness of the layer, by adjusting the oxidation 
or reduction time, and the amount of enzyme entrapped into the polymer 
matrix, by calculating the enzyme remained in the monomer solution24a. 
Additionally, the relatively low potential required for electropolymerization 
provides sufficiently mild conditions to avoid enzyme denaturation24a-b. 
 
 
 
Figure 3. Molecular structures of the main monomers employed: (a) o-aminophenol, (b) 
pyrrole, and (c) the amphiphilic pyrrole derivative, kindly supplied by Cosnier’s Lab.  
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 Table 3. Comparison among some electropolymerization methods investigated for GOx 10µm 
Pt UME biosensor. All the potentials are given vs Ag/AgCl 3M KCl. 
# Monomer [GOx X-S]  
(mg/mL) 
Electrochemical 
Method (Chap. 4) 
Time of 
Fabrication 
Sensitivity 
(pA/µM) 
Ref. 
1 oAP 20 Cyclic voltammetry 
E = -0.24 ÷ -1.04 V  
10 min 0.11 25  
2 oAP 8 Cyclic voltammetry 
E = -0.04 ÷ -0.84 V  
10 min 0.10 26 
3 oAP 10 Amperometric i-t 
E = +0.65 V  
2 h 0.20 22 
4 oAP 0.8 Cyclic voltammetry 
E = 0.032 ÷ 0.832V  
15 cycles at 
50mV/s 
0.14 27 
5 Pyr 1 Double Pulse Amp 
E1 = 0V; E2 = 0.95V  
10x 
t1 : 5s; t2 :0.1s 
0.01 28 
6 Pyr 4 Amperometric i-t 
E = +0.65 V  
300 s 0.01 29 
7 Pyr 8 Multi Step Pot. 
E1 = 0V; E2 = 0.95V  
10x 
t1 : 10s; t2 :0.1s 
0.06 30 
8 Pyr 0.5 Amperometric i-t 
E = +0.62 V  
260 s 
Q = 1.96⋅10-7C 
0.09 24b 
9 Pyr 0.9 Chronoamperometry 
i = 0.05 mA 
500 s 
Q = 25mC/cm2 
0.05 31 
10 Pyr-
derivate 
3.75 Amperometric i-t 
E = +0.7 V  
1000 s  0.015 32-
33 
Table 4. Comparison among some electropolymerization methods investigated for LOx 10µm 
Pt UME biosensor. All the potentials are given vs Ag/AgCl 3M KCl. 
# Monomer [LOx]  
(mg/mL) 
Electrochemical 
Method (Chap. 4) 
Time of 
Fabrication 
Sensitivity 
(pA/µM) 
Ref. 
1 oAP 2 Cyclic voltammetry 
E = 0.0 ÷ 0.8 V  
15 cycles at 
50mV/s 
0.13 27 
2 Pyr 2 Amperometric i-t 
E = +0.62 V  
≈ 300 s 
Q = 1.96⋅10-7C 
0.16 24b 
3 Pyr  
- Phen 
- oPD 
2.8 Amp. E = +0.8 V 
Amp. E = +0.8 V 
Amp. E = +0.8 V 
60 s 
 60 s 
1800 s 
0.11 34 
4 Pyr 
- oPD 
1.4 Amp. E = +0.7 V 
CV E = -0.3 ÷ 0.7V 
170 s 
20 sw 50mV/s 
0.056 35 
5 Pyr 
- oPD 
1.4 Amp. E = +0.7 V 
Amp. E = +0.7 V 
170 s 
900 s 
- 36 
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oAP 
Protocol 
Herein the two main protocols based on electropolymerization for GOx 
biosensor are described in detail. They gave the best compromise for our 
biosensing setup, with comparable results in term of sensitivity, time of 
fabrication and enzyme consumption. 
 
Protocol #4: The enzyme (0.8 mg/mL for GOx type X-S) and the o-AP 
monomer (0.55 mg/mL) are dissolved in 0.2 M acetate buffer pH 5.0. The 
solution is degassed using Argon bubbling for at least 10 min and the 
electrochemical polymerization of enzyme film is carried out by cycling in the 
potential range from 0.032 to 0.832V vs Ag/AgCl 3M KCl at a scan rate of 50 
mV/s. The film is grown for 15 cycles. The resulting enzyme electrodes were 
washed with MQ water and stored in 50 mM phosphate buffer pH 7.0 at RT 
until use.  
Pyr  
Protocol 
Protocol #8: enzyme (0.5 mg/mL for GOx type X-S) is dissolved in 0.1 M KCl 
pH 7.0 containing 0.05 M pyrrole. The solution is degassed using Ar for at 
least 10 min. Films are grown potentiostatically at 0.671 V vs Ag/AgCl 3M 
KCl for approximately 5 min. The amount of charge transferred during 
electropolymerization is measured by on-line integration of anodic current 
according to Euler’s method. The thickness of the film is estimated by 
assuming that 45 mC/cm2 of charge yields a film of 0.1 µm24-31.  The resulting 
enzyme electrodes are washed with MQ water and stored in 50 mM phosphate 
buffer pH 7.0 at RT until use. 
 
 
 
 
Pyr  
+ Phen 
+ oPD 
Protocol 
 
 
 
 
 
Regarding LOx, we implemented the previous protocol by adding other two 
different polymer layers, in order to increase the biosensor sensitivity and to 
reduce the interferences due to the presence of other species. 
Protocol #3: firstly polypyrrole layer is obtained by 1 min electrodeposition 
from 0.4 M monomer solution in PBS pH 7.4 at 0.8 V vs Ag/AgCl 3M KCl. 
Successively, a polyphenol layer is deposited, above the previous one, by 1 
min electrodeposition from 5 mM monomer solution in PBS 7.4 at 0.8 V vs 
Ag/AgCl 3M KCl. Finally, a third enzyme layer is formed by 30 min 
electrodeposition from 5 mM o-phenylenediamine and 2.8 mg/mL of LOx 
dissolved in 0.2 M acetate buffer pH 5.0 at 0.8 V vs Ag/AgCl 3M KCl. The 
resulting enzyme electrodes are washed thoroughly with MQ water and stored 
in 50 mM phosphate buffer pH 7.0 at 4°C until further use. 
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Limitations 
 
The use of an electrodeposited bilayers of polypyrrole and polyphenol 
between the Pt electrode and the enzyme layer provides satisfactory 
elimination of interferences due to electroactive species and allows the 
determination of lactate also in cell culture medium. The benefits of the co-
immobilization of LOx during electrosynthesis of phenylenediamine include: 
excellent interference rejection characteristics, protection of the electrode 
surface from biofouling, an improved sensitivity and a great stability of the 
polymerized layer17. The electric process does not affect the enzymatic 
activity.  
 
However, the electrochemical formation of all these polymers proceeds via 
intermediate, highly reactive radical cations, which makes the exclusion of 
molecular oxygen indispensable, thus implying a complicate procedure that 
limits the reproducibility and the mass production capabilities. In addition, the 
enzyme concentration in the deposition solution has to be kept small due to the 
possible nucleophilic attack of protein side chains at the radical cations. For 
these reasons, electropolymerization has been proved to be a method more 
difficult to implement in respect to cross-linking one.  
 
5.3.5 Third 
Technique: 
pH shift-
induced 
deposition 
 
 
 
 
 
 
EDPs 
 
 
 
Enzymes can be deposited by a mechanism involving their entrapment during 
the precipitation of organic layers, such as electrophoretic deposition paints 
(EDPs), triggered by a local pH change at the electrode surface37. 
The basic methodology has been widely used in automotive, tin and cans 
industries, as protection from corrosion, but it was recently adapted for 
biotechnological applications, using as substrates carbon-fiber or platinum 
micro-electrodes, and for modification in situ of scanning tunnelling 
microscopy tips. In fact, besides being attractive due to their electrical 
insulating properties, these materials are biocompatible and porous, so they 
can be used as encapsulating matrices for the entrapping of a wide variety of 
species, such as enzymes, proteins and other molecules37.  
Currently, two different types of electrophoretic paints are commercially 
available: i) cathodic EDP based on positively charged polymers with amino 
groups containing side chains, and ii) anodic EDP based on negatively 
charged polymers with carboxylic group containing side chains. The water-
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EDPs 
Protocol 
soluble forms of EDPs are mixture of micellar polyacrylates due to the 
presence of protonated amino groups, in the case of cathodic EDP, or of 
deprotonated carboxylic groups, in the case of anodic EDP.  
Electrochemically induced pH-modulation of the solution in the diffusion zone 
of the electrode, caused by the oxidation or reduction of water, leads to 
pronounced changes in the polymer solubility and hence to precipitation on 
the electrode surface. Subsequent curing of the deposited polymer layer 
characterizes the hardness and the insulation properties of the film37. 
Cathodic and anodic electrophoretic deposition paints (Clearclad HRS) were 
kindly supplied by LVH Coating Ltd. (Coleshill, UK). On company 
suggestion, we have tried only the cathodic system, which is more immune to 
bioactive materials. On the contrary, anodic paint may provide a good 
environment, in terms of nutrient substrates, for growing bacteria and other 
microorganisms (personal communication); therefore, it is not suitable for 
biological analysis. 
 
The enzyme (2mg/mL of GOx type X-S) is dissolved in MQ water, successively, 
the cathodic Clearclad HRS EDP suspension (70 µL/mL, stock solution) were 
mixed and the enzyme/paint suspension is stored for 3h at 4°C. For 
enzyme/paint film formation, the cold preparation is filled into the 
electrochemical chamber. A potential-pulse profile (2.2V for 0.2s; 0.8V for 1s; 
0V for 5s vs Ag/AgCl 3M KCl) is applied for 30 cycles, leading to the local 
generation of H+ and concomitantly to the precipitation of the paint on the 
electrode surface simultaneously entrapping the enzyme. The modified 
electrode surface are rinsed with MQ water and stored before use at least 12h 
in PBS at 4°C 37. 
 
5.3.6 CuCl2 Nano-
particles 
 
 
 
 
 
Since we want to monitor the lactate release at single cell level, we expect to 
detect very low concentrations, in the order of nM to µM. For this reason, 
especially in lactate analysis, we need a really high sensitivity; however, we 
cannot increase too much the concentration of LOx onto the electrode surface, 
because otherwise there is no polymer nucleation process20. Therefore, for 
LOx, we decided to cover the electrode area with a layer of Cu-nanoparticles 
before polymer electropolymerization.  
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CuCl2-oAP 
Protocol 
Copper is specifically selected in order to increase the electroactive area of the 
electrode and consequently to enhance the sensitivity of the UME biosensor. 
Moreover, the Cu nanoparticles can electrochemically oxidise lactate by 
themselves, it is relatively inexpensive, commercially available and the 
method for its deposition is well established. The diameter of Cu 
nanoparticles formed on the electrode surface should be around 200 nm27. 
 
Cu is electrochemically deposited on Pt by applying a potential equal to 
0.032V for 180 s (max Cu loading) in a 0.2 M acetate buffer solution (pH 4.0) 
containing 5.0 mM CuCl2 (Sigma). Successively, Cu-modified UME is placed 
in 0.2 M deareated acetate buffer solution (pH 5.0) containing 1 mg/mL of 
LOx and 5.0 mM oAP monomer. The electrochemical polymerization of 
PoAP/LOx film is carried out by cycling the potential range from 0.0 to 0.8V 
vs Ag/AgCl 3M KCl, at a scan rate of 50 mV/s, at RT. The film is grown for 15 
cycles. The resulting electrode is thoroughly washed with MQ and stored in 
PBS (pH 7.4) at 4°C 27.  
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Chapter 6 
Enzyme Ultramicroelectrode Biosensors Features 
 
 
Abstract 
Protein immobilization is a key step in biosensor preparation that impact on the overall performance. Among the wide 
variety of immobilization techniques currently available, only few of them have been proven to be reliably when 
applied in this thesis for SECM applications. In this chapter the full characterization of the features of GOx- and LOx-
based UME biosensors, prepared within this thesis work, is reported. By using amperometric calibrations, the most 
important biosensor characteristics, which determine the analysis performance, such as sensitivity, detection limit, 
response time, reproducibility, spatial resolution, biosensor efficiency, permeability, selectivity and degradation are 
analyzed. A theoretical model is also introduced in order to describe the kinetics of the enzyme entrapped into the 
matrix. 
 
Key words GOx and LOx UME biosensor, Sensitivity, LOD, Reproducibility, Spatial Resolution, Kinetics 
 
6.1  Enzyme-Related Biosensors Parameters 
6.1.1 UME 
Biosensors 
Calibration 
 
Since each enzyme-based UME biosensor can perform differently according to 
the coating procedures, each electrode must be calibrated prior any SECM 
application. To investigate the influence of the immobilization method on the 
most important biosensor parameters, we determined their sensitivity, time 
resolution, reproducibility, stability, and kinetics by amperometric calibrations. 
The calibration experiments are performed in PBS solution (pH 7.4) at room 
temperature (RT), where a known concentration of analyte, such as β-D-glucose 
or L-lactate, is added under slow stirring. The electric potential of the electrode 
is kept at E = +0.65 V vs Ag/AgCl 3M KCl, at which the oxidation of the H2O2 
takes place; the system is allowed to equilibrate at least for 300 s. The current is 
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recorded during each analyte addition, and since H2O2 concentration is directly 
proportional to the concentration of the analyte, a typical amperometric 
calibration curve is obtained (Figure 1). Several range of analysis, from very 
low (0.01 - 0.5 mM) to relative high concentrations (1.0 - 10 mM) were 
explored, focusing the attention on the physiological ranges of glucose and 
lactate concentrations involved in the metabolic pathways of single living cells. 
A typical calibration plot for a drop-cast GOx (for the preparation and 
immobilization procedure see Chapter 5.3.3) 10 µm Pt UME biosensor exhibits 
fairly linear sensitivity to glucose for concentrations from 10 µM up to 4 mM 
(Figure 2a): this result shows that the physiological range of glucose 
concentration and its variation due to single-cell consumption are perfectly 
covered by the microsensor. After reaching the concentration of 4-5 mM any 
addition of glucose does not affect the current.  
 
 
 
Figure 1. Typical example of amperometric calibration curve for a drop-cast GOx UME 
biosensor. The sensor is sensible even at small addictions of glucose and there is no response 
for blank ones. E = +0.65 V vs Ag/AgCl 3M KCl. Every current step corresponds to a glucose 
addition/concentration: 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.12, 0.14, 0.16, 
0.18, 0.2, 0.25, 0.3, 0.35, 0.4, 0.5, 0.75, 1 mM.  
 
 The typical calibration plot for a drop-cast LOx UME biosensor (Figure 2b) 
displays two distinct linear ranges: from 0.1 to 0.5 mM lactate, that covers the 
physiological range for single-cell release, and from 0.5 to 2.0 mM lactate.  
We studied the catalytic kinetics of GOx and LOx by performing some 
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experiments with the enzyme both free in solution and entrapped in the matrix 
and we verified that the decay in sensitivity at high concentration is due to a 
saturation of the enzyme and it is not caused by its constriction in the electrode 
matrix. Since the local concentration of lactate released from a single cell is 
very low (lower than 0.1 mM), the enzyme saturation does not hinder the 
detection for this purpose.  
 
 
 
Figure 2. Calibration plots of drop-cast (a) GOx and (b) LOx-based 10 µm Pt UME biosensors. 
E = +0.65 V VS Ag/AgCl (3M KCl) in PBS buffer. (a) GOx-based biosensor displays a linear 
sensitivity to glucose for concentration up to 4 mM, while (b) LOx-based biosensor exhibits a 
linear sensitivity to lactate for concentration up to 0.4 mM. 
 
6.1.2 Sensitivity 
 
Electrochemical biosensors are mostly used in their linear range and the 
sensitivity of the sensor is defined as the initial slope of the current-
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LOD 
concentration curve and it is usually expressed in pA/µM of substrate or, more 
accurately, in µA/mM/cm2 of electrode surface1. 
Our experiments show that UME sensitivity increases with thickness of the 
layer, due to the higher concentration of enzyme entrapped, up to a point that 
levels off, where there is the blockage of the analyte and H2O2 diffusion; 
however, response time becomes longer as a thicker diffusion barrier is applied 
to the UME.  
Another critical parameter is the real amount of enzymatic units per grams of 
the purchased compound. We observed a huge difference on drop-cast LOx 
UME biosensor performance for LOx with the same code and from the same 
company but belonging to different stocks. LOx with 57 U/mg shows high 
sensitivity, up to 1.9 pA/µM, while with the stock containing 32 U/mg of LOx, 
the sensitivity drops off to 0.6 pA/µM. GOx compound is more homogeneous, 
because its extraction protocol is easier; therefore the sensitivity is not 
dependent on the used stock of the compound. Table 1 summarizes the values 
of sensitivity, detection limits and linear range for each protocol. The limit of 
detection (LOD) is determined using the widely applied criterion of three times 
the standard deviation of the noise1. The linear range is defined as the highest 
concentration for which a successful fit at R2 = 0.998 is still possible1. Overall, 
the tests indicate that covalent immobilization methods using glutaraldehyde 
yield more sensitive biosensors than methods based on enzyme entrapment 
(electropolymerization and pH shift induced deposition). 
 
 Table 1. Calibration Data 
 
Immobilization  
Method 
Enzyme Sensitivity 
(pA/µM) 
LOD 
(µM) 
Linearity 
(mM) 
1. GDA 
 
GOx 
LOx 
0.91 
1.94 ÷ 0.63 
1 ÷ 10 
1 ÷ 10 
0 ÷ 4 
0 ÷ 0.3 
2. p-o-aminophenol GOx 
LOx 
0.14 
0.13 
50 
50 
0 ÷ 10 
0 ÷ 0.3 
3. Poly-pyrrole GOx 
LOx 
0.09 
0.16 
100 
50 
0 ÷ 10 
0 ÷ 0.3 
4. PPyr-Phen-oPD LOx 0.11 100 0 ÷ 0.1 
5. Cathodic EDP GOx 
LOx 
0.026 
0.05 
100 
100 
0 ÷ 5 
0 ÷ 0.5 
6. Cu Nanoparticles LOx 0.018 100 0 ÷ 0.1  
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6.1.3 Response 
Time 
UME biosensors designed for SECM applications should detect metabolites 
with a good temporal resolution. We observed that the response time becomes 
longer with the thickness of the matrix, containing the enzyme, as a ticker 
diffusion barrier is applied to the microelectrode. Additionally, enzymatic 
biosensor response times are limited by the kinetics of the enzymatic reaction 
and usually display response time of the order of seconds. We tested that the 
enzyme layer itself does not act as a diffusion barrier to H2O2 detection 
contributing to the signal response delay1.  
The UME response time is typically calculated as the time required for the 
current response to reach 90% of the maximum amplitude for the concentration 
step1. After testing the different types of biosensors, we found that the 
immobilization method significantly influenced the response time of the 
electrodes. For example the average 90% response times to 0.5 mM D-glucose 
for drop-cast GOx UME biosensors, built with the standard procedure, is 
around 2 ÷ 4 sec, for a double “deeping” matrix the time increases to 12 s. 
While for very thin coatings, such as for electropolymerization methods, the 
response time is faster, around 0.5 ÷ 1.5 sec. For the electrode with Cu 
nanoparticles the response time grows up to 35 s. 
Several experiments were performed changing the thickness of the enzyme 
layer in order to obtain the best sensitivity with a suitable temporal resolution 
for our SECM measurements. 
 
6.1.4 Stability 
 
 
 
 
 
 
 
 
 
 
 
In order to work with living systems, the stability of the enzyme layer is also a 
very important parameter. Important aspects of biosensor stability are: i) its 
interaction with the solution of the analysis and ii) its susceptibly to fouling 
processes1. The typology of the material used for electrode construction and the 
method of enzyme immobilization can have significant impact on the lifetime 
of the biosensor. The stability of drop-cast and electropolymerized UME 
biosensors, both for GOx and LOx, was tested in simple PBS buffer. Regarding 
the first method (Figure 3a and 3c), we have the best sensitivity just after 
preparation (time 0h), while after 24h it is slightly decreased. Biosensors, 
prepared using GDA immobilization, are stable for up to 3 days. In contrast, 
with the second immobilization method (Figure 6b and 6d), at time 0h the 
sensors are less sensible than after 24h or 48h. We suppose that this effect is 
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due the slow reassembly of the enzymes into the polymer matrix. After 72h the 
sensitivity decreases until it reaches constant values and the sensors remain 
stable for several days.  
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Figure 3. Representative measurements of biosensors stability in the linear range of analyte 
detection; serial amperometric calibrations in PBS: (a) drop-cast GOx-based, (b) 
electropolymerized GOx-based, (c) drop-cast LOx-based, and (d) electropolymerized LOx-
based UME biosensors. The current of each point is normalized for the maximum response 
value obtained within the linear range. 
 
6.1.5 Reproduci-
bility 
 
Reproducibility, defined as the ability to reproduce an entire experiment, is 
another biosensor feature to control. It was calculated for each method as the 
current variation for additions up to 1 mM of glucose or 0.1 mM of lactate for 
GOx-based and LOx-based UME biosensors, respectively. As reported in 
literature2, electropolymerized methods have a good reproducibility (Figure 4), 
because there is an electrochemical control on deposition.  
 
 
 
Figure 4. Reproducibility of electropolymerized GOx-based UME biosensors. Average value of 
current responses and standard deviation of five different experiments are reported. Calibrations 
were done in PBS buffer. 
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 Considering five different experiments performed in different days and with 
different enzyme/polymer solutions in order to take into account the variability, 
we obtained a standard deviation in current response around 10% for GOx 
sensors and a value for LOx sensors of 18%. While for drop-cast methods the 
standard deviations are larger: the values are 22% for GOx UME biosensors and 
26% for LOx ones. 
 
6.1.6 Spatial 
Resolution 
 
A key advantage of SECM is the ability to perform measurements with very 
high spatial resolution (micrometer range), such as experiments at single cell 
level. Therefore, the size of the electrode biosensor, the nature of the probe and 
the thickness of the enzymatic coating are of paramount importance to allow the 
monitoring of metabolite levels on single living cells. A large biosensor would 
increase the analyzed zone, decreasing the spatial resolution. The overall 
dimension of the UME biosensor and enzymatic matrix should be in the micron 
or sub-micron range, because the spatial resolution of SECM scales with the 
probe electrode dimension. Thinner is the enzymatic layer the higher will be the 
spatial resolution of the SECM experiments and microscopic information of cell 
metabolism can be obtained. For each method, the spatial resolution of the 
UME biosensor was calculated as the width of the current peak (wpeak) due to 
glucose concentration variation on the top of the scanned cell in respect to its 
real dimension (wcell): the lower is the ratio higher is the spatial resolution.  
 
 
 
Scheme 1. Schematic representation of typical drop-cast (on the left) and electropolymerized 
(on the right) UME biosensors with their relative profiles. 
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 Drop-casting method has the lower spatial resolution, because the drop of the 
solution containing the enzyme, when it dries, entraps the enzyme not only over 
the active part of the electrode (10 µm Pt) but also onto the glass support.  
Hence, the biosensor converts the analyte in H2O2 for the entire dimension of 
the electrode and it is sensible to variations of analyte concentration in all the 
position of the active enzymatic layer. For more details see Table 2 and Chapter 
9 and 10. However, the drop-cast method was extensively optimized and a 
spatial resolution comparable with the electropolymerized ones, in which the 
enzyme is locally deposited only onto the UME active part, was achieved.  
 
Table 2. Calibration Data of one single set on analysis taken as representative.  
Immobilization  
Method 
Enzyme Deposition 
Time 
Sensitivity 
(pA/µM) 
Spatial 
Resolution 
(wpeak / wcell) 
1. GDA 
[Classical approach] 
GOx1 
LOx 
10 min 
10 min 
0.34 
1.94 
6.2 
5 
1. GDA  
[New approach] 
GOx 
LOx 
6 min 
6 min 
0.91 
0.95 
2.8 
1.8 
2. p-o-aminophenol GOx - 0.14 2.1 
3. Poly-pyrrole GOx - 0.09 1.4 
  
6.1.7 AFM 
Analysis 
The enzyme/polymer layer was characterized by Atomic Force Microscopy 
(AFM) in order to assess the full coverage of the electrode surface, the 
thickness and morphology of the electropolymerized enzyme-based biosensors 
(for technique principles and experimental details see Appendix #1). 
AFM imaging of thin films requires the use of a solid and flat supporting 
surfaces, on which the film itself is deposited. Ideally, the substrate surface 
should be atomically flat and there should be not strong interactions between 
the film and the underlying surface. Relatively large roughness and strong 
interactions may cause image misinterpretation and wrong evaluations about 
surface ripple and deposited structures3. We chose Pt arrandeeTM surface 
(platinum planar electrodes: 11mm x 11mm) as active surface to characterize 
our electropolymerized GOx biosensors and evaluate their homogeneity. Such 
Pt substrate surfaces have very smooth regions with large atomically flat 
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terraces (see Figure 5a and 5b) extending over more than 0.1 µm (sample 1).  
Following the protocol #4, already described in Chapter 5.3.4, we 
electropolymerized the o-aminophenol monomer in sample 2 and the solution 
composed by the monomer and the enzyme (in this specific case glucose 
oxidase) in sample 3. Figure 8 displays the Tapping Mode AFM images 
obtained for the three samples: 5(a)/5(b) are related to the bare Pt, 5(c)/5(d) 
represent the platinum covered only with the polymer layer and 5(e)/5(f) show 
the GOx enzyme entrapped into the polymer matrix onto the platinum surface.  
 
 
 
Figure 5.  Tapping mode AFM images of: the bare platinum arrandeeTM, the poly-o-
aminophenol layer on platinum, the enzyme (GOx) entrapped into the polymer matrix on 
platinum [(a), (c) and (e) correspond to height images and (b), (d) and (f) correspond to phase 
images]. On the right there are three 1µm-sections of the height profiles relative to each sample. 
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Table 3. Main surface parameters of the three analyzed samples expressed as mean values 
calculated on the previously presented height AFM images (surface area: 9 µm2). 
 Pt arrandeeTM Pt – oAP Pt – oAP/GOx 
Average Roughness (Ra) 0.74 nm 1.47 nm 15.3 nm 
Average Height (Rz) 1.79 nm 3.87 nm 24.5 nm 
Average Grain 26 nm 35 nm 66 nm 
 
In tapping mode AFM the probe is excited into resonance oscillation with a 
piezoelectric driver and the oscillation amplitude is used as a feedback signal to 
measure topographic variations of the sample4. In this way high-resolution 
topographical (or height) images (Figure 5a, 5c and 5e) can be achieved without 
inducing destructive frictional forces on the “soft” and sticky samples under 
investigation. Moreover, thanks to the phase imaging system, incorporated in 
the used AFM setup, some material properties, such as homogeneity, adhesion 
and viscoelasticity can be monitored. Phase images (Figure 5b, 5d and 5f) can 
also act as a real-time contrast enhancement technique, as they highlight edges, 
such as grain edges, which can be obscured by rough topography, and they are 
not affected by large-scale height differences.  
Table 3 summarizes the main physical parameters obtained by the analysis of 
the topographical AFM images of each sample (5a, 5c and 5d). The results 
show that both the average roughness and the average height drastically 
increase from sample 1 (bare Pt) to sample 3, where the polymer layer, 
encapsulating the enzymes, covers the platinum surface. This increase confirms 
that i) the o-aminophenol monomer efficiently polymerizes onto the active 
surface and ii) when the electropolymerization is carried out in presence of the 
GOx the enzyme is entrapped in, as it can be easily seen from the comparison of 
images 5c and 5e and even more evident considering the corresponding scan 
line sections in Figure 85.  
Therefore, the proposed electropolymerization approach can be considered a 
valid method to form a very homogeneous layer, as can be noted also from the 
relative phase images (Figure 5b, 5d and 5f). Furthermore, the average grain 
sizes allow to evaluate the dimension and the space occupied by the enzyme 
entrapped into the polymer, which is in line with the literature4-5, in which the 
GOx is assumed to be a dimeric globular protein having overall dimension of 
7.0 x 5.5 x 8.0 nm3. 
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6.1.8 Effects of 
Analysis 
Solutions on 
Biosensors 
Performance 
Since the goal of the project is to study metabolic alterations on single living 
cells, it is mandatory to work in a physiological environment, which is also 
reach of metabolites to avoid stressing the cells and in order to evaluate their 
metabolism in standard conditions. At the same time the biosensor has to be 
enough sensitive and the components of the analysis solution should not affect 
the biosensor performance to locally monitor the little metabolites changes. In 
literature most of the in vitro experiments are usually performed in PBS buffer 
(pH 7.4), but we observed that the cells are negatively affected by this 
condition, because all the nutrients, vitamins, amino acids etc. are missing, and 
they start to block their metabolism within half an hour. For this reason, 
enzymatic layer responses to various analysis solutions were examined in order 
to find the best working condition. Several buffers were used and tested: 50 mM 
Phosphate Buffer (PB) pH 7.0, PBS pH 7.4, Hank’s Balance Salt Solution 
(HBSS), PBS plus 2.5÷10% horse serum and 10 µM of insulin. The most 
common cell media were also analyzed, such as RPMI 1640, DMEM, 
DMEM/Ham’s F-12, DMEM without red phenol, and the complete culture 
medium for the investigated cell lines (see Chapter 7.1.3 for the composition). 
It is worth to mention that all the tested media are without glucose, because 
usually the latter one is present at very high concentration (around 11 mM), 
which hides the small variations during the analysis due to the cell consumption 
and exceeds the saturation limit of the developed GOx-based UME biosensors.  
Considering the physiological range of the local glucose and lactate 
concentration variations (ranging from 0 to 0.1mM), the results (Figure 6) show 
that: i) the best sensitivity of drop-cast electrodes results in PBS, and PBS plus 
serum, because there are no other interfering species, such as some amino acids, 
and ii) it is not possible to use the complete cell culture medium with this UME 
probes because its mixture of compounds disturbs the sensor performance. 
While, in presence of RPMI or DMEM, both with and without glucose, 
composed by several inorganic salts, amino acids, vitamins and other 
components7-8, the electrodes present a very reduced sensitivity. Consequently, 
at the beginning of the study, the SECM measurements coupled with the GOx-
based biosensors for the investigation of glucose uptake of a single cell were 
performed in PBS containing 2.5% of horse serum and 10 µM of insulin. 
However, the measurements for LOx biosensors show that horse serum 
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interferes with the monitoring of lactate, due to its complex chemical 
composition, and also the sodium pyruvate contained in DMEM and Ham’s 
media disturbs the detection of lactate (see next section). Therefore, considering 
all the tested solutions and in order to find the best compromise between 
biosensor sensitivity and cell growing conditions for both GOx- and LOx-based 
biosensors the measurements were performed in RPMI medium without glucose 
and serum. It is mandatory to find a common solution in order to 
simultaneously measure both glucose concentration variations and lactate 
release on the same cell for further combined studies on cellular metabolism.  
 
 
Figure 6. Calibration plots of GOx- and LOx-based biosensors in different analysis solutions: 
only the glucose and lactate physiological ranges were considered.  
 
6.1.9 Other 
Sensoristic 
Parameters 
 
 
The main analytical parameters of the enzyme-based biosensor performance are 
related to: i) the sensitivity of the sensor to the target analyte (e.g. glucose and 
lactate) and to the enzyme-transducer molecule H2O2, and ii) its ability to block 
electroactive interference species. In this section a brief discussion of evidences 
of the used enzyme biosensors is given in order to elucidate their behaviour. 
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Biosensor 
Efficiency 
 
 
The biosensor efficiency (BE%) is a very useful parameter, which normalizes 
the biosensor response with respect to H2O2 sensitivity9.  
 
 
 
 Where slope (Substrate) is the related to the enzyme-based biosensor sensitivity 
and corresponds to the linear range for substrate calibration and slope (H2O2) is 
the calibration slope for H2O2, measured at the same electrode biosensor9.  
In theory, the maximum value of BE% is 100% if the following hypothesis are 
satisfied: i) presence of enough active enzyme on the surface to generate 
sufficient H2O2 to mimic its flux during calibration, ii) all the hydrogen 
peroxide molecules, produced by the enzyme, have to be oxidized at the 
electrode surface, and iii) the diffusion coefficient of substrate (DS) should be 
equal to the diffusion coefficient of H2O2 (DH2O2 = 1.0x10-5 cm2 s-1).  
Since these hypotheses are not completely satisfied in real conditions because: 
DS is usually less than DH2O2 and some hydrogen peroxide is lost into the bulk 
solution, then (BE%)max < 100%. In literature an empirical maximum value for 
BE% is given close to 60%10. For our manufactured drop-cast GOx UME 
biosensors, considering the linear range of concentrations for both glucose and 
hydrogen peroxide (ranging from 0 to 1 mM), the mean BE% calculated is 
around 45%, which is not too far from the theoretical value. 
 
Permeability Another important parameter of enzyme-based biosensor is the permeability of 
the enzymatic matrix, seen as its capability to allow the transport of the analyte 
(or another molecule) from the bulk solution up to the electroactive part of the 
electrode9. Aspects involved in membrane transport include: i) the permeant’s 
partition coefficients, which reflect the interaction between the chemical species 
and the enzymatic matrix, ii) the species diffusion coefficients and iii) the 
matrix thickness11-12.  
Because the first two values are not known accurately, the ‘true’ permeability 
cannot be determined in a straightforward manner11. Instead, the apparent 
permeability has been defined as the ratio of the analyte (or the enzyme-
transducer molecule H2O2) currents recorded with the same electrode, before 
and after deposition of the enzymatic matrix9.  
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The apparent permeability is therefore a relative, normalized measurement of 
the analyte/substrate flux to the metal surface when the coating is present. This 
parameter has been proved useful for comparing permoselective matrix 
properties for biosensors applications. The ideal value should be close to 100 ± 
10%, but for polyphenol layer the value has been estimated lower than 10%13. 
We have estimated the apparent permeability value of our manufactured drop-
cast GOx UME biosensors in respect to hydrogen peroxide equal to 30% 
considering a linear sensitivity to H2O2 concentration ranging from 0 to 1 mM. 
 
Another way to have an immediate qualitative idea about the permeability of 
the coating is to perform a cyclic voltammetry using the Pt UME probe, with 
and without the matrix, in a solution containing a redox mediator, such as 
[Ru(NH3)6]3+, which is well-known to be a reversible redox couple:  
[Ru(NH3)6]3+ + e-→ [Ru(NH3)6]2+  [Ered = -0.11V vs Ag/AgCl 3M KCl] 
Despite the presence of the coating, which causes a slightly increase of 
capacitive current, the electrode is perfectly able to reduce the redox mediator, 
as shown in Figure 7. The oxidative signal around 0.1 V could be due to a not 
identified species present in RPMI medium. 
 
 
 
Figure 7. Cyclic voltammetry of 500 µM [Ru(NH3)6]3+, in RPMI medium. With the enzymatic 
coating the capacitive current slightly increases due to the organic layer itself. Speed: 20mV/s.  
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Selectivity A very important quality criterion of a biosensor is its capability to detect 
signals free from interferences. The ability to discriminate between the analyte 
and the interfering components in a complex mixture is expressed in terms of 
selectivity of the sensor; specificity is just the ultimate of selectivity14. A high 
selectivity is crucial for biosensor applications.  
The effect of some species that are commonly present in cell culture medium 
for cell growth were tested; interferences due to penicillin/streptomycin, insulin, 
glutamine, epidermal growth factor, and cholera toxin, were investigated on our 
drop-cast LOx-based UME biosensors. Figure 8 shows that there is no response 
in current due to the addiction of these species, while the current increases 
adding lactate in presence of the other medium additives.  
As already mentioned, other components, such as horse serum and sodium 
pyruvate, have effects on our LOx-based UME biosensors. The exact 
composition of the serum is unknown and it may contain lactate or lactate 
oxidase itself that may influence the analysis, while pyruvate can intercalate 
into the matrix, producing H2O2 itself, hence in both cases the final 
measurement of lactate could be misrepresented. However, the sensitivity to 
these interfering species is much lower in respect to lactate, therefore we can 
overlook this issue.  
 
 
Figure 8. Typical amperometric calibration of a LOx-based UME biosensor in RPMI medium. 
After 300 s of equilibration time the current is recorded at E = 0.65 V vs Ag/AgCl 3M KCl. 
Each spike corresponds to a single addiction, in sequence: 10 mg/mL of penicillin/ 
streptomycin, 10 mg/mL of insulin, 500 ng/mL of hydrocortisone, 10 mg/mL of glutamine, 20 
ng/mL of growth factor, 50 ng/mL of cholera toxin and finally 0.1 mM of lactate (twice). 
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Biofouling Upon electric potential application, enzyme-based biosensors undergo an 
equilibration phase that might cause a loss in sensitivity due to a slow partial 
oxidation of the Pt electrode surface and/or a modification of the enzymatic 
matrix; the outcome of this equilibration time is a progressive and continuous 
reduction of the oxidation current registered at the electrode15. 
Sensors are composed by: a sensitive bioreceptor and an electrochemical 
transducer, and both of them can be affected by the applied potential. For 
example, concerning the bioreceptor, namely the enzymatic coating, there are 
several phenomena that can occur, such as the saturation and the depletion of 
the enzyme, the denaturation or degradation of the matrix, etc. While regarding 
the transducer part, we have to consider that the enzymatic reaction produces 
hydrogen peroxide that is detected at the electrode surface, therefore the 
platinum, even if is an inert metal, can be modified by this reaction and the 
effective active area might decrease. We have noticed that the sensitivity both 
to H2O2 and to glucose or lactate, after 20s of equilibration time, is much bigger 
that after 300s, but after 300s each addition has the same current response, so 
that the system is completely equilibrated. Moreover, working with living 
systems, in complex media, could damage the enzymatic matrix; hence, 
biosensor decreases its sensitivity to the analyte, but at the same time this 
degradation increases its permeability to hydrogen peroxide or other redox 
mediators that could reach more easily the electrode surface. 
The sum of these processes, that gives a loss in sensitivity, is called electrode 
biofouling, and for this reason it is mandatory to perform amperometric 
calibrations before and after any SECM measurements, in order to find the 
correction factors indispensable for the elaboration data.  
In literature there are reported some non-conductive polymers16 and patented 
protection layers17, that are employed to prevent electrode fouling, a common 
problem in the biosensors field. 
 
6.2  Kinetics of Enzyme-Based UME Biosensors 
6.2.1 Introduction 
 
Generally, enzymatic biosensors convert a specific substrate to its product while 
producing electrochemically detectable peroxide. The activity of the most 
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enzymes can be described by the Michaelis-Menten (MM) equation1: 
 
 
 
where V is the reaction rate to the substrate, [S] is the concentration of the 
substrate, Vmax represents the maximum rate of conversion, and KM is the 
Michaelis constant (see definition below), which correspond to the substrate 
concentration when the reaction rate is half of Vmax. When the diffusive effects 
may be neglected, as in the present case, and a quasi steady-state (QSS) has 
been established for enzymatic reaction, the rate of the process is given by the 
following equation3-6: 
 
 
therefore, the current-concentration relationship that characterized a biosensor 
can be approximated by the modified equation: 
 
 
 
where I is the current and Imax is the maximum current recorded by the 
biosensor, F is the Faraday constant (96485 s⋅A⋅mol-1), A is the geometric area 
of the electrode (for ∅ 10 µm Pt, A = 7.85x10-7 cm2), and KM
App
 is the apparent 
MM constant for the biosensor. KM
App
 
is related not only to the KM of the enzyme 
immobilized on the electrode, but also depends on other parameters such as the 
diffusion rates of the substrate (glucose and lactate), O2, and hydrogen peroxide 
within the enzymatic layer. Because of these reasons, the KM
App
 
of a biosensor 
could be very different from the KM of its free enzyme1. 
To experimentally determine the relationship between the current detected by 
the biosensor and the substrate concentration, we measured the current steps 
produced by the addition of increasing amounts of enzyme substrate to the 
recording medium. Plotting the value of the oxidation current against the 
substrate concentration gives a curve that can be fitted to the modified MM 
equation to yield the approximate value of KM
App. 
A graphical representation widely employed for enzymatic reactions, when the 
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QSS has been establish, is the Lineweaver-Burk plot, where the reciprocal 
values of the oxidation current are plotted against the reciprocal values of 
substrate concentration. From the linear fit of the straight line the approximate 
value of KM
App (Figure 9) can be calculated: the
 
values found for glucose 
biosensors are very variable, ranging from 1.5 ± 0.5 mM with glutaraldehyde 
fixation to around 4.3 ± 0.7 mM and 4.1 ± 1.5 mM for o-aminophenol and 
polypyrrole, respectively. As we expected, KM
App is substantially lower than the 
KM of the free enzyme, which is normally between 26 mM and 30 mM1. The 
KM
App of lactate biosensors is slightly variable, ranging from 0.16 ± 0.05 mM 
with glutaraldehyde fixation to 0.06 ± 0.05 mM for polymer entrapment. The 
first value is close to the KM of the free enzyme, which was measured for our 
LOx sample, equal to 0.35 mM.  
The theoretical calculations of MM model predict that the linear range of 
biosensor sensitivity should extend up to concentrations around KM
App/10, our 
biosensors do not follow this rule1, therefore this suggest that our micro-
biosensor may not follow the theoretical kinetics of Michaelis-Menten model. 
 
 
 
 
 
 
 
 
 
 
Figure 9. Typical linear Lineweaver-Burk Plot of a drop-cast GOx UME biosensor; glucose 
addiction from 0.1 mM to 2 mM. [E] << S0. From the linear fitting we can calculate Vmax from 
the intercept, and consequently Km from the angular coefficient. 
 
 We further investigated the kinetics of drop-cast GOx UME biosensors in 
presence of very small amounts of substrate (from 1 µM to 100 µM): a very 
interesting situation because the typical concentration of substrate in respect to 
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the enzyme in living cells is [E] ≈ [S0]18. Analyzing the enzymatic kinetics at 
small substrate concentrations, we found that there is no linear dependency 
between the reciprocal values of oxidation current and substrate concentrations 
(Figure 10). These results suggest, once again, that the enzyme entrapped in 
those biosensors, at such low concentrations, might not follow the Michaelis-
Menten theoretical kinetics.  
Nevertheless, the enzymatic reaction rates are fast enough compared to the 
speed movements of the electrode during SECM measurements; therefore the 
enzyme-based biosensors can monitor metabolite changes without being 
affected by enzymatic kinetics restriction. 
 
 
 
Figure 10. Lineweaver-Burk Plot of a drop-cast GOx UME biosensor; glucose addiction from 1 
µM to 100 µM. [E] ≈ [S0].  
 
In literature there are several sophisticated mathematical models that describe 
the behaviour of enzymes in membranes19; these complex analyses are often 
needed to understand and optimize the behaviour of thick conducting layers. 
We used a recently introduced theoretical model20 that can accurately predict 
formation of product even if the initial enzyme and substrate concentrations are 
comparable, such as in our developed drop-cast UME biosensors.  
 
6.2.2 New 
Stochastic 
Model 
 
Most of enzymatic reactions can be reduced to a two-steps process and are 
described by the following diagrammatic equation: 
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where E, S, C and P denote the time dependent concentration of the enzyme, the 
substrate, the intermediate complex, and the product, while k1 (M-1s-1), k-1 (s-1) 
express the forward and the reverse constants for enzyme/substrate complex 
formation respectively and k2 (s-1) express the catalytic rate constant.  
The mathematical formalism of this equation depends on the environment in 
which the reaction occurs. In homogeneous environment, all the k are constant, 
and it should be noticed that k-1 and k2 are frequencies of reaction competitive 
with each other and their comparison is essential to find analytical solutions4. In 
a general system, the common condition [E] << S0 ensures the applicability of 
MM model kinetics. However, as observed, when the concentrations of the 
substrate are very small, the kinetics becomes oscillatory. As a consequence, in 
order to understand and quantify the real enzymatic activity, the formation 
product over time has to be considered to estimate the rate constants. 
In order to assess this new model20, several amperometric calibration 
measurements have been done by using our drop-cast GOx UME biosensors 
and by adding in solution glucose concentrations ranging from 1 µM to 60 µM 
(values lower or equal to the hypothetical enzyme concentration entrapped into 
the matrix that is estimated to be around 40 µM). The KM
App calculated by mean 
of the classical MM approach is equal to 15.86 µM.  
The experimental data were also fitted with the model -ad hoc- developed in 
order to estimate the real reaction rates (k), that are not constant at each 
experiment, but they are dependent on substrate concentration. Figure 1q shows 
just two examples of a set of experimental measurements of current vs time, 
upon addition of 2.5 µM of glucose ([E0] > [S]) and 60 µM of glucose ([E0] ≈ 
[S]), fitted with the new theoretical equation.  
Table 4 summarizes the main kinetics values obtained for the best fitting of the 
experimental data. It is worth to mention that for each group of experiments, 
each data set follows a different behaviour: this demonstrates the possibility of 
the existence of extra mechanisms that play important role. The results in the 
table reveal that: i) as the initial concentration of the substrate increases the 
forward rate constant decreases and the backward and catalytic rates increase, 
but in any case the backward rate constant is lower than the catalytic rate 
constant, ii) the theoretical concentrations of E0 are different from the 
hypothetical values due to expectable reasons, such as the enzyme freezing 
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owing to the matrix entrapment, and as a consequence, iii) the ratio between the 
initial enzyme and substrate concentration is always greater than 0.1. In this 
case the analytical solution can give reasonable results only if k-1 < k2.  
 
 
 
Figure 11. Representative graphs of amperometric calibrations; the current is firstly converted 
in product concentration and then the latter is normalized for the final substrate concentration. 
Each black line corresponds to an experimental data, while the colour lines correspond to the 
fitting obtained using the developed model. 
 
Table 4. Mean reaction rates obtained for drop-cast GOx UME biosensor. In the first set of 
experiment we added (1) 2.5 µM, (2) 5 µM, (3) 20 µM and (4) 60 µM of glucose.  
# So (µM) Eo (µΜ) k1x105 (M-1s-1) k-1 (s-1) k2 (s-1) KM (µΜ) So/Eo 
1 2.5 0.48 7.61 0.173 0.285 0.602 4.81 
2 5 0.6 5.61 0.317 0.815 2.018 8.03 
3 20 3.33 5.211 1.06 3.851 9.42 6.04 
4 60 6.23 4.25 3.315 7.083 24.5 8.72 
 
Figure 12 shows the dependency of k1 (M-1 s-1), k-1 (s-1), k2 (s-1) and KM over 
different substrate concentrations. As the initial concentration of substrate 
increases the MM constant, KM, the backward (k-1) and the catalytic rate (k2) 
linearly increase. Instead, the forward rate (k1) constant decreases and its 
reduction does not follow a linear trend. The mean average value over the four 
different fits is KM = 9.13 µΜ, smaller than the corresponding value estimated 
by the classical methods. In the classical Michaelis-Menten regime, under 
homogeneous conditions, the rates are constant (independent of substrate 
concentration) because the substrate molecules are in excess and they have a 
high and equal probability to be captured by active sites of the enzyme. 
 91 
Therefore, the rate constants are not affected by the concentration of substrate. 
Whereas, the enzymatic mechanisms at microscopic point of view are linked to 
a perfect balance among the involved species: if this balance breaks down, a 
strong dependence of reaction rates on substrate concentration is generated21.  
 
 
 
Figure 12. Graphical representations of the dependency between the enzymatic reaction rates 
and the substrate concentrations. k-1, k2, and kM are increasing, while k1 is decreasing with [S0].  
 
6.3  Conclusion and Remarks 
 In investigating the most used immobilization procedures available in the field 
of biosensors for UME application, the goal of this thesis was to identify the 
most efficient methods and to select them for the coupling with SECM in order 
to study metabolism in living cells.  
Considering that the local variations of glucose concentration and the absolute 
concentration of lactate around a single cell are very low, the sensitivity is the 
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most critical parameter to take care. After assessing and comparing the different 
modification routes, we concluded that the most sensitive electrodes are the 
ones obtained by drop-casting, which have also the highest enzyme 
concentration entrapped in the hydrogel matrix used to modify the probe. Other 
advantages of this deposition route are the easy manufacturing procedure and 
the low realization costs. Additionally, in these years a procedure to fine control 
the thickness of the drop cast matrix layer was developed, achieving a good 
reproducibility of the electrodes and a good spatial resolution; reproducibility 
and cost effective procedures are essential characteristics of “disposable” 
sensors.  
Therefore, for the application of SECM toward the study of the basic 
metabolic processes, very sensitive and non-invasive drop-cast GOx and LOx 
UME biosensors were mainly employed in order to obtain glucose uptake and 
lactate release profiles of single living cells. 
 
However, considering the operational parameters of all the tested and 
manufactured biosensors, it is not possible to identify a single specific 
immobilization procedure, which optimizes all the biosensor parameters. For 
example, cross-linking with GDA gives the highest sensitivity, but it is 
mitigated by its slightly lower resolutions both temporal and spatial. Moreover, 
GDA lacks the electrochemical control on membrane growth, which is available 
with electropolymerized methods. A lot of efforts are needed to build up a 
consensual protocol for enzyme immobilization that would satisfy all the 
criteria such as low toxicity, simplicity, stability, sensitivity, fast kinetics and 
fine control of deposition.  
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Chapter 7 
In Vitro Cell Culture Models 
 
 
Abstract 
Understanding the mechanism behind the metabolic alterations, which characterize cancer cells and collocate them 
among neighbouring healthy ones, represents a promising approach for diagnosis and treatment. Ras encoding gene is 
frequently mutated in human tumors; therefore, activation of Ras pathway, in in vitro cell cultures, offers a good 
experimental system to study the molecular mechanisms of transformation. pBabe-puro-based retroviral constructs were 
used to express an oncogenic form of ras (H-RasGlycine12Valine, RasV12) in human mammary epithelial cell line: 
MCF10A. Moreover, in order to assess the efficacy of some metabolism interacting anticancer drugs, other human 
cancer cell lines were investigated, such as A549 (lung carcinoma), HeLa (cervical carcinoma) and HepG2 (liver 
carcinoma). 
 
Key words MCF10A RasV12, MCF10A pBabe, A549, HeLa, HepG2, Cell Cycle, Cell Counting, Western Blot  
 
 
7.1  Human Mammary Epithelial Cells (MCF10A)  
7.1.1 Introduction 
 
Breast cancer is one of the most common malignancies affecting women in 
Western countries1. Despite extensive research efforts worldwide for 
understanding and eradicating this type of cancer, the cellular processes leading 
to carcinogenesis have yet to be definitively elucidated. Mutations in the 
cellular genome, affecting the expression or function of protein controlling cell 
growth, differentiation and survival, are considered to be the main cause of 
cancer. Metabolic alterations have been reported as one of the main effect of 
carcinogenesis1. Identify the altered genes involved in the various tumor types 
and understand the role and the effects of these genetic mutations on cell 
metabolism would be very useful also to elucidate therapeutic target. 
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Ras 
Oncogene in 
Human 
Cancer 
A family of genes that is frequently found to lead alterations, causing cancer, is 
the one of the ras genes2. Point mutations occurring in Ras codons at the critical 
positions 12 (H-ras), 13 (K-ras), and 61 (N-ras), leading to an altered protein 
amino acid sequence, convert these genes into active oncogenes2. Ras genes can 
be found mutated in a variety of tumor types, although the incidence of ras 
activating mutations varies greatly. The highest incidences are found in 
adenocarcinoma of the pancreas, colon, lung, thyroid tumors and myeloid 
leukemia2. Despite extensive research, the signals that induce activation of Ras 
and the proteins affected by Ras in the signal transduction cascade are still not 
fully undertood. However a relationship between the presence of ras mutations 
and clinical and histopathological features of the tumor may exist. 
 
7.1.2 In vitro 
Cancer 
Model: 
RasV12 & 
pBabe 
MCF10A  
The in vitro model employed for this study is an immortalized, non-tumorigenic 
epithelial cell line derived from human fibrocystic mammary tissue (MCF10A). 
These cells are defined as "normal" breast epithelial cells as they have a near 
diploid karyotype and are dependent on hexogeneous growth factors for 
proliferation3. MCF10A cells were infected using a puromycin-resistant 
retroviral construct containing an oncogenic form of ras, H-RasVal12, (pBabe-
RasV12) or an empty vector (pBabe) used as a control4. Forty-eight hours post 
infection cells were selected using 2 µM puromycin for 4 days (for details see 
paragraph. 7.1.4).  
Human breast epithelial MCF10A cells were obtained from ATCC: crl-10317 
(American Type Culture Collection, Manassas (VA), USA).  
RasV12-transformed MCF10A cells display a slightly altered morphology 
(Figure 1a and 1b), an increased aerobic glycolysis, glucose consumption, 
lactate production and reduced respiration rate with respect to the control cells 
expressing the empty vector pBabe. Indeed, as preliminary results, we measured 
lactate release in cell culture medium, expressed in nM/cell/hour, with the 
EnzyChrome Lactate Assay kit (Bioassay Systems, see Appendix 1). As shown 
in Figure 1c, Ras cells display an amount of lactate release significantly higher 
than control cells. Moreover, O2
 
consumption rate was measured, previously in 
our lab, with an oxygraph under basal conditions using the same number of 
cells (3x106 cells/mL) in order to monitor how the expression of oncogenic ras 
results in reduced respiratory activity of these cells (Figure 1d)5.  
 101 
7.1.3 MCF10A 
Growth 
Media 
Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM)/Nutrient 
Mixture F-12 Ham (1:1) (Gibco-Life Technologies Corporation) supplemented 
with 5% horse serum, 2 mM L-glutamine, 50 U/mL penicillin/streptomycin, 
0.01 mg/mL insulin, 500 ng/mL hydrocortisone, 50 ng/mL cholera toxin and 20 
ng/mL epidermal growth factor (EGF)6. Cells were kept in incubator at 37°C, 
10% CO2, 21% O2 and split upon trypsin digestion every three or four days 
using a splitting ratio of 1:6 or 1:12 avoiding cells to reach full confluence. 
 
 
 
 
Figure 1. Transmission optical microscopy images of confluence dishes of RasV12 (a) and 
pBabe (b) MCF10A cells. Phenotypically, Ras-V12 expression resulted in altered morphology, 
including blown up and less spread shape, filopodia-like structure and loss of contact inhibition. 
(c) Lactate production and (d) basal respiration of Ras-V12 and pBabe cells. The values 
represent the means of three independent experiments ± standard error.  
 
7.1.4 RasV12 
Retroviral 
Infection 
For MCF10A cells infection, the supernatant produced by the amphotropic 
packaging cell line Phoenix were used. 24h prior transfection Phoenix cells 
were plated at 2.000.000-3.500.000 cells per 10 cm plate in DMEM, 10% 
bovine calf serum, 2 mM L-glutamine, 50 U/ml penicillin/streptomycin. 
Phoenix cells were transfected using calcium phosphate co-precipitation 
method. 5min prior transfection, to each plate of Phoenix was added 25 µM 
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chloroquine that inhibits lysosomal DNases. 15-20 µg DNA was diluted in 0.2 
M of CaCl2 solution and 0.5 mL 2xHBS was added quickly while bubbling 
vigorously with the pipettor. The mix was incubated at RT for 10 min and then 
was distributed evenly on top of the Phoenix cells. After 8h the medium of 
Phoenix cells was changed with a fresh one. 24h post transfection the target 
cells were plated in normal growth medium, 300000 cells per 10 cm plate. 48h 
post transfection the medium of target cells was replaced with the viral 
supernatant produced by Phoenix cells filtered through a 0.45µm filter and 
supplemented with 1µg/ml polybrene. 48h post infection MCF10A cells were 
selected with 2 µg/ml puromycin 4. 
 
7.1.5 Ras 
Expression 
by Western 
Blot Analysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RasV12 protein expression and Ras-induced activation of the Raf/MEK/ERK 
signaling pathway were revealed by western blot analysis of cellular protein 
extract using antibodies against ras and the phosphorylated form of ERK 
kinase, a ras downstream effector (Figure 2). Briefly, cells were washed with 
ice-cold PBS and lysed in RIPA buffer, 1 mM PMSF, and both protease and 
phosphatase inhibitors. After lysis on ice for 30 min, cells were centrifuged at 
18000 g for 15 min, and supernatants analysed for protein content. Protein 
concentration of lysates was determined by the Bradford assay (Bio-Rad). 
Equal amounts of protein were separated on Sodium Dodecyl Sulphate - 
PolyAcrylamide Gel Electrophoresis (SDS-PAGE) and transferred onto a 
PVDF Immobilon-P membrane (Millipore). SDS-PAGE and Western blotting 
were carried out by standard procedures. Membranes were blocked with 5% of 
BSA in Tris-buffered saline (TBS), 0.1% Tween20 (TBS-T) for 30 min at RT 
and probed with anti-H-Ras (C-20) (Santa Cruz Biotechnology), anti-p44/42 
MAP Kinase (Erk1/2) (Cell Signaling Technology), and anti-Phospho-p44/42 
MAPK (Thr202/Tyr204) (E10) (p-Erk1/2) (Cell Signaling Technology) 
antibody in blocking solution overnight at 4°C. After three washes in TBS-T, 
membranes were incubated 1h at RT with the appropriated horseradish 
peroxidase-conjugated secondary antibodies diluted in blocking solution. After 
three washes in TBS-T, detection was performed using enhanced 
chemiluminescence Western Blotting System (GE Healthcare). Vinculin was 
used as internal control in order to normalise for gel loading and transfer 
efficiency.  
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Figure 2. RasV12 expression transforms MCF10A cells. 
(a) Representative Western blot analysis of total protein 
lysate of MCF10A cells infected with empty retroviral 
vector (pBabe) or retroviral vector expressing RasV12 
probed with anti-total Erk1/2, anti-phosphorylated form 
of Erk1/2 (p-Erk1/2), anti-Ras and anti-vinculin 
antibodies. Cropped images were obtained from the 
same gel/blot probed sequentially with the different 
antibodies. (b) In the graph is reported the ratio of p-
Erk1/2 / total Erk1/2 as resulted from densitometric 
analysis of the blot. Protein levels were quantified by 
densitometric analysis of immunoblots using ImageJ 
software from NIH Image. 
 
7.1.6 Ras 
Expression 
by Immuno-
fluorescence 
Analysis  
 
Protein expression and the subcellular localization of Ras protein in pBabe and 
RasV12 MCF10A cells was revealed by immunofluorescence (Figure 3). 
MCF10A cells were plated on glass coverslips and subjected to immunostaining 
protocol. Briefly, cells were fixed with 4% PFA in PBS, permeabilized using 
0.1% Triton X-100, 0.2% BSA, in PBS and blocked with 2% BSA for 30 min. 
Ras staining was subsequently performed using anti-Ras primary antibody 
properly diluted in blocking solution. After incubation, cells were washed in 
PBS and stained with the appropriate anti IgG Alexa Fluor® antibody. Nuclei 
were stained with DAPI diluted in PBS, prior to final mounting using Mowiol 
(Calbiochem) or an anti-fade glycereol-based mounting medium. Slides were 
examined with a widefield fluorescence microscope and images were processed 
with ImageJ (NIH). 
 
 
 
 
Figure 3. Fluorescence images of pBabe and RasV12 MCF10A cells after immunofluorescence 
staining with anti-Ras antibody (white) and dapi nuclear dye (blue). Ras proteins are expressed 
in all cell lineages. When ras genes are “switched on” by an incoming signal, those mutated 
genes become oncogenes, that lead to activated the production of permanently activated Ras 
proteins (panel b; more fluorescent signal –white color- means more Ras proteins). 
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7.2  Other Models of Human Carcinoma Cell Lines 
7.2.1 A549 
 
 
 
 
 
 
 
 
Growth 
Media 
A549 cells are adenocarcinomic human alveolar basal epithelial cells, 
developed in 1972 through the removal and culturing of cancerous lung tissue 
in the explanted tumor of a 58-year-old male. In vitro this type of cells grows as 
a monolayer of cells, adherent or attaching to the bottom of the culture dish.  
A549 cell line is known to have a fast metabolism, causing high levels of 
lactate released7; for this reason it is widely used as an in vitro model for type 
II pulmonary cancer for assessing the efficacy of some new metabolic drugs, 
which should inhibit the lactate release during anaerobic glycolysis.  
 
Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco-
Life Technologies Corporation) supplemented with 10% fetal bovine serum 
(FBS) South-America, 2mM L-glutamine and 50U/mL penicillin/streptomycin8. 
Cells were kept in incubator at 37°C, 10% CO2, 21% O2 and were passed upon 
trypsin digestion every three or four days using a splitting ratio of 1:4 avoiding 
cells to reach full confluence. 
 
7.2.2 HeLa 
 
 
 
 
 
 
 
 
 
Growth 
Media 
HeLa cells are human cervical carcinoma epithelial cells, which were taken 
from a patient who died of cancer in 1951, Henrietta Lacks. The cell line was 
found to be remarkably durable and prolific, because these cells do not die after 
in vitro cell division. Before this “immortal” model, cells cultured from other 
cells would survive in culture only for few days. This has represented an 
enormous bond to medical and biological research. HeLa cells are known to 
have a slow metabolism comparing to other cancer cells, but still higher than 
normal cells7; the model was employed to monitor the level of lactate release 
during proliferation. 
 
Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco-
Life Technologies Corporation) supplemented with 10% fetal bovine serum 
(FBS) South-America, 2mM L-glutamine and 50U/mL penicillin/streptomycin9. 
Cells were kept in incubator at 37°C, 10% CO2, 21% O2 and were passed upon 
trypsin digestion every three or four days using a splitting ratio of 1:3 avoiding 
cells to reach full confluence. 
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7.2.3 HepG2 
 
 
 
 
 
 
 
 
 
 
 
Growth 
Media 
 
HepG2 cells are human liver carcinoma epithelial cells, derived from the liver 
tissue of a 15-year-old male with a well-differentiated hepatocellular carcinoma. 
In vitro they grow in adherence to the bottom of the culture dish, forming small 
and circumscribed groups of cells (Figure 4).  
Because of their high degree of morphological and functional differentiation in 
vitro, HepG2 cell line is a suitable model for studying intracellular trafficking 
and protein dynamics through the cellular membranes, for exploring the liver 
metabolism and for enhancing the drug targeting studies. It is worth to 
underline that these cells have a particular metabolism, since they recycle the 
lactate produced from anaerobic glycolysis in order to support their high 
proliferation (personal communication).  
 
Cells were cultured in RPMI 1640 Medium (Gibco-Life Technologies 
Corporation) supplemented with 10% fetal bovine serum (FBS) South-America, 
2 mM L-glutamine and 50 U/mL penicillin/streptomycin10. Cells were kept in 
incubator at 37°C, 10% CO2, 21% O2 and were passed upon trypsin digestion 
every three or four days using a splitting ratio of 1:3 avoiding cells to reach full 
confluence. 
 
 
 
Figure 4. Transmission optical microscopy images of HepG2 cells. Low (a) and high (b) 
magnification. 
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Chapter 8 
Investigation of  D-Glucose Uptake on Breast 
Cancer and Normal Human Cells 
 
 
Abstract 
We contributed to develop a sensitive, cheap and not invasive glucose biosensoring technique able to provide detailed 
and spatially resolved information on metabolism of cancer cells by monitoring their glucose uptake. The method is 
based on electrochemical measurements using ad hoc manufactured GOx-based UMEs used as a probe of Scanning 
Electrochemical Microscopy (SECM). This system allows the investigation the cell metabolism with high spatial and 
time resolutions, since it can resolve the electrochemical activity across the surface of a single cell and it can 
dynamically record metabolic changes in time. By SECM approach curves the UME biosensor is positioned at a known 
distance above cells, then the tip is laterally scanned at constant height to get the glucose uptake profiles of the cells and 
bi-dimensional images. With this set up, we were able to monitor the glucose consumption of both transformed and 
normal human breast epithelial (MCF10A) cells, confirming the Warburg’s observations1.  
 
Key words GOx, glucose biosensors, ACs, SECM (profiles and images), Warburg Effect, RasV12 and pBabe. 
 
 
8.1  Drop-cast 10 µm Pt GOx-based UME Biosensors 
8.1.1 Approach 
Curves 
 
As already described in previous chapter, we optimized the drop-casting method 
for the realization of GOx-based UME biosensors, achieving a very precise 
procedure in order to control the thickness of the drop-cast matrix, which is 
necessary for having a good spatial resolution, maintaining at the same time high 
sensitivity and reproducibility. In order to use SECM for the study of metabolic 
processes of cancerous cells, we employed these drop-cast GOx sensors as probes 
of our BioSECM apparatus (Chapter 4).  
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We have measured glucose uptake profiles on normal and transformed human 
breast epithelial MCF10A cells. As a reminder, MCF10A cells were infected 
either by a pBabe empty retroviral vector, used as control, and by a vector 
expressing the oncogene RasV12. RasV12 transformed cells have already been 
shown to be a good cancer in vitro model2. 
By using approaches curves (ACs) the electrode tip is positioned at a known 
distance from the plastic bottom Petri dish on which cells are cultured at low 
density to permit the imaging of single cells without interference from 
neighbouring ones. The tip-substrate separation distance is very accurately 
controlled by piezo and stepper motors, and the tip movement along the axes is 
monitored through the current response (ACs) and by the optical inverted 
microscope to minimize the risks of damaging the enzymatic film of the 
biosensor during the experiment. The optical microscope is also useful to check 
the morphology of scanned cells. During ACs we can monitor either the analyte 
(such as glucose) or a redox mediator added in the solution, which may have a 
faster feedback response at the electrode surface. The approach curves were 
performed on the dishes recording a negative feedback. Figure 1 shows a typical 
approach in which the current decreases with decreasing of the UME/dish 
distance because of the hindering of redox mediator; in this specific case we used 
[Ru(NH3)6]3+ (Ered = -0.3V vs Ag/AgCl, 3M KCl).  
 
 
 
Figure 1. Typical approach of#a#drop-cast GOx 10 µm Pt UME biosensor to the Petri dish. E"= -
0.3 V vs Ag/AgCl, 3M KCl, in PBS buffer containing 500µM of [Ru(NH3)6]3+. The current has 
been normalized in respect to the steady-state bulk current value. The vertical dashed line 
represents the point where the UME touches the Petri dish coming from the solution side.  
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 The vertical dashed line represents the point where the UME biosensor touches 
the Petri dish. The distance of UME-dish contact is defined the zero distance. The 
final current does not reach the zero value probably due to the presence of the 
enzymatic matrix. It is worth to underline that we cannot use the classical ACs 
representation, with IT vs L = d/a, because with the enzymatic coating it is 
difficult to exactly define the active part of the electrode (a). 
For approach curves performed using the glucose signal during the approach, 
which is indirectly measured by the oxidation of H2O2, secondary product of the 
catalytic reaction of the enzyme entrapped into the matrix attached at the 
electrode tip, the shape of ACs for enzyme-coated UMEs do not obey to the 
classical SECM feedback theory (Figure 2). In fact, the current decreases slowly 
and the attempts of fitting them to simple kinetically limited (or mass transfer 
limited) feedback modes for SECM did not succeed. The reason of this behaviour 
is the very complex processes occurring at the tip.  
 
 
 
Figure 2. Typical approach curve of#a#drop-cast GOx 10 µm Pt UME biosensor to the Petri dish.  
E"= +0.65 V vs Ag/AgCl, 3M KCl, in PBS buffer containing 10 µM of insulin, 0.1 mM of glucose 
and 2.5% of horse serum. The current has been normalized respect to the steady-state bulk current 
value. During ACs experiments the current is blocked at 75% of the total steady-state current 
value, in order to avoid sensor damaging.  
 
 After the approach curve, the tip is retracted at the desired distance from the dish 
using the z-axis motor controller of the SECM, and it is scanned horizontally in a 
plane parallel to the bottom Petri dish above the living cells to get their metabolic 
profiles of glucose uptake (Scheme 1). The images are carried out in constant 
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height mode. It is possible that the hydrogel matrix slightly adheres to the surface 
of the dish or the geometry of the enzymatic film can be disturbed during scans. 
For this reason, beyond the control of matrix degradation, it is necessary to 
perform calibration experiments prior and after any SECM applications, which 
clearly indicate if the UME biosensor is altered or not upon recording ACs or 
SECM scans. 
 
 
Scheme 1. Schematic representation of SECM glucose uptake profile above a single cell by mean 
drop-cast GOx-based UME biosensor. 
 
8.1.2 Glucose 
Uptake 
Profiles 
 
The amperometric current recorded at the UME tip is directly correlated with the 
local concentration of the metabolites and with the distance due to the negative 
feedback. For glucose investigation the current above single cell is lower because 
the cell is consuming glucose and its concentration locally decreases with respect 
to the bulk solution that contains 0.1 mM of glucose (Figure 3).  
The first experiments were conducted in simple PBS buffer containing 0.1mM of 
glucose, 10 µM of insulin and 2.5% of horse serum in order to have a good 
sensitivity of GOx UME biosensors, but administrating to the cells essential 
growth factors. By using cell counting and cell cycle analysis by Flow Cytometry 
(FACs), we controlled that these conditions do not affect the cellular metabolism 
of the analyzed cell line in the time required to perform the SECM measurements. 
For more details see next sections: 8.3.1 and 8.3.2. 
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Figure 3. Representative SECM measurements of glucose uptake profiles of single RasV12 
(oncogene) and pBabe (control) MCF10A cells, obtained by using a single drop-cast GOx-based 
UME biosensors in PBS buffer containing 10 µM of insulin, 0.1 mM of glucose and 2.5% of 
horse serum. E = +0.65 V vs Ag/AgCl 3M KCl. Scan speed 3 µm/s. 
 
 In order to obtain the value of concentration depletion of glucose, due to the 
uptake of single cell, the current of each scan is normalized by the current 
obtained from the calibration post SECM analysis, in which a known amount of 
analyte is added. Usually, we add 0.5 mM of glucose, in order to remain in the 
linear range of electrode sensitivity; the sensitivity in general slightly decreases 
comparing with calibrations done before SECM experiments (Figure 4).  
 
Figure 4. Drop-cast GOx UME biosensor sensitivity to glucose prior and after approach curves 
and SECM experiments. 
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Upon performing several experiments on pBabe and RasV12 MCF10A cells, 
belonging to different culturing dishes, the results show for the first time at this 
high spatial resolution, that glucose uptake is statistically higher for transformed 
cells than in normal ones, proving exactly what Warburg noticed almost 90 years 
ago (Figure 5). A value of 27.61 ± 14.33µM for RasV12 and of 14.93 ± 0.38µM 
for pBabe were obtained. For statistics, we employed different drop-cast UMEs, 
prepared with the same experimental protocol but changing enzymatic solutions. 
The standard deviation of transformed cells is larger likely due to the 
heterogeneity of Ras vector infection entity. This effect can only be noticed with 
a single cell experimental setup. 
 
 
 
Figure 5. Local variation of glucose concentrations due to the cell consumption at single cell 
level. The decrease of glucose concentration for transformed (RasV12) MCF10A cells is 27.61 ± 
14.33 µM upon 9 exp, while for normal (pBabe) MCF10A cells is 14.93 ± 0.38 µM upon 11 exp.    
 
 Considering that the cell topography is not flat, the electrode-sample separation 
distance changes during scanning and the current above the cells decreases for 
two main reasons: one is the real cell’s consumption of glucose and the other one 
is due to the cell topographical contribution, which hinders the diffusion of 
glucose to the sensor. To discriminate the topographical contribution to the 
current decrease, we adopted a strategy to record at the same time i) the molecular 
fluxes and ii) the topography of living cells using the same enzymatic probe. We 
will discuss this issue in depth in Chapter 9. However, even if those values have 
still to be corrected for the topography, the results are in line with the hypothesis 
of aerobic metabolism; in fact, the hemispherical topography of pBabe and 
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RasV12 cells are quite similar (see previous studies in Chapter 11), thus we 
expect to approximately subtract the same current values from both. 
 
8.2  Electropolymerized 10 µm Pt GOx-based UME Biosensors 
8.2.1 Approach 
Curves 
 
Although the drop-cast electrodes are more sensitive and easier to manufacture, 
they have less spatial resolution and reproducibility with respect to the 
electropolymerized ones, as discussed in Chapter 6. Therefore we employed 
electropolymerized with o-aminophenol GOx-based UME biosensors to obtain 
SECM profiles and images of local variations of glucose concentration at high 
spatial resolution. Before imaging, approach curves are performed in order to 
position the electrode tips above the single living cells without touching them 
(Figure 6). The images are carried out in constant height mode.  
 
 
 
Figure 6. Typical approach curve of an electropolymerized (o-aminophenol) GOx 10µm Pt UME 
biosensor to the Petri dish. E = +0.65 V vs Ag/AgCl, 3M KCl, in PBS buffer containing 10 µM of 
insulin, 0.1 mM of glucose and 2.5% of horse serum. The current has been normalized respect to 
the steady-state bulk current value and it is blocked at 75% of the total steady-state current.  
 
8.2.2 Glucose 
Uptake 
Profiles  
 
The amperometric current recorded at the UME is lower for RasV12 than pBabe 
MCF10A cells (Figure 7); as a consequence, the glucose uptake for transformed 
cells results, once again, higher than normal ones (Figure 8). The values of 
glucose concentration depletion, obtained with these probes, slightly increase 
compared to drop-cast biosensors. This increase is due to the fact that with a 
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thinner enzymatic layer the probe-cell working distances are smaller; therefore, 
the UME biosensor above the cell is more sensitive to little variations in glucose 
concentration due to the cell consumption. 
 
 
 
Figure 7. Representative SECM measurements of glucose uptake profiles for single cancer 
(RasV12) and normal (pBabe) MCF10A cells, obtained by using electropolymerized GOx-based 
UME biosensors in PBS buffer containing 10 µM of insulin, 0.1 mM of glucose and 2.5% of 
horse serum. E = +0.65 V vs Ag/AgCl 3M KCl. Scan speed 3 µm/s. 
 
Figure 8. Local variation of glucose concentrations due to the cell consumption at single cell 
level. The decrease of glucose concentration for cancer (RasV12) MCF10A cells is 35.61 ± 13.79 
µM upon 5 exp, while for normal (pBabe) MCF10A cells is 25.4 ± 7.23 µM upon 5 exp.    
 
8.2.3 SECM 
Imaging  
 
As aforementioned, with the electropolymerized method the spatial resolution of 
measurements considerably increases. Considering for example a RasV12 
MCF10A cell, with a diameter of 20 ÷ 40 µm; the width range of the current peak 
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of glucose uptake, using a drop-cast GOx UME biosensor, is around 150 ÷ 230 
µm, while, using an electropolymerized one the width range is 70 ÷ 125 µm, 
which is closer to the expected gradient around a cell of such dimension. Thanks 
to this feature, electropolymerized GOx UME biosensors are suitable to obtain 
SECM images of single and multiple cells, as shown in Figure 9. Comparing 
Figure 9c and Figure 9d a good correlation between the optical and the 
electrochemical images, achieved measuring the local variations of glucose 
concentration is observed.  
 
 
  
Figure 9. Representative SECM images at constant height of multiple (a) and single (b) RasV12 
MCF10A cells. (c) and (d) show the comparison between the electrochemical and the optical 
images of the same culturing dish area. SECM experiments are performed with 
electropolymerized 10 µm Pt GOx-UME biosensors in PBS buffer containing 10 µM of insulin, 
0.1 mM of glucose and 2.5% of horse serum. Scan speed 15 µm/s. E = +0.65 V vs Ag/AgCl 3M 
KCl.  
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 From Figure 9c, one can observe that two cells are missing compared to the 
optical image; probably they were either removed during the SECM analysis or 
these cells have a much lower metabolism and they cannot be visualized. 
However, from SECM images of glucose uptake we can conclude that the current 
is lowest on the top of the cell and the uptake profile is uniform around the single 
cells. Furthermore, it is possible that glucose uptake observed here is a 
combination of both diffusion and distribution profile of glucose and other 
nutrients around the single cell3. Consequently, for the study of cell metabolism 
one should acquire glucose uptake images in conjunction with measuring the 
cellular production of an analyte, such as lactate3. 
 
Electropolymerization method has many advantages, such as great spatial 
resolution and reproducibility, but i) it lacks in sensitivity, ii) the matrixes are 
more breakable, and iii) the protocol of polymer layer formation is more complex 
in respect to drop-cast. In fact, as already explained, the electrochemical 
formation of all these polymers strictly requires the exclusion of molecular 
oxygen from the electropolymerization solution, thus implying complicated 
procedures that limits their applications. For these reasons the drop-cast method is 
preferred to implement the further metabolic studies, which has a more facile 
manufacturing protocol. With this purpose, in these years we developed a 
procedure to finely control the thickness of the drop-cast matrix, achieving a very 
good reproducibility of the electrodes and a satisfactory spatial resolution, with a 
peak width in the order of 100 µm (see Chapter 9 for more details; in which we 
discuss on the cell topography contribution). 
 
8.3  Effects of Solutions Analysis on Cellular Metabolism 
8.3.1 Cell 
Counting 
 
Since we are working at single cell level, the local variations of metabolite 
concentrations are very small, in the order of micro or even submicro-molar. For 
this reason it is mandatory to use a sensor with high sensitivity, but at the same 
time the working environment should not adversely affect cell metabolism. We 
have deeply addressed this fundamental issue, by studying cell viability and cell 
cycle of our cell line model in different solutions analysis and at the same time 
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assessing the UME biosensor sensitivity in the same solution (Chapter 6). 
The most common way to assess cell viability is to count viable cells is using 
Trypan Blue exclusion method (for the experimental protocol see Appendix #2). 
Briefly, Trypan Blue is a vital dye, whose reactivity is based on the fact that the 
chromophore is negatively charged and does not interact with cell unless the 
membrane is damaged. Hence, all the cells that exclude the dye are viable.  
Figure 10 represents the cellular-growth curves of RasV12 and pBabe MCF10A 
cells in different environments: in complete MCF10A medium (with 5% of 
serum), used as control, in medium with 1% of serum or without it and in RPMI 
with 1% of serum or without (as we observed that 5% of serum interferes too 
much with our biosensors performance).   
 
 
 
Figure 10. Representative cellular-growth curves of RasV12 (upper part) and pBabe (lower part) 
MCF10A cells in different solutions: (■) complete MCF10A Medium (5% of horse serum), (●) 
Medium (1% serum), (▲) Medium (no serum), (×) RPMI (1% serum), (✭) RPMI (no serum).  
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 From the cellular-growth curves, we can assert that: a) in normal conditions 
(complete medium, full of all the nutrients), cancer (Rasv12) cells are more 
proliferative than normal ones, as expected, b) both types are affected by the 
decrease of serum concentration, but c) cancer cells suffer more this condition, 
because, while normal cells simply slow down their growth, cancer cells die, and 
d) both types are alive in RPMI within 24h from the treatment.  
For the PBS buffer + 2.5% serum, a large mortality is already observed after 6h of 
treatment, expecially for RasV12 cells. However, the complete SECM 
experiments take less than 3 hours, and we decided to check the cell cycle by Flow 
Cytometry Analysis (FACS, see next section) in order to check that durign the 
experiments cells did not arrest theri cell cycling. 
 
8.3.2 Cell 
Cycle by 
FACs 
 
The cell cycle is a series of events that lead to cell division and replication, 
consisting of four phases: G1, S, G2 and M. The activation of each phase depends 
on the proper completion of the previous one. The cell cycle starts with the G1 
phase, during which the cell increases its size, increasing their supply of nutrients 
and proteins. During the S phase the cell synthesizes DNA, and in the G2 phase it 
synthesizes proteins to prepare for cell division. Finally during the M phase 
(mitosis) the cell divides and the two daughter cells enter the G1 phase. Cells that 
have temporarily stopped dividing can enter a resting phase called G04-5. 
In cell biology Cell Cycle Analysis by Flow Cytometry (FACs, for the 
experimental protocol see Appendix #3) is a method to distinguish cells into the 
different phases. A fluorescent dye is used, such as propidium iodide (PI), which 
intercalates into DNA, and as a consequence, the fluorescent intensity of the 
stained cells is correlated with the amount of DNA they contain. As the DNA 
content of cells duplicates during S phase of the cell cycle, the relative amount of 
cells in G0/G1, S or G2/M phases can be determined, as the fluorescence of cells in 
G2/M phase will be twice as high as that of cells in G0/G14-5. 
Cell cycle anomalies can be symptoms of various kinds of cell damage (e.g. DNA 
damage) or lack of nutrients, such as serum deprivation, which cause the cell 
cycle interruption at certain points. Therefore, monitoring the cell cycle gives 
information about the cell status and the cellular balance5.  
We have analyzed the cell cycle by flow cytometry of RasV12 and pBabe 
MCF10A cells after 3h of incubation in complete medium, used as control 
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(Figure 12), in RPMI medium and in PBS + 2.5% of serum.  
These are the two main analysis solutions, which we have identified as the best 
compromises among all, in which the sensors are still sensitive and the cell 
viability is active.  
 
 
 
Figure 12. (a) Typical flow cytometric analysis for cells cycle distribution. Diagrams about the 
percentage of RasV12 and pBabe MCF10A cells in the correspondent phases: (b) G0/G1 phase, (c) 
S phase and (d) G2/M phase in the different media. 
  
After 3h we did not observe a visible variations in cell cycles due to the changing 
environment; in fact, as it is shown in diagrams of Figure 12, among all systems, 
the amount of cells in G0/G1 phase, S phase and G2/M phase are close to each 
others. It means that the metabolism is not altered during our experiments. 
However, as we have noticed extensive cell death after few hours in PBS, 
particularly in RasV12 expressing cells; therefore, we have used RPMI medium 
(without glucose) as the most suitable analysis solution. 
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Chapter 9 
Study of Cell Topographic Contribution 
 
 
Abstract 
The cell topography is not flat on the Petri dish and, as a consequence, the electrode-sample distance changes during 
scanning, complicating SECM measurements and their analysis. In this chapter, our strategy for measuring the cellular 
topographical contribution upon metabolism studies is described. We have adopted a voltage-switching mode scanning 
electrochemical microscopy in which our drop-cast enzyme based UME biosensors are used as probes to acquire, 
simultaneously, high-quality topographical and electrochemical images of living cells. This is possible by changing the 
applied potential so as to change the faradaic current from a hindered diffusion feedback signal, attributed to a redox 
mediator that does not interact with cells and suitable for distance control and topographical imaging, to the 
electrochemical flux measurement of the analyte of interest, such as glucose or lactate.  
 
Key words Topographic contribution, RasV12 and pBabe MCF10A cells, glucose, metabolism, [Ru(NH3)6]Cl3  
 
 
9.1  Voltage-Switching Mode on SECM 
9.1.1 Introduction 
 
The cell topography is not flat on the Petri dish, as a consequence, the 
electrode-sample distance changes during scanning, complicating the SECM 
measurements and their analysis. Various approaches for studying cellular 
topographic contribution have been developed and investigated in these years, 
such as AFM1-3, shear-force4-7, impedance8-11, faradaic current12-13, ion 
current14-16 and electrochemical17-19 feedback distance-control. However, most 
of the approaches require additional probe modifications for distance control or 
they lack in terms of resolution. We adopted a voltage-switching mode20-21 
developed to perform measurements of cellular topographic contribution and 
electrochemical fluxes using the same enzymatic probe.  
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9.1.2 Operational 
Strategy on 
Glucose 
Uptake 
Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In glucose analysis, current decreases above the cells for two reasons: one is the 
real consumption of glucose and the other one is due to the cell topographic 
contribution, which hinders the diffusion of glucose to the sensor.  
To discriminate between the topographic contribution and the functional 
response, we adopted a voltage-switching protocol to record at the same time i) 
the molecular fluxes and ii) the topography of living cells, using the same 
enzymatic probe. We added in the analysis solution a hydrophilic redox 
mediator, that cannot cross the cell membrane, and whose redox potential 
cannot interfere with the oxidation of hydrogen peroxide, Eox = +0.65V vs 
Ag/AgCl 3M KCl. After testing a variety of electrochemical mediators to 
control their toxicity on our cell line model, we selected hexaammineruthenium 
chloride, [Ru(NH3)6]Cl3, 500 µM as the most suitable redox mediator with a 
Ered = -0.3V vs Ag/AgCl 3M KCl (Figure 1 displays a schematic representation 
of the analytical protocol).  
We performed approach curves with our optimized drop-cast GOx UME 
biosensor by monitoring the activity of the redox mediator, which exhibits a 
pure negative feedback due to its hindered diffusion. The desired distance of 
probe from the cell surface corresponded to current diminished by 75% 
compared to bulk solution. Then the approach of probe was stopped and tip was 
scanned horizontally parallel to the bottom Petri dish passing over the cell 
surface. The current at the tip is lower above the cell than elsewhere because of 
hindered diffusion of the redox mediator, and this provide the necessary 
feedback to obtain the topographical profiles. Subsequently, a second scan was 
carried out along the same line, for the detection of metabolic fluxes, after 
switching the UME potential to +0.65V, corresponding to H2O2 oxidation 
(Figure 2). As a matter of fact, both the cell metabolic activity and topography 
contribute to determine the level of the latter signal whereas the former contains 
only the topographic contribution.  
Subtracting the topographic signal from the current measured at +0.65 V,  
(Figure 2) and normalizing those values using calibration curves recorded after 
SECM analyses, the absolute value of glucose concentration changers 
associated to cellular uptake was finally estimated.  
Adopting this protocol, cells with arrested metabolism could be discriminated 
from healthy ones (Figure 3). 
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Figure 1. Schematic representation of the two mechanisms that occur at the drop-cast GOx 
UME biosensor during SECM glucose uptake analysis. On the left there is the reaction involved 
in glucose uptake monitoring, while on the right there is the cellular topographic contribution 
measurement, performed by adding in RPMI 500 µM of [Ru(NH3)6]Cl3, as redox mediator.  
 
Voltage 
Switching 
Mode 
 
 
Figure 2. Schematic representation of a typical voltage-switching mode/SECM analysis in 
monitoring glucose uptake at single cell level. The upper part shows the mechanism and the real 
SECM measurement of cellular topographic contribution of a RasV12 MCF10A cell using 
[Ru(NH3)6]3+ as redox mediator. E = -0.3 V vs Ag/AgCl, 3M KCl. The current is directly 
correlated to the distance between the electrode surface and the cell membrane. The lower part 
shows the glucose uptake contribution of the same cell. E = +0.65 V vs Ag/AgCl, 3M KCl. The 
measurements were performed with the same drop-cast 10 µm Pt GOx UME biosensor in RPMI 
medium containing 1 mM of glucose, 10 µM of insulin and 500 µM of [Ru(NH3)6]3+. On the 
right we compare the two profiles, the currents were normalized by the respective steady-state 
bulk current values. The subtraction of the two lines gives the real of glucose concentration 
variations due to uptake of a single cancer cell that is 13 µM (Δ β-D-glucose). 
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Healthy & 
Metabolically 
Stopped Cells  
 
Living cells exhibhit two different current profiles, as described above: a higher 
one corresponding to the hydrogen peroxide oxidation current and the lower 
one due to the feedaback response of the redox mediator. The first one is linked  
to both the cellular glucose uptake and topographical contribution, while the 
second one is due only to cell topography.  By contrast, in case of 
metabollically or death cell the two profiles are perfectly superimposable, as the 
glucose metabolism of dead cells is stopped and the recorded signal is due only 
to the cellular topographical contribution, as shown in Figure 3. 
 
 
 
Figure 3. Difference in feedback between healthy cell and metabolic stopped cancer cells. Blue 
lines refer to the H2O2 detection, while red lines refer to cell topography. The measurements 
were done in 500 µM of Ru(NH3)6]Cl3,/RPMI, 1 mM of glucose and 100 µM of insulin. For 
metabolically stopped cell the profiles are identical, meaning that cell is not consuming glucose. 
 
 The number of the voltage-switching mode experiments has to be increased for 
improving the statistical analysis, but the preliminary results on RasV12 and 
pBabe MCF10A cells, obtained on different culturing dishes, confirmed that the 
cellular topographic contribution for pBabe and RasV12 MCF10A cells are 
quite similar. In this specific case, the topographical contribution calculated for 
transformed cells (RasV12) is around 45% of the total current response, while 
for pBabe it is around 69%. This issue confirms the altered morphology that we 
usually observe on cancer cells, which are commonly smaller and more 
spherical and rigid than normal cells. Therefore, after subtracting this 
contribution, the glucose uptake for cancer cells remains statistically higher 
than in normal ones, as a proof of the Warburg Effect (Figure 4). The standard 
deviation of transformed cells is larger due to the heterogeneity of Ras vector.  
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Figure 4. Statistical diagram that compares glucose concentrations locally consumed at single 
cell level before and after topographic correction. The absolute amount of glucose uptake for 
RasV12 MCF10A cells is around 15.57 ± 8.9 µM upon 4 experiments, while for pBabe 
MCF10A cells is around 4.6 ± 1.7 µM upon 2 experiments.  
 
9.1.3 Biofouling 
Correction 
 
Another important aspect to take care during the analysis of the electrochemical 
response is the biofouling of the hydrogel matrix. 
As already discussed, the outcome of equilibration times is a progressive and 
continuous reduction of the oxidation current registered at the electrode. 
Additionally, when we consider an enzymatic biosensor, several events 
detrimental to its functioning may occur, such as saturation of the enzyme, the 
depletion and/or the degradation of the hydrogel matrix, etc. Therefore, the 
sensitivity of the GOx UME biosensor to glucose may in some cases decrease 
while, at the same time, its sensitivity to the redox mediator, [Ru(NH3)6]3+ 
whose access to the active part of the electrode may be easier through the 
membrane defects, would increase or stay constant. A way to control and 
monitor this phenomenon is to perform amperometric calibrations after any 
SECM investigation using known amounts of glucose and [Ru(NH3)6]3+, in 
order to find correction factors for the data elaboration. Figure 5 shows an 
example of this treatment of experimental data, after a measurement where the 
hydrogel matrix was very damaged. The peaks due to the cell topography are 
much higher than those correlated with the glucose uptake. However, in the post 
measurement calibrations, the GOx UME biosensor current response to 
[Ru(NH3)6]3+ (Figure 5d) exhibits a sensitivity almost seven times higher than 
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that to glucose (Figure 5c) (3.42 nA per 1 mM [Ru(NH3)6]3+ versus 0.495 nA 
per 1 mM of β-D-glucose addiction). The ratio between glucose and 
[Ru(NH3)6]3+ sensitivity can be calculated, and by normalizing by this value 
both scans (Figure 5a), recorded in voltage-switching mode, the real cellular 
topographical contribution is obtained and subtracted from the metabolic 
current. This is an extreme example; usually, the degradation does not affect to 
such an extent the measurements because of the high matrix stability. 
Nevertheless, for each measurement calibration curves have to be performed to 
exactly determine the sensitivity of the biosensors. 
 
 
 
Figure 5.  Example of biofouling and fouling correction, in case of high damaged matrix. (a) 
Linescans correlated to hydrogen peroxide (lower scan) and to [Ru(NH3)6]3+ (upper scan) above 
3 RasV12 MCF10A cells. (b) Correct profiles for biofouling factor. Drop-cast GOx UME 
sensitivity to (c) 1 mM of glucose and (d) 1 mM [Ru(NH3)6]3+. 
 
9.2  Redox Mediators 
9.2.1 Redox 
Mediator 
Selection 
Aim of this paragraph is to describe the investigation performed to assess the 
suitable redox mediators for topographical control during SECM glucose and 
lactate measurements. Redox mediators used for feedback imaging must meet 
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several criteria: 1) the mediator must be nontoxic for cells, or at least over the 
time course of the experiments, 2) the mediator should not cross the cell 
membrane, 3) the redox potential of the mediator should be distinct from the 
redox potential of the analyzed species, and 4) the release of metabolites from 
the cell must not be adversely affected by the presence of the mediator.  
An extensive list of redox mediators is present in literature23; however, on the 
basis of the results of biocompatibility testing of many redox mediators only 
three of them were further investigated here: hexaammineruthenium(III) 
chloride [Ru(NH3)6]Cl3, ferrocenemethanol [FcMeOH] and potassium 
haxacyanoferrate(III) [K3(Fc(CN)6].  
 
 
Figure 6. Cell viability of (a) RasV12 and (b) pBabe MCF10A cells, measured using trypan 
blue exclusion method after treatment with 1 mM of each redox mediator.  
  
 
 
 
 
 
 
[Ru(NH3)6]3+ 
 
 
 
 
The selected mediators exhibit completely different behaviours on RasV12 and 
pBabe cells. In fact, in literature there are evidences that the cellular membrane 
in cancer cells should be more permeable than in normal ones, therefore the 
redox mediator can easily interact, influencing the viability of living systems24. 
In our experimental system [(Fc(CN)6]3- does not show any negative effect on 
cellular growth, FcMeOH reduces cell growth particularly in RasV12 
expressing cells, and [Ru(NH3)6]3+ causes high mortality within 24/48h, and the 
cells began to appear unhealthy and exhibit changes in morphology already 
after 3 hours of treatment, that is however the time required for a complete 
SECM analysis. Moreover, the redox potentials of these possible mediators are: 
+0.4 V, +0.43 V, and -0.3 V vs Ag/AgCl 3M KCl for FcMeOH, [(Fc(CN)6]3- 
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and [Ru(NH3)6]3+, respectively. Considering that the redox potential of H2O2 
detection (our biosensor's electroactive molecule) is +0.65 V, the first two 
mediators strongly influence the metabolites' analysis. Therefore, for 
monitoring the cell topography, we have decided to use [Ru(NH3)6]3+, as the 
most suitable mediator, and to limit and avoid viability concerns, its 
concentration was decreased from 1 mM to 500 µM and every experiment was 
stopped after 2h of exposure.  
Furthermore, we have performed MTT cell viability assay to verify that in our 
conditions (500 µM [Ru(NH3)6]3+ - RPMI medium) both RasV12 and pBabe 
MCF10A cells were metabolically active. 
 
9.2.2 MTT Test The MTT assay is a colorimetric assay for assessing cell viability and 
proliferation (for details on protocol see Appendix #4). The reduction of 
tetrazolium salts is widely accepted as a reliable way to examine cell viability. 
Briefly, the yellow tetrazolium MTT, (3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide), is reduced by metabolically active cells, in part 
by the action of dehydrogenase enzymes, to generate reducing equivalents such 
as NADH and NADPH. The resulting intracellular purple formazan can be 
solubilized and quantified by spectrophotometric means at a certain wavelength 
(usually between 500 and 600 nm). Figure 7 shows the results on cell viability 
after 3 h of treatment with: 1) simply medium, used as control, 2) medium with 
500 µM [Ru(NH3)6]3+, to assess the effect of the mediator on cells, 3) RPMI 
medium and 4) 500 µM [Ru(NH3)6]3+ in RPMI medium.  
The MTT cell viability assay determines the cell proliferation rate and 
conversely, when metabolic events lead to apoptosis or necrosis and the rate of 
cells death. From this analysis, we can conclude that 500 µM [Ru(NH3)6]3+ in 
RPMI medium is slightly cytotoxic compared to a standard system. It is still the 
best solution found for investigations on cellular topographic contribution and 
electrochemical fluxes investigations, adopting a voltage-switching mode and 
using the same enzymatic probe. 
It is very important to asses all of these parameters, we want to study the 
metabolic alterations on single living cells in physiological environment in 
order to evaluate the metabolism in standard conditions without, at the same 
time, loose the sensitivity of our enzyme-based UME biosensors. 
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Figure 7. MTT Test for detecting cell viability of RasV12 and pBabe MCF10A cells for 3 h of 
treatment with 1) simply medium, used as control, 2) 500 µM [Ru(NH3)6]3+ in medium, 3) 
RPMI and 4) 500 µM [Ru(NH3)6]3+ in RPMI. Absorbance measured at 570 nm. 
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Chapter 10 
Investigation of L-Lactate Release on Breast 
Cancer and Normal Human Cells 
 
 
Abstract 
A very sensitive and stable lactate biosensor able to provide detailed information on location and stage of cancer cells 
by monitoring lactate release was developed. The method is based on electrochemical measurements using ad hoc LOx-
based UMEs in conjunction with Scanning Electrochemical Microscopy (SECM). This system allows the cell 
metabolism investigation with high sensitivity, spatial and time resolutions, since it can resolve the electrochemical 
activity across the entire surface of a single cell and it can dynamically record metabolic changes in time. Using this set 
up, the lactate release of both breast cancer and normal epithelial human (MCF10A) cells was monitored, proving 
evidence about the glycolytic switching present in tumors. Moreover, this application can be very useful and powerful 
for studying the kinetics of the oncogene expression during carcinogenesis and for monitoring the efficacy of metabolic 
anticancer drugs. Levels of lactate release were investigated also in other cancer cell lines, such as A549, HeLa and 
HepG2. 
 
Key words LOx, lactate biosensors, SECM, Warburg Effect, RasV12, pBabe, anticancer drugs, kinetics of cancer 
 
 
10.1  Drop-cast 10µm Pt LOx-UME Biosensors 
10.1.1 Introduction 
 
As already mentioned in previous chapters, most invasive tumor phenotypes 
show a metabolic switching from oxidative phosphorylation to an increased 
rate of glycolysis1. This switch ensures a sufficient energy supply from 
glucose and thus high viability, even in hypoxic environments2-3. This 
metabolic situation is accompanied by: i) higher consumption of glucose, due 
to the lower efficiency in energy production by glycolysis and ii) increased 
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extracellular acidosis because of the high production of lactate and other 
acidic species3. Monitoring the level of these two molecules can give peculiar 
information about the location, the characteristics and the stage of tumors. 
Moreover, it may possible to take advantage of this peculiar metabolic feature 
of cancer cells for selective anticancer therapies4.  
In this project drop-casting method for the realization of LOx-based UME 
biosensors was optimized, achieving a very sensitive, reproducible and precise 
procedure in order to monitor the level of lactate released from one single cell 
(Figure 1a). These drop-cast LOx sensors were employed as probes of our 
BioSECM apparatus, measuring lactate release profiles on cancer and normal 
epithelial human breast MCF10A cells. As a reminder, MCF10A cells were 
infected either by a pBabe empty retroviral vector, used as control, and by 
vector expressing the oncogene RasV12, an oncogene successfully used in in 
vitro model.  
In lactate detection, the sensitivity is the most critical parameter, because the 
physiological range for single cell lactate release is very low (in the range of 
µM); for this reason a high sensitive electrode is needed. The 
electropolymerized biosensor for lactate analysis manufactured and 
characterized in this work seems to lack this property, while the drop-cast one 
is very sensitive and the protocol was deeply optimized in order to increase as 
much as possible the spatial resolution. To confirm the capability of our 
system, the results were compared, in term of analysis, with the lactate 
concentrations obtained with a classical colorimetric assay. 
 
10.1.2 Comparison 
with the 
EnzyChrom 
BioAssay Kit 
In general, lactate is generated by lactate dehydrogenase (LDH) under 
hypoxic or anaerobic conditions. Therefore, monitoring lactate level is a good 
indicator of the balance between tissue oxygen demand and utilization and is 
useful when studying cellular and animal physiology. Nowadays, one of the 
most common way to measure lactate level is a simple, direct and automation-
ready procedure based on colorimetric determination. Briefly, the lactate 
dehydrogenase catalyzes the oxidation of lactate to pyruvate; the reaction is 
accompanied by the reduction NAD+ to NADH, which consequently reduces 
a formazan (MTT) reagent, which turns its colour from yellow to purple. The 
intensity of the product colour, measured at 565 nm, is proportionate to the 
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lactate concetration in the sample (for more details see Appendix #5). 
The EnzyChromTM L-Lactate Assay Kit (ECLC-100) for the colorimetric 
analysis was used as a control in this work. The concentration of lactate in the 
culture media of both RasV12 and pBabe cells in function of time were 
measured using the assay and our drop-cast LOx sensors (Figure 1). The 
comparison and analysis of the results showed that: i) the biosensor results are 
found to tally closely with those measured by colorimetric assay and ii) 
RasV12 cells produce more lactate than pBabe ones, as we expected. This 
difference in lactate levels is visible even after 6h of monitoring; underlining 
the glycolytic switching that characterizes cancer cells. 
 
 
 
Figure 1. Diagrams of L-lactate concentrations as function of time. The concetration are 
measured in the same medium by using the drop-cast LOx UME biosensor (a) and the 
colorimetric bioassay kit (b), for RasV12 and pBabe MCF10A cells, after 3- 6- 9 and 12 h.  
 
10.1.3 Approach 
Curves 
 
 
 
To study the lactate release at single cell level, the drop-cast LOx UME 
biosensors were used as probes of our BioSECM apparatus. As for GOx 
biosensors, the electrode tip was positioned at a known distance from the 
plastic bottom Petri dish by using approaches curves. However, the 
concentration of lactate in the extracellular solution is insufficient to allow 
ACs curves; hence, a known amount of L-lactate (100 µM) was added in 
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solution and the hindered diffusion of this molecule to the sensor was 
followed while the probe is approaching the surface (Figure 2).   
It is worth to underline that also in this case the classical ACs representation 
(IT vs L = d/a) cannot be used because the exact radius of the active part of the 
electrode is difficult determined due to the presence of the enzymatic coating.  
Furthermore, the shape of ACs for enzyme-coated UMEs does not obey to the 
classical SECM feedback theory, pointing to the fact that the processes 
occurring at the UME are very complex.  
 
 
 
Figure 2. Typical approach curve of a drop-cast LOx 10µm Pt UME biosensor to the Petri 
dish in 0.1 mM lactate /RPMI medium. E = +0.65 V vs Ag/AgCl, 3M KCl. The current has 
been normalized respect to the steady-state bulk current value. During ACs experiments the 
current is blocked at 75% of the total steady-state current value, to avoid sensor damaging.  
 
10.1.4 Lactate 
Release 
Profiles 
After the approach curve, the lactate previously added was removed, in order 
to avoid interferences during analysis, then, the tip is retracted at the desired 
distance and it is moved along x or y above the live cell to get the metabolic 
profiles of lactate release. Even in this case SECM is used in constant height 
mode. The tip-substrate separation distance is very accurately controlled by 
piezoelectric and stepper motors, and the tip movement along axes is 
monitored through the optical inverted microscope to minimize the risk of 
damaging the enzymatic film of the biosensor during the experiment. The 
microscope is also useful to check the morphology of the scanned cells and the 
scan area. It is possible that the hydrogel matrix would be damaged during 
ACs, therefore it is mandatory to perform calibration experiments prior and 
after any SECM applications. 
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The amperometric current recorded at the UME probe is directly correlated 
with the concentration of the metabolite at a certain distance from the cell. For 
lactate investigation the current above single cell is higher because the cell is 
releasing lactate and its concentration locally increases with respect to the 
background solution that contains no lactate (Figure 3).  
 
 
 
Figure 3. Representative SECM measurements of lactate release profiles of single RasV12 
(cancer) and pBabe (control) MCF10A cells, obtained by using a single drop-cast (10 min 
deposition) LOx-based UME biosensor in RPMI medium. E = +0.65 V vs Ag/AgCl 3M KCl. 
Scan speed 3 µm/s. 
 
 In order to obtain the concentration values of glucose uptake for every single 
cell, the response current of each scan is normalized by the response current of 
the post-calibrations curves, in which we add 100 µM of lactate. Usually, the 
sensitivity slightly decreases comparing to calibrations done before SECM 
experiments. Upon performing several measurements on pBabe and RasV12 
MCF10A cells, belonging to different culturing dishes, we have demonstrated 
for the first time at this high spatial resolution, that lactate release is 
statistically higher for cancer cells than in normal ones, proving exactly the 
Warburg observations1 (Figure 4).  
For statistical analysis, different drop-cast electrodes were employed, which 
are prepared with the same experimental protocol but changing enzymatic 
solutions. Even here, the error bar of transformed cells is larger likely because 
of the heterogeneity of the Ras vector infection entity.  
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Figure 4. Statistical diagram that compares the lactate concentrations locally released at 
single cell level. The lactate release for cancer (RasV12) MCF10A cells is estimated to be 
1.43 ± 0.41 µM upon 20 experiments, while for normal (pBabe) MCF10A cells is estimated to 
be 0.51 ± 0.16 µM upon 27 experiments.    
 
 Although the sensitivity is very high, this specific drop-cast procedure (with 
10 minutes of hydrogel deposition) lacks in term of spatial resolution. 
Therefore, in order to increase this feature, the time of UME immersion in the 
enzymatic solution was decreased and optimized. In this way the width range 
of the current peak was reduced from 350 µm to 70 µm maintaining a great 
sensitivity (Figure 5). 
 
 
 
Figure 5. Representative SECM scans of lactate release of single RasV12 and pBabe 
MCF10A cells, obtained by using two different drop-cast LOx-based UMEs biosensors in 
RPMI medium. E = +0.65 V vs Ag/AgCl 3M KCl. Scan speed 3 µm/s. 
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 Even in lactate monitoring the electrode-sample separation distance takes a 
role, however the topographical contribution analysis of pBabe and RasV12 
cells were carried out, as reported in Chapter 11, and the results showed that 
the cell topographies are not statistically different. Therefore, this contribution 
does not affect the calculated difference of lactate release between normal and 
transformed MCF10A cells.  
 
10.2  Application #1:  
Kinetic Study on Oncogene Expression Monitoring Lactate Release 
10.2.1 Experimental 
Strategy 
 
The aim of this application is to study the kinetics of the expression and 
oncogene-induced metabolic changes during carcinogenesis. With our set up 
(BioSECM and LOx UME biosensors), the glycolytic switching (or the 
Warburg effect) as function of time can be monitored, by measuring the lactate 
production in time after microinjection of an oncogene vector, such as 
RasV12, in the cellular nucleus of normal MCF10A cells.  
In detail, the experimental strategy was the following (Figure 6):  
- MCF10A cells were plated at a proper confluence on a glass coverslips 
located in appropriated Petri dishes, equipped with a labelled grid on the 
bottom.  
- Few µL of a solution containing 80 ng of DNA RasV12 (oncogene) vector 
plus 10 ng of Red Fluorescent Protein (RFP) vector were injected in the 
nucleus of some cells, and few µL of a solution containing 80 ng of DNA 
pBabe (control) vector plus 10 ng of Green Fluorescent Protein (GFP) 
vector in the nucleus of other cells. The location of the injected cells is 
exactly known thanks to the grid on the bottom.  
- After 6h of incubation the cells started to express the fluorescent proteins 
and both red and green fluorescence was observed. Therefore, one could 
suppose that even the oncogene vector (RasV12) might be expressed, and 
the control pBabe as well. One sample was also incubated for 24 h after 
injection for further investigations. 
- SECM analysis were performed with drop-cast LOx UME biosensors on 
both injected RasV12 and pBabe cells in order to monitor if the Warburg 
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effect was already detectable (see next section, Figure 7). 
- To confirm SECM results, immunofluorescence analysis of the same 
scanned cells was performed (for the details see Chapter 7.1.6).  
This technique is commonly used in biology for visualizing the distribution 
of target molecules, such as proteins, through the sample. The method uses 
the specificity of antibodies to their relative antigens to monitor fluorescent 
dyes bound to specific biomolecules, used as targets, within a cell. 
Immunofluorescence can be also used in combination with non-antibody 
methods of fluorescent staining, for example by employing DAPI (4,6-
diamidino-2-phenylindole) to label nuclear DNA allowing identification of 
the cells. A specific anti-RasV12 antibody that binds a particular peptide, 
mapping at the C-terminus of Ras protein vector of human origin was 
employed in this analysis (Figure 8).  
 
 
 
 
 
Figure 7. Experimental strategy scheme for the study of the kinetics of the oncogene 
(RasV12) expression during carcinogenesis. The fluorescent red cells tag the cells injected 
with the oncogene vector RasV12, while the green ones tag the cells injected with the empty 
vector (pBabe), used as control. At the bottom of the Petri dish containing the coverslip there 
is a grid that allowed us to perform the analysis on the same cells using SECM. 
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10.2.2 Preliminary 
Results 
Preliminary SECM results show that after 6h of injection there was no 
difference in lactate production among MCF10A cells, MCF10A cells with 
RasV12 vector and MCF10A cells with pBabe vector. After the post-
calibration of the electrode the local concentration of lactate for the analyzed 
cells was estimated to be equal to 1.5 µM. As it is shown in Figure 8, the three 
current peaks relative to lactate release from the three cells injected and non-
injected are really similar from each other, meaning that 6h after oncogene 
microinjection were not enough to achieve the glycolytic switching. This 
observation was confirmed by the immunofluorescence analysis (Figure 9); 
indeed, after 6h the fluorescence (white) signal, relative to the Ras expression, 
was very weak. In order to appreciate an increased expression of the oncogene 
vector by immunofluorescence 24h would be required. We expect to measure 
also an increased amount of lactate release for cancer cells at the same time. 
 
 
 
Figure 8. On the right are reported the fluorescent images of the analyzed cells: (a) no-
injected (blue) and RasV12-injected (red) MCF10A cells (c) pBabe-injected (green) MCF10A 
cells. On the left the corresponding SECM measurements monitoring lactate release of (b) non 
injected and RasV12-injected MCF10A and (d) pBabe-injected MCF10A cells.  
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10.2.3 Immuno-
fluorescence 
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Figure 9. Immunofluorescence images of our samples, from 6h to 24h of incubation after 
RasV12 + RFP injection (magnification 20x and 60x). The first series of images (RFP) show 
the expression of the red fluorescent protein on the injected cells: the intensity is much higher 
after 24h than 6h. The second series of images is related to the expression of RasV12 as 
oncogene vector: also in this case the expression is higher after 24h, both in term of intensity 
and number. The last series overlay the RFP and RasV12 expression signals with DAPI 
signal, which tag the nuclear DNA present in the all cells.  
  
In conclusion, is evident that after 6 hour the onceogene expression of RasV12 
signal is very weak. At this time point also the lactate analyses performed with 
SECM and UME biosensors did not show an increased amount of lactate 
released in cancer model due to the glycolytic switching. However, for the first 
time with a BioSECM apparatus the kinetics of oncogenic expression during 
carcinogenesis was mapped with a high spatial resolution. This finding could 
be very useful in future in order to study the metabolic behaviour of cancer 
cells and metabolic anticancer drugs efficacy. 
 
10.3  Application #2:  
Efficacy of Anticancer Drugs on Lactate Release Inhibition 
10.3.1 Overview on 
Analyzed 
Drugs 
Drop-cast 10 µm Pt LOx-based UME biosensors coupled with BioSECM 
apparatus is a suitable device for monitoring the efficacy and the kinetics of 
experimental anticancer drugs on single cancer cells. 
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 Regarding metabolic anticancer drugs, there are only few molecules in 
preclinical studies or clinical trials that are known to exploit, or interfere with, 
the increased glycolytic process of invasive tumors4. However, lactate 
dehydrogenase (LDH) is considered one of the major check-point for the 
switch from aerobic to anaerobic glycolysis by catalyzing the reduction of 
pyruvate into lactate. There are two types of LDH subunits: LDH-A and LDH-
B, which differ from each other by the location in the living systems. The 
combination of them gives the structure of the five tetrameric LDH isoforms 
present in human. LDH-A4 has been found to be over-expressed in several 
highly invasive and hypoxic carcinomas. This factor, together with the 
overexpression of the main glucose transporter, further promotes glycolysis 
and it was found as a common feature in several tumor lines4. For this reason, 
LDH-A was recently proposed as one of the most promising tumor targets4. 
Indeed, repression of its expression reduces the invasiveness of cancer cell 
lines. Compounds able to inhibit LDH-A enzymatic activity may constitute 
safe agents able to interfere with tumor growth and progression. There are just 
few LDH-A inhibitors already reported in literature, but there are many under 
study4. We have deeply investigated the effects of a series of compounds 
(Figure 9) based on the same N-hydroxyindole structural motif, with the 
difference on aromatic ring substituents. We examined them looking for a 
satisfactory level of LDH-A inhibition within this chemical class.  
 
 For all of them we measured the 
concetration of lactate released in the 
culture medium and the cell viability 
upon treatment, changing several 
parameters, such as drug concentration 
(from 10 µM to 100 µM) and time 
exposure (from 15 minutes to 6 hours).  
As cell line models we used A549 
(human lung carcinoma) known to have 
a very fast metabolism, causing high 
levels of lactate released and MCF10A 
(RasV12 and pBabe).  
 
Figure 9. N-Hydroxyindoles 
designed as LDH-A inhibitors4. 
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 The aim of this analysis was to find the best condition for studying the 
efficacy and the kinetics of a metabolic anticancer drug by SECM analysis 
monitoring the level of lactate released at single cell level.  
Unfortunately, the majority of these compounds have been found highly toxic 
on our cell line models; only compounds 1i and 1j seem to block effectively 
LDH-A, reducing the lactate amount in the culture medium (Figure 10). The 
best performance is achieved after 15 min of treatment with a drug 
concentration equal to 100 µM. In particular 1j is more active in both cancer 
cell lines (A549 and RasV12), while it has not any effect on normal cells. 
 
 
 
Figure 10. Colorimetric measurement (Bio-assay kit) of LDH-A inhibition analyzed on A549 
and MCF10A cell lines. Normal (pBabe) cells do not affect the drug administration, while 
both cancer cells (A549 and RasV12) decrease their amount of lactate production. 
 
10.3.2 Results and 
Discussion 
From the diagrams of Figure 10 one can affirm that: i) A549 cell line 
effectively produces a higher concentration of lactate, compared to that 
produced by MCF10A, ii) already after 15 minutes of treatment with these 
drugs the amount of lactate for A549 and RasV12 is slightly decreased (the 
effect seems to be greater for 1j than for 1i, and iii) there is no visible 
mortality. Therefore, upon these observations, we decided to employ 1j as the 
most suitable drug in order to monitor the kinetics of lactate release inhibition 
at single cell level. We employed our drop-cast LOx-based UME biosensors 
coupled with the BioSECM apparatus. The probe, after the first scan above the 
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cells (two RasV12 MCF10A) performed at high constant mode, was 
accurately retracted at the fixed starting point. Then, the scan was 
consecutively repositioned several times after 1, 3, 5 and 10 minutes of drug 
administration (Figure 11). It is worth to underline that this kind of analysis is 
possible mainly because the UME movement is very accurately controlled by 
piezo and stepper motors, and it can be monitored with the cell morphologies 
through the optical microscope.  
As conclusion, these measurements demonstrated that the RasV12 cells 
stopped to produce lactate already after 5 minutes upon drug injection. The 
biological mechanism behind this inhibition is not exactly known, but with 
this approach the efficacy and the kinetics of a metabolic anticancer drug can 
be evaluated by studying the lactate release at single cell level. Moreover, the 
non-invasive nature of the SECM measurements opens up the possibility of 
continuously monitoring the effect of a drug dose response. This paves the 
way for choosing the most effective drug and concentration for treating an 
individual patient’s condition (personalized therapies applications). 
 
 
 
Figure 11. SECM measurements of a metabolic anticancer drug (1j) efficacy and kinetics on 
two Rasv12 MCF10A cells, using a drop-cast LOx UME biosensor. Drug concetration: 
100µM in RPMI medium. E = +0.65 V vs Ag/AgCl 3M KCl. Scan speed 3 µm/s. 
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10.4  Application #3:  
Monitoring L-Lactate Level on Other Cancer Cell  Lines 
10.4.1 HeLa and 
HepG2 cells 
Lactate 
Production 
Drop-cast LOx UME biosensors have been also demonstrated to be suitable 
devices for measuring lactate concentrations directly in cell culture medium, 
without any kind of pre-treatment, which is usually required in the 
colorimetric assay. Using our LOx biosensors, lactate release of other two 
cancer cell line models has been investigated in function of time:  
- HeLa cells (Chapter 7.2.2) are known to have a slow metabolism 
comparing to other cancer cells, but still higher than normal ones. In fact, as 
shown in Figure 11, the level of lactate released is not so high and it starts to 
slightly increase only after 48 hours of incubation. 
- HepG2 cells are very particular because they recycle the lactate released 
from anaerobic glycolysis in order to support their high proliferation. In fact, 
from Figure 11 it is evident that the amount of lactate in the first 24 hours 
decreases instead to increase to fulfil cell’s nutrients demand.  
 
 
 
Figure 11. Lactate concetration released in HeLa and HepG2 culture media, measured in 
function of time with a drop-cast LOx UME biosensors at E = 0.65V Vs Ag/AgCl. 
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Chapter 11 
Investigation on Breast Cancer Human Cells 
Oxygen Consumption  
 
Abstract 
The detection of cellular respiration activity is important for the assessment of the metabolic status of a biological cell. 
Due to its non-invasive character and high spatial resolution SECM is a powerful tool for single cell measurements. A 
flexible potential pulse profile with a time-dependent data acquisition is adopted in order to overcome some common 
limitations of single cell respiration studies performed by SECM. Differential pulse amperometry measurements were 
recorded while the tip was scanning the cells in a constant height mode. In order to investigate the respiration capability 
of cancer and normal cells a pool of drugs able to interact with the mitochondrial respiration chain were used. 
 
Key words Oxygen consumption, pBabe and RasV12 MCF10A cells, FCCP, Rotenone, uncoupling respiration 
 
 
11.1  Flexible Potential Pulse Profile  
11.1.1 Introduction 
 
 
Cellular respiration is an indicator of the metabolic activity of living cells. 
Beyond glucose and lactate levels, monitoring the local concentration of 
oxygen gives important information about the cell status1.  
The first attempt for visualizing the oxygen consumption rate of single living 
cells by mean SECM was described by Matsue et al.2 in 1998, however, 
evaluation of the respiratory activity of individual cells remains challenging 
and complex. In particular, the dimensions and the morphology irregularity 
of living cells, used as sample, lead to limitations of using the conventional 
constant-height mode for SECM investigations.  
Recently, many strategy were developed to overcome these restrictions by 
positioning the tip at a distance outside the feedback range, embedding cells 
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into cavities or subtracting the topographic contribution after cell death. To 
efficiently control the tip-sample separation researcher coupled SECM with 
other scanning probe techniques, such as AFM3, scanning ion conductance 
microscopy (SICM)4, shear-force5-6 and impendence-based7 methods.  
Although SECM distance control systems are available, the detection of the 
respiration activity of single living cells remains challenging, owing also to 
the small rate of oxygen consumption by a single cell. Indeed, only small 
current variations on the top of the cell can be measured.   
 
11.1.2 Technique Herein, an efficient experimental strategy was employed, this approach is 
based on the use of a second potentiostat to record a flexible potential pulse 
profile with time-dependent data acquisition during SECM scan at constant 
height mode8-9. This implementation enables the measurement of the O2 
consumption avoiding artifacts due to oxygen depletion inside the gap 
between the SECM tip and a living cell, caused by the UME reaction. The 
oxygen consumption and the topographic contribution of RasV12 and pBabe 
MCF10A cells, using 100µM of [Ru(NH3)6]Cl3 in the culture medium 
(without serum) (see Chapter 7.1.3), were simultaneously measured. 
All experiments were carried out directly in a 3.5 cm Petri dish located on 
the inverted microscope plate holder and constituting the electrochemical 
chamber by itself, and by mean of a 10 µm Pt UME without any coating. The 
flexible potential pulse cycle used was: a first pulse of -0.3 V kept for 1s and 
a second pulse of -0.7 V kept for 1s. This sequence was repeated for all the 
scan curve duration. Data were sampled in the second part of both first and 
second pulses, the difference between the two signals is directly reported by 
the program. However, the two separated data sets related to the first and 
second pulses are also available. The time step is chosen in order to have a 
good compromise between i) longer sample intervals with better signal 
averages and decreased noises and ii) less oxygen depletion due to the UME 
reaction for shorter time steps. In order to investigate the respiration 
capability of cancer and normal cells we used a pool of drugs able to interact 
with the mitochondrial respiration chain.  
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11.2  O2 uptake upon drug administration on MCF10A pBabe cells 
11.2.1 Results on 
pBabe O2 
Consumption 
 
The signals, related to the basal MCF10A pBabe cells O2 consumption and 
the relative topographic contribution, were measured directly in the cell 
culture medium (Figure 1a and 1b, black lines, respectively). Then, the cells 
were stimulated with p-trifluoromethoxycarbonylcyanidephenylhydrazone 
(FCCP), an uncoupling agent of the electron transport chain (ETC), which 
dissipates the proton gradient across the mitochondrial inner membrane, and 
maximize mitochondrial respiration (uncoupled state), see Scheme 1. 
Addiction of 1 µM FCCP, just after few minutes, maximizes the respiration 
rate and generated a decrease of current signal due to an increase of O2 
consumption from cells and a consequent reduction of local oxygen 
concentration. Instead, the signal at -0.3 V, which is due to the topographical 
contribution, only slightly changes (Figure 1a and 1b, green lines) upon 
FCCP administration. Successively, 1 µM rotenone was added, this drug 
interferes with the electron transport chain in mitochondria. It inhibits the 
transfer of electrons from iron-sulfur centres in complex I to ubiquinone (see 
Scheme 1). After rotenone administration the measurements show that the 
MCF10A O2 consumption decreases, (Figure 1a and 1b, red lines), while the 
current due to the cell topography is almost identical to the basal level.  
 
 
 
Figure 1. (a) O2 consumption of pBabe MCF10A cells. Profiles measured at E = -0.7V. (b) 
Cellular topographic contribution owing to the negative feedback of the redox mediator 
(100µM of [Ru(NH3)6]Cl3) recorded simultaneously at E = -0.3V. Black lines correspond to 
the basal levels, green lines after FCCP addition, and red lines after rotenone addition. 
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FCCP$causes$uncoupling$of$ETC$→$Increasing$of$the$respiratory$rate$↑$
Rotenone$causes$inhibition$of$Complex$I$→$Reduction$of$the$respiratory$rate↓$
 
Scheme 1. Mitochondrial respiratory chain or electrons transfer chain (ETC) where 
oxidative phosphorylation takes place. The process is an oxygen-dependent transmission of 
electrons down the chain, which maximize the production of ATP.  
The chain consists of five multimeric enzyme complexes (Complex I, II, III, IV and V) 
positioned along the mitochondrial membrane. FCCP is an uncoupling agent; it disrupts 
ATP synthesis by transporting hydrogen ions through a cell membrane before they can used 
to provide the energy for oxidative phosphorylation. At the beginning the cell increase the 
respiration rate, then the cell dies. Rotenone is a drug that inhibits the transfer of electrons 
from iron-sulfur centres in complex I to ubiquinone. This interferes with NADH during the 
creation of ATP. Complex I is unable to pass off its electron to CoQ, creating a back-up of 
electrons within the mitochondrial matrix. [reproduced with permission from Nijtmans et al., 
2004]10.  
 
 The comparison of the respiration activities at basal level, upon the FCCP 
(uncoupled respiration) and upon rotenone administration (inhibited 
respiration) is commonly used to assess the overall respiration capability of 
the mitochondria11. The present approach allows a study of the respiration 
activities of intact cells and single cell level. Moreover, the cells are kept in 
their adhesion state and in their original culture medium avoiding stressing 
procedures. To better compare the O2 consumption and the relative 
topographic contribution in the analysed respiratory states, the differences of 
the oxygen current signals obtained upon drug administrations in respect to 
the basal level signals (Figure 2a and 2c), and the corresponding differences 
obtained for the signals at -0.3 V were plotted (Figure 2b and 2d). 
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Figure 2. Differences on oxygen current signals obtained upon subtracting drug 
administration signals from the basal level signals: (a) FCCP-Basal and (c) Rotenone-Basal. 
Differences on the topographic current signals obtained upon subtracting drug 
administration signals from the basal level signals: (b) FCCP-Basal and (d) Rotenone-Basal. 
(e) optical image of the investigated cell area. 
 
11.3  O2 uptake upon drug administration on MCF10A RasV12 cells 
11.3.1 Results on 
RasV12 O2 
Consumption 
 
 
The O2 consumption signals and the cell topography of MCF10A RasV12 
cells at basal level were measured (Figure 3a and 3b, black lines). As for 
normal cells, the cancer cells were stimulated, firstly, with 1µM of FCCP 
and, then with 1µM of rotenone in order to measure the relative oxygen 
consumption and their cell topography. On the contrary of previous data the 
oxygen consumption does not increase after FCCP injection (Figure 3a and 
3b, green lines). While, the O2 current increases comparing to the currents 
recorded at basal level, consistently with a decrease of O2 consumption when 
rotenone is added (Figure 3a and 3b, red lines). The current due to the cell 
topography at basal level and after rotenone injection is almost identical.  
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Figure 3. (a) O2 consumption of a single RasV12 MCF10A cell. Profiles measured at E = -
0.7V. (b) Cellular topographic contribution owing to the negative feedback of the redox 
mediator (100µM of [Ru(NH3)6]Cl3) recorded at E = -0.3V. Black lines correspond to the 
basal levels, green lines after FCCP addition, and red lines after rotenone addition. 
 
 
 
Figure 4. Differences on oxygen current signals on a single RasV12 cell, obtained upon 
subtracting drug administration signals from the basal level signals: (a) FCCP-Basal and (c) 
Rotenone-Basal. Differences on the topographic current signals obtained upon subtracting 
drug administration signals from the basal level signals: (b) FCCP-Basal and (d) Rotenone-
Basal. 
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 To better compare the O2 consumption and the relative topographic 
contribution in the analysed respiratory states, the differences of the oxygen 
current signals obtained upon drug administrations in respect to the basal 
level signals (Figure 4a and 4c), and the corresponding differences obtained 
for the signals at -0.3 V were plotted (Figure 4b and 4d). In this case the 
differences are not evident due to the very weak and noisy signals. More 
experiments are planned in future in order to increase the statistics.  
 
11.4  Final Remarks 
11.4.1 RasV12 and 
pBabe Cell 
Topography 
 
Regarding RasV12 and pBabe MCF10A cell topographical contributions, the 
signal obtained at -0.3V was statistically further analyzed. The results 
demonstrated that RasV12 transformed cells and pBabe cells are not 
significantly different: the mean average of the obtained values and the 
relative standard deviations are reported in Figure 5.  
 
 
 
Figure 5. Cell topography characterisation by SECM. Average values ± SD of negative 
feedback currents, calculated as the difference between the currents on the top of the cells 
and the background currents, recorded by SECM scans in 500µM of [Ru(NH3)6]Cl3 of 
control or RasV12 transformed cells, the t-test gave a value of p>0.05 and assessed that the 
contributions are not significantly different.  
 
11.4.2 Conclusions 
 
In conclusion, the FCCP uncoupling agent increases the respiration rate of 
normal cells and does not affect the cancer cell respiration, confirming that 
mitochondria in cancer cells are already uncoupled in their basic state11. 
Mitochondrial uncoupling results in a metabolic switching from the 
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oxidative phosphorylation of pyruvate to the uncoupled oxidation of 
glutamine or other fatty acids to maintain mitochondrial function. This task 
highlights two critical concepts: first, glycolysis remains the critical pathway 
by which cancer cells meet their energy demands. Indeed, the shift is 
required by cancer cells because of the inability of uncoupled mitochondria 
to generate ATP. Second, the continued reduction of oxygen, in the absence 
of pyruvate oxidation, suggest that reactions from non-glucose carbon 
sources must be reorganized and involved in order to support the oxidation 
of fatty acids or glutamine.  
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Chapter 12 
Concluding Remarks 
 
12.1  Main Advantages and Disadvantages 
12.1.1 Innovations 
of our 
system 
 
 
 
 
 
The aim of this PhD thesis project was to study the metabolism of living cells 
with high spatial and time resolutions by monitoring mainly two important 
metabolites, such as glucose and lactate, in order to provide a better insight in 
cancer metabolism. In fact, most tumors are characterized by metabolic 
alterations, involving a shift in ATP generation from oxidative 
phosphorylation to aerobic glycolysis, also known as Warburg effect.  As a 
consequence, cancer tissues metabolize approximately tenfold more glucose to 
lactate in a given time and the amount of lactate released from cancer tissues 
is much greater than from normal ones. Therefore, the investigation of the 
above metabolic changes between normal and transformed cells may represent 
an important contribution in cancer research with great potential impact in 
clinical applications. 
We used a set up based on amperometric measurements using ad hoc modified 
GOx- and LOx-based ultramicroelectrodes biosensors used as probes of 
Scanning Electrochemical Microscopy (SECM). Enzyme-based amperometric 
biosensors coupled with SECM technique is an irreplaceable analytical 
method for the non-invasive study of metabolism at single cell level for 
several reasons.  
Among the advantages of using SECM compared to other techniques:  
! It can detect electrochemical activities across the entire surface of single 
cells with high spatial resolution; 
! It dynamically records the metabolic changes and fluxes with high 
temporal resolution; 
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! It can be used under physiological conditions; such as in cell culture 
medium, at room or physiological temperature and under atmospheric 
condition (no vacuum or inert systems required). 
As already mentioned in Chapter 6, the use of UMEs has several advantages, 
such as:  
! The response current is immune to convective effects due to the fact that 
diffusive fluxes to the small electrode disk are quite large; 
! Currents reach steady state values in relatively short times, fractions of a 
second (SECM probe can be treated as a steady-state system); 
! The ohmic potential drops in solution and in double-layer charging 
current are negligible due to the small currents that characterize most 
SECM experiments with UME probe (generally nA to pA);  
! They have very small size allowing experiments in microscopic domains, 
like living cell systems (typical cell dimensions are 20 ÷ 100 µm). 
Moreover, real-time quantitative measurements on living cells are feasible 
through the application of enzyme-based biosensors by virtue of their: 
! High selectivity toward a single analyte; 
! Possibility to improve sensitivity, time scale and information content; 
! High specificity on the recognition of particular analytes, such as glucose 
and lactate, based on their structural complementarity. 
Upon reviewing some of the major enzymatic immobilization procedures 
available in the field of enzyme-based UME biosensors to be coupled with 
SECM, one of the goals of this work was to optimize the micro-biosensor 
performances and to provide the relative experimental protocols in detail. The 
ensuing full characterization of UME biosensors was then aimed at identifying 
the most efficient ones for the metabolic studies of single living cells.  
In this regard, covalent immobilization with GDA displays suitable properties, 
such as: 
! Easy and cheap manufacturing procedure. The reagents are commercially 
available and enzyme immobilization does not require a customized 
chemical synthesis; 
! High sensitivity to the analyte of interest. With the optimized protocol, 
the drop-cast enzyme-based UMEs biosensors reach a detection limit of 
metabolites concentration in the order of 1 µM; 
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! Fast response. Indeed, we can measure differences in current response in 
the order of less than one second. Note that the response time given in 
chapter 6 is defined for variations of concentrations much larger then the 
one explored in a SECM analysis of a single cell; for the typical variation 
of concentration in a cell scan the response time is much faster then a 
second. Therefore, we are able to map metabolic variations directly when 
the tip is moving during the SECM scanning, also thanks to the fast 
enzymatic kinetics; 
! High spatial resolution. The optimized protocol gives us the opportunity 
to control almost perfectly the thickness of the enzymatic matrix. This 
parameter is indispensable in SECM imaging; 
! High reproducibility; 
! Physical and enzymatic stability (storage for 2 weeks at room 
temperature). The hydrogel matrix is not degraded by the solutions 
utilized during the measurements of living cells, even if cell media are 
often very complex; 
! Good permeability and selectivity for the analytes of interest. 
Thanks to the above described features of the manufactured electrochemical 
biosensors optimized in this work, it was possible to quantify with great 
precision and in a very reproducible way the glucose uptake and lactate 
release - at the single cell level - of either cancer or normal breast epithelial 
human cells, thus assessing the Warburg effect.  
 
A voltage-switching mode strategy was employed, in which the enzyme-based 
UMEs biosensors were used as probes to acquire, subsequently, high quality 
images of cell topography and molecular fluxes of living cells. By switching 
the applied potential it was in fact possible to measure alternatively i) the 
faradaic current generated by a redox mediator that does not interact with 
cells, suitable for distance control and topographical imaging of cell surface, 
and ii) the electrochemical fluxes of the metabolites of interest, such as 
glucose and lactate.  
The above method proved to be also very powerful, due to its ability of 
recording little analytic gradients, for studying the kinetics of the oncogene 
expression, and for monitoring the efficacy of metabolic anticancer drugs at 
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single cell level. Indeed, the procedure and protocol herein developed can be 
employed for validating the efficacy of an anticancer drug and determining its 
optimal dose by measuring the specific metabolic response upon treatment. 
 
12.1.2 Limitations 
 
 
 
However, besides all the advantages mentioned before, which make drop-
casting method suitable for biosensor applications, and considering all the 
operational parameters of the several tested biosensors, it is difficult to 
identify a single specific immobilization procedure with overall optimal 
biosensor performance. For example, GDA is slightly toxic; therefore it might 
present some limitations in vivo applications. Moreover, procedures based on 
GDA lack of the electrochemical control over membrane growth that is 
instead available with sol-gel or electropolymerization method. More efforts 
should be made to single out a method for enzyme immobilization that would 
satisfy all the criteria of low toxicity, easy manufacturing, stability, sensitivity, 
fast kinetic parameters, and precise control of membrane deposition. As 
biosensor technology continues to develop and spread among different 
laboratories worldwide, one may however expects that such an ideal 
biosensing device will emerge in the near future. 
 
12.2  Future Tasks 
12.2.1 Technology 
Upgrades 
 
 
 
Dual 
Electrode 
 
 
 
 
in vivo 
Application 
Cancer cell metabolism can be identified by the simultaneous increase of 
glucose uptake and release of lactate in the presence of normal oxygen levels.  
Definitely, monitoring simultaneously glucose uptake, lactate release and 
oxygen consumption with the same probe would be more effective and 
informative.  
With this purpose, the next upgrade of the developed system will be the 
encapsulation of two 10 µm Pt wires in a double glass capillary in order to 
obtain a dual ultramicroelectrode system. One Pt wire will be activated with 
glucose oxidase and the other with lactate oxidase to measure the 
concentration gradients of glucose and lactate. The probe would also allow the 
investigation of the cell topography. 
For the in vivo measurements, a sensor provides a reliable detection of the 
analyte concentration in the surrounding tissues and the mutual interactions 
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 with the biological medium must not influence the results. However, often the 
implanted device perturbs the environment and initiates a response.  
Therefore, for in vivo application, it is necessary to minimize the interference 
of the environment on sensor performance. Despite the use of specific 
molecular recognition elements to detect analytes, the sensors are susceptible 
to also detect endogenous electroactive molecules present in tissues such as 
uric acid, dopamine and ascorbate. Adsorption of such biomolecules and 
biofouling would decrease the sensitivity when the sensor is initially 
implanted1. The reduction of biofouling has predominantly been accomplished 
by developing particular permselective coatings on the outermost membrane 
surface, which minimally comprises the enzymatic matrix and inhibits protein 
adhesion to the surface. In literature, hydrogels1, flow-based systems, 
NafionTM 5, surfactants, o-phenylendiamine5, cellulose acetate6, polyester 
sulfonic acid and other methods have been employed with varying degrees of 
effectiveness. However, some acidic anions, such as pyruvate and lactate, are 
challenging because traditional anionic barriers, e.g. NafionTM, will also 
exclude the access of the analyte of interest1.  Alumina sol-gel have also 
proven to be an effective material for enzyme immobilization as well as to 
provide permselectivity and stability over extended periods of time and 
response times lower than 10 s1. Moreover, there are several patents that 
describe protocols to prevent biofouling5. 
One of these methods can be implemented in the enzyme immobilization 
protocol of this work to prevent protein penetration through the matrix and 
biofouling of the electroactive biosensor surface for real in vivo applications. 
 
12.2.2 Biological 
Claims 
By using the herein implemented setup, new biological claims could be 
investigated: a step forward might be the study of the transcriptional 
regulation of the Warburg effect.  
One well-defined mechanism by which numerous tumors establish the aerobic 
glycolysis, involves the transcriptional upregulation of glucose transporters 
and glycolytic enzymes that would strongly contribute to tumor progression. 
With enzyme-based UME biosensors coupled with the BioSECM apparatus, 
effects of MYC overexpression and p53 suppression could be investigated. 
Briefly, MYC is an oncogene that upregulates several glucose transporters and 
 166 
glycolytic enzymes, such as PDK1 and lactate deydrogenase A. These 
molecules enhance the Warburg effect by increasing flux of glucose through 
the glycolytic pathway and by attenuating entry of pyruvate into the Krebs 
cycle2-3. While loss of p53 causes: i) down-regulation of TP53-induced 
glycolysis and TIGAR (apoptosis regulator); ii) blockage of Cyt C oxidase-2. 
Such factors enhance the Warburg effect by simultaneously increasing flux 
through glycolysis and by decreasing oxidative phosphorylation3-4. Monitoring 
these phenomena and how they are influenced by other factors would 
represent an important contribution to cancer research also from a therapeutic 
point of view. 
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Appendix 1. AFM Setup and Technique Principles 
 Setup. Tapping Mode AFM imaging and analysis were performed using a Digital 
NanoScope IIID Multimode (Veeco, USA), instrument operated in tapping mode 
and in air (resonance frequency around 360 kHz). Images were recorded on 
different sample areas to check the surface homogeneity. The protein (GOx) was 
immobilized following protocol #4 on platinum supports consisting of glass 
substrates (11 x 11 mm2) covered with a chromium under-layer (1 ÷ 4 nm thick) on 
which a platinum layer (200 ÷ 300 nm thick) was deposited (ArrandeeTM, 
Germany). NanoScope 6.14r1 software was used for data elaboration. 
 
Technique principles. AFM is a scanning probe technique based on the use of a 
cantilever as probe, which is used to scan the investigated surfaces. In the 
proximity of the substrate, there is a deflection of the cantilever, due to the forces 
generated from the interactions between the tip and the sample, such as Van der 
Waals forces, capillary forces, chemical bonding, electrostatic and magnetic 
forces. Typically the cantilever deflection is measured by using a laser spot, which 
is reflected from the top surface of the cantilever into an array of phodiodes. AFM 
can operate in three imaging modes: contact mode, tapping mode and non-contact 
mode. Tapping mode is the most suitable approach when soft, fragile or sticky 
samples have to be analyzed, because it achieves high-resolution topographic 
images, preventing the risk of sample damaging.  
The cantilever is driven to oscillate near the surface until it begins to slightly touch 
or tap the surface at its resonance frequency, which is controlled by a small 
piezoelectric element mounted in the AFM tip holder. Selection of the optimal 
oscillation frequency is software-assisted. The oscillation amplitude depends on 
the forces acting on the cantilever when the tip comes close to the surface. This 
amplitude variation is used as a feedback signal to measure topographic changes of 
the sample substrate. Phase imaging is a powerful extension of tapping mode 
AFM, which goes beyond simple topographical mapping in order to detect 
variations in homogeneity, composition, adhesion, friction, viscoelasticity and 
other properties. Phase imaging can also act as a real-time contrast enhancement 
technique, because highlights the edges, providing clearer observation of fine 
features, which can be obscured by rough topography (height images).  
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Appendix 2. Protocol for Cell  Counting Using Trypan Blue 
 Trypan Blue is one of several stains recommended for use in dye exclusion 
procedures for viable cell counting. This method is based on the principle that live 
(viable) cells do not take up certain dyes, whereas dead (non-viable) cells do. 
Staining facilitates the visualization of cell morphology. The used protocol is: 
1. Prepare a cell suspension in a balanced salt solution (PBS); 
2. Transfer 0.4% of Trypan Blue solution (w/v) to a 96-well plate. Add 10 µL of 
the cell suspension previously diluted in PBS (x 2) and mix thoroughly;  
3. Allow to stand a couple of minutes. NOTE: If cells are exposed to Trypan 
Blue for extended periods of time, viable cells, as well as non-viable cells, 
may begin to take up dye; 
4. Use a pipette to transfer 10 µL of Trypan Blue-cell suspension mixture to one 
of the hemocytometer chambers. Carefully touch the edge of the chamber 
with the pipette tip and allow each chamber to fill by capillary action. Do not 
overfill or under-fill the chamber; 
5. Start to count all the cells in the 1 mm center square and four 1 mm corner 
squares for chamber 1. Non-viable cells will stain blue. NOTE: Count cells on 
top and left touching middle line of the perimeter of each square. Do not 
count cells touching the middle line at bottom and right sides; 
6. Repeat this procedure for chamber 2. NOTE: If greater than 10% of the cells 
appear clustered, repeat entire procedure making sure the cells are dispersed 
by vigorous pipetting in the original cell suspension as well as the Trypan 
Blue-cell suspension mixture. If less than 200 or greater than 500 cells (i.e., 
20-50 cells/square) are observed in the 10 squares, repeat the procedure 
adjusting to an appropriate dilution factor; 
7. Withdraw a second sample and repeat count procedure to ensure accuracy; 
8. CELL COUNTS: each square represents a total Vol of 0.1 mm3 or 10-4cm3. 
Since 1 cm ≈ 1 mL, the subsequent cell concentration per mL (and the total 
number of cells) will be determined using the following calculations:  
Cells per mL = the average count per square x dilution factor x 104 
Total cells = Cells per mL x the original volume of cell suspension (from 
which cell sample was removed). 
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Appendix 3. Cell  Cycle Analysis by Flow Cytometry 
 In cell biology Cell Cycle Analysis by 
Flow Cytometry (FACS) is a method 
to distinguish cells into the different 
cell cycle phases. The first step in 
preparing cells for cell-cycle analysis, 
which is the permeabilization of the 
cellular plasma membranes. Then, the 
cells are treated with a fluorescent dye 
that stains DNA quantitatively, 
usually Propidium iodide (PI). They are fixed in ethanol, but prior or during the 
staining step, the cells are commonly treated also with RNase A in order to remove 
RNAs from cells, which one would create artefacts in the results. The fluorescence 
intensity of the stained cells at certain wavelengths is correlated with the amount of 
DNA they contain. As the DNA content of cells duplicates during S phase of the 
cell cycle, the relative amount of cells in G0/G1, S or G2/M phases can be 
determined, as the fluorescence of cells in G2/M phase will be twice as high as that 
of cells in G0/G1. 
 The used protocol of PI staining is the following: 
1. Use 106 cells per sample; 
2. Wash cells once with PBS in 1.5mL Eppendorf tubes (spin down cells at 
5000rpm for 4 min); 
3. Re-suspend the obtained cells’ pellet in 300 µL of cold PBS in order to obtain 
a mono-dispersed cell suspension, with minimal cell aggregation; 
4. Fix cells by adding 300 µL of pure cold ethanol (-20°C) dropwise while 
gently vortexing; 
5. Leave cells in fixative for at least 30 min on ice (fixed cells can be kept at 4°C 
for several weeks); 
6. Wash once with 1% BSA/PBS; 
7. Re-suspend pellet in 1 mL of PI (50 µg/mL) and RNase (250 µg/mL) and 
incubate for 1h at room temperature, light protected; 
8. Keep stained cells at 4°C until FACS analysis. 
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Transfer sample to the flow cytometer and measure cell fluorescence. Maximum 
excitation of PI bound to DNA is at 536 nm and emission is at 617 nm. Blue (488 
nm) or green light lines of lasers are optimal for excitation of PI fluorescence.  
Instrumentation. FACScalibur (Beckton Dickinson) equipped with 488nm and 
633nm lasers. Cellquest PRO software was used for acquisition and analysis and 
Modfit LT3 software was used for elaboration data. 
 
Appendix 4. Cell  Viability MTT Test 
 Description. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide; 
thiazolyl blue) is a water soluble tetrazolium salt yielding a yellowish solution 
when prepared in media or salt solutions lacking phenol red. Dissolved MTT is 
converted to an insoluble purple formazan by cleavage of the tetrazolium ring by 
dehydrogenase enzymes. This water insoluble formazan can be solubilized using 
isopropanol and the dissolved material is measured spectrophotometrically 
yielding absorbance as a function of concentration of converted dye.  Active 
mitochondrial dehydrogenases of living cells will cause this conversion. Dead cells 
do not cause this change.  
Procedure. MTT (5 mg/mL) is dissolved in RPMI-1640 without phenol red. The 
solution is filtered through a 0.2 µm filter and can be stored at 2–8°C for short 
period. MTT solution is added to each culture being assayed to equal one-tenth the 
original culture volume and incubated for 4h. At the end of the incubation period 
the medium is removed and the converted dye crystals are solubilized with acidic 
isopropanol (0.04 - 0.1N HCl in absolute isopropanol).  
Measurement method. Absorbance of converted dye is measured at a wavelength 
of 570 nm with background subtraction at 630 - 690 nm.  
The MTT cell viability assay determines the cell proliferation rate and conversely, 
when metabolic events lead to apoptosis or necrosis and the rate of cells death.  
(From www.sigmaaldrich.com/technical-documents/articles/biofiles/cell-viability) 
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Appendix 5. Protocol for EnzyChrom L-Lactate BioAssay Kit  
 Description. Lactate is generated by lactate dehydrogenase (LDH) under hypoxic 
or anaerobic conditions. Monitoring lactate levels is, therefore, a good indicator of 
the balance between tissue oxygen demand and utilization and is useful when 
studying cellular and animal physiology. L-lactate is produced in only minor 
quantities in animals and measuring for L-lactate in animal samples is a means to 
determine the presence of bacterial infection.  
Simple, direct and automation-ready procedures for measuring lactate 
concentration are very desirable. BioAssay Systems EnzyChromTM lactate assay 
kit is based on lactate dehydrogenase catalyzed oxidation of lactate, in which the 
formed NADH reduces a formazan (MTT) Reagent. The intensity of the product 
color, measured at 565 nm, is proportional to the lactate concentration in samples.  
Sensitivity. Detection limit of 0.1 mM and linearity up to 1 mM L-lactate in 96-
well plate assay for cell culture samples containing red phenol.  
Measurement method. The procedure involves adding a single working reagent and 
reading the optical density (absorbance at 565 nm) at time 0 and after 20 min. 
Components. Assay Buffer [BSA/Tris(hydroxymethyl)aminomethane], Enzyme A 
[Lactate deydrogenase], Enzyme B [Diaphorase], NAD solution [b-nicotinamide 
adenine dinucleotide], MTT solution [Thiazolyl Blue Tetrazolium Bromide] and 
Standard [Lithium Lactate]. 
Procedure.  
1. Standard curve preparation: prepare 1 mL 1.0 mM L-lactate Premix by mixing 
50 µL of 20 mM Standard Reagent and 950 µL culture medium without serum. 
Dilute standard as explained in the following table.  
 
 N° Premix + Medium Vol (µL) L-lactate (mM) 
1 100 µL + 0 µL 100 2.0 or 1.0 
2 80 µL + 20 µL 100 1.6 or 0.8 
3 60 µL + 40 µL 100 1.2 or 0.6 
4 40 µL + 60 µL 100 0.8 or 0.4 
5 30 µL + 70 µL 100 0.6 or 0.3 
6 20 µL + 80 µL 100 0.4 or 0.2 
7 10 µL + 90 µL 100 0.2 or 0.1 
8 0 µL + 100 µL 100 0 
 
Transfer 20 µL standards into wells of a clear bottom 96-well plate. For samples 
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with potential endogenous enzyme activity (i.e. serum) two reactions should be 
run: one reaction with Enzyme A added and a No Enzyme A control. Serum and 
plasma should be diluted at least 2x with dH2O prior to assay. Transfer 20 µL 
sample per well in separate wells. 
1. 2. Reagent Preparation: For each sample and standard well, prepare Working 
Reagent by mixing 60 µL Assay Buffer, 1 µL Enzyme A, 1 µL Enzyme B, 10 µL 
NAD and 14 µL MTT. For the No Enzyme A control, the Working Reagent 
includes 60 µL Assay Buffer, 1 µL Enzyme B, 10 µL NAD and 14 µL MTT. 
3. Reaction. Add 80 µL Working Reagent per reaction well quickly. Tap plate to 
mix briefly and thoroughly.  
4. Read optical density for time “zero” (OD0) at 565nm (520-600nm) and OD20 
after a 20min incubation at room temperature.  
5. Calculation. Subtract OD0 from OD20 for the standard and sample wells. Use the 
∆OD values to determine the sample L-lactate concentration from the standard 
curve. For samples requiring a No Enzyme A control, subtract the ∆OD (no-
enzyme)
 
value from the ∆OD (sample)
 
and use this ∆∆OD value to determine the 
sample L-lactate concentration from the standard curve. Note: if the sample OD 
value is higher than OD for 2 mM L-lactate standard, dilute sample in water and 
repeat the assay. Multiply the results by the dilution factor.  
General Consideration. The following substances interfere and should be avoided 
in sample preparation: ascorbic acid, SDS (>0.2%), sodium azide, NP-40 (>1%) 
and Tween-20 (>1%). 
(From EnzyChromTM L-Lactate Assay Kit (ECLC-100) product document) 
 
Appendix 6. Microinjection Setup 
 DNA Microinjection was performed by mean of Zeiss Axiovert S100 Microscope 
equipped with a fully motorized micro injector (AIS2) and a Femtojet pump 
(Eppendorf). Time of injection 0.2 sec with a pressure equal to 150-200hPa. 
The cells were cultured in gridded 35mm Ø glass bottom uncoated coverslips 
(P35G-2-14-CGRD Case purchased from MatTek Corporation) which permit to 
have cells and grid on the same focal plane.  
A 10x UPlanFL 10x NA 0.30 Olympus Microscope was used to monitor the 
fluorescence, with an exposure time equal to 600 ms and a binning value of 2. 



